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 ABSTRACT 
 
C8-Arylguanine Modified Hairpin Oligonucleotides:  Synthesis, 
Conformational Analysis, and Tools for the  
Investigation of Z-DNA Formation 
 
Brian C. Train 
 
Z-DNA is the only DNA conformation that has a left-handed helical twist.  Z-DNA has 
been implicated in carcinogenesis from its role in gene expression.  Z-DNA formation has been 
linked to mutagenesis since it may play a role in genetic instability and can induce gene deletions.  
However, the specific biological role for Z-DNA in vivo remains uncertain.  Arylhydrazines are 
carcinogenic compounds that are known to form DNA adducts, although it is unknown how DNA 
adduct formation is related to their carcinogenicity.  Previous work in our lab has demonstrated 
that the formation of C8-arylguanine DNA adducts, derived from arylhydrazines, shifts the 
B-/Z-DNA equilibrium toward the Z-DNA conformation in d(CG)5 sequences.  However, our 
previous work examined the effect of two adducts in the duplex and it was unclear whether the 
two base modifications were working together to cause the equilibrium shift toward the Z-DNA 
conformation.  Here we sought to determine the conformational effects of a hairpin oligonucleotide 
sequence (d(CG)5T4(CG)5) containing only one C8-arylguanine modified base to compare with 
our previous results.   
Synthesis of C8-arylguanine modified hairpin oligonucleotides began at the nucleoside 
level and then the C8-aryl-2’-deoxyguanosine phosphoramidite was incorporated into a hairpin 
sequence (d(5’CGCGCG*CGCGTTTTCGCGCGCGCG3’) where G*= C8-arylguanine).  The 
conformational effects of a single C8-arylguanine modification on the hairpin oligonucleotide 
were determined and quantitated by a combination of NMR, CD and molecular modeling.  The 
unmodified hairpin and the previously studied unmodified double-stranded oligonucleotide were 
conformationally similar and each required ~3 M NaCl to yield a B-/Z-DNA ratio of 1:1.  The 
introduction of a single C8-arylguanine modification significantly reduced the NaCl concentration 
needed to produce a 1:1 B-/Z-DNA ratio in the hairpin.  Further, the addition of MgCl2 and 
spermine to the C8-arylguanine modified hairpin shifts the B-/Z-DNA equilibrium such that the Z 
form predominated under physiological conditions.  NMR and molecular modeling indicated the 
conformational effects produced by the C8-arylguanine modification occurred locally at the site 
of modification while CD data demonstrated that the C8-arylguanine modified base destabilized 
the B form.  Additionally, the data show that adopting the Z-DNA conformation is preferred over 
denaturation to the single-stranded form.  Finally, the conformational effects of the C8-arylguanine 
modifications were not additive and the introduction of any such modifications drive Z-DNA 
formation under physiological conditions, which may provide a novel carcinogenesis mechanism 
where DNA adducts confer their carcinogenicity through a Z-DNA mediated mechanism.   
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Chapter 1:  Introduction 
 
Deoxyribonucleic acid (DNA) has the structural flexibility to adopt many different 
conformations.  The most well-known conformations of DNA are A-DNA,1 B-DNA,2 and Z-DNA3 
(Figure 1.1), although there are also several other biologically significant conformations including 
hairpin,4,5 cruciform,6 triplex7-9 and quadruplex DNA.10,11  All of the aforementioned DNA 
conformations adopt a right-handed helix except Z-DNA, which has a left-handed helix.   
The initial discovery of Z-DNA was reported by Pohl and Jovin12 in 1972 though the 
structural nature of this conformation of DNA was unknown.  In Pohl and Jovin’s study, it was 
clear that the DNA conformation they produced gave CD spectral characteristics that were not 
consistent with A- or B-DNA.  In 1979, the term Z-DNA was first used to describe a DNA X-
RAY structure obtained when DNA was crystallized under high salt conditions.  These conditions 
produced a new form of DNA that had a ‘zigzag’ phosphate backbone and, hence, was named Z-
DNA.  Later it was confirmed by Raman spectroscopy13 that the high salt structure of DNA 
determined by Pohl and Jovin in 1972 was analogous to the crystal structure by reported Wang et 
al.3   
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In the 1980’s, Z-DNA became the subject of extensive research and at the same time 
became the source of significant debate regarding the biological significance of this DNA 
conformation.  Initially, all conditions where the Z conformation was favored over the B 
conformation were beyond the range thought to be physiologically relevant.  Thus, Z-DNA became 
thought of as an artifact of experimental curiosity and an example of the polymorphic capacity of 
DNA.14  However, during the 35 years since the first crystal structure of Z-DNA, there have been 
more than 4,000 publications leading to over 70,000 citations on Z-DNA.   
While controversy still surrounds the biological relevance of Z-DNA conformation, the 
review presented below and the original research presented herein, provides evidence in support 
of a biological role for Z-DNA and further supports a regulatory role during transcription for the 
Figure 1.1. Depictions of the major conformations of DNA.  A-DNA (left) and B-DNA (middle) adopt a 
right-handed left helix.  Z-DNA (right) is the lone conformation of DNA that adopts of a left-handed helix 
twist. 
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left-handed conformer of DNA.  Specifically, this work provides insight into the conformational 
effects generated by the introduction of C8-arylguanine modifications in oligonucleotides, the 
biological relevance of these adducts with respect to Z-DNA formation, and suggests a novel 
carcinogenic mechanism by which DNA adducts on the C8 position of guanine nucleotides confer 
their carcinogenicity through a Z-DNA mediated mechanism. 
 
A. Structural and Sequence Dependence 
 
The zigzag nature of the phosphate backbone of Z-DNA is a direct result of the 
configuration of the glycosidic group that alternates between the syn- and anti-conformation.3  A 
major structural requirement for Z-DNA formation is sequence and generally an alternating 
purine-pyrimidine (APP) repeat sequence is required.  This requirement is derived from the purines 
ability to adopt the syn-conformation about the glycosidic bond while the pyrimidines 
predominantly adopt the anti-conformation (Figure 1.2).  The d(CG)n repeat sequence has been 
demonstrated to be the most favorable Z-DNA forming sequence,15,16 however the d(CA):d(TG) 
sequence17 can also form Z-DNA as well as some other non-APP sequences.18   
 
 
 
 
 
4 
 
 
The preference for B- over Z-DNA has been ascribed to electrostatic repulsion between 
adjacent phosphate oxygen anions which are approximately one angstrom closer in the Z form.  
Consequently, Z-DNA formation requires the stabilization by external conditions.  For example, 
the unfavorable electrostatic interactions present in Z-DNA can be attenuated by screening the 
negative charges with high salt concentrations (2-4 M NaCl),19 magnesium or other divalent metal 
ions,20 spermidine and other polyamines,21,22 and other positively charged species such as Z-DNA 
binding proteins (ZBP).23,24   
 
B. Z-DNA in gene expression and transcription 
 
The most common occurrence of Z-DNA in vivo arises during transcription and is caused 
by the torsional stress produced during negative supercoiling25 though it was not until 1987 that 
this phenomena was demonstrated to have a potential biological role.  Initially, it was thought that 
the RNA polymerase rotated around the DNA helix during transcription.26,27  However Liu and 
Figure 1.2.  Illustration of the syn- (A) and anti-glycosidic bond in the deoxyguanosine nucleotide.  The anti-
conformation is the preferred conformation for the DNA nucleotides in the B form where the H1’ and C8H are away 
from each other relative the glycosidic bond.  C8-deoxyguanosine DNA adducts cause steric hindrance between the 
group at C8 and H2’ that drives the deoxyguanosine syn-conformation where the H1’ and C8H are on the same side 
as the glycosidic bond. 
A) Syn B) Anti 
1’ 
8 
8 
1’ 
2” 
2’ 
3’ 
4’ 
5” 5’ 
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Wang28 demonstrated that, in fact, the RNA polymerase drives through the middle of the DNA 
helix which in turn creates negative supercoiling behind the RNA polymerase complex.  Relieving 
the torsional stress induced by negative supercoiling provides the energy required to stabilize DNA 
in the Z-DNA conformation and therefore a role for Z-DNA in transcription was suggested.  
Further, analysis of the human genome revealed many potential Z-DNA forming sequences that 
are non-randomly located near transcription start sites.29  Subsequent studies by Wittig et al.30,31 
demonstrated that Z-DNA formation was correlated with the expression of the human oncogene 
c-MYC and Wolfl et al.32 also found Z-DNA during the transcription of human corticortopin-
releasing hormone.33  
 
Another major breakthrough was found by the Zhao lab at the NIH.  These workers 
demonstrated that Z-DNA formation was required, along with the NF1/CTF transcription factors 
and SWI/SNF/BAF complex to the promoter region, to initiate transcription of the human colony-
stimulating factor 1 (CSF1).33  This group established that the ATP-dependent subunit of SWI/SNF 
complex, BRG1, was able to induce Z-DNA formation even in the absence of transcription and 
thus the torsional strain may be the result of the nucleosome remodeling before transcription and 
not necessarily the action of the transcribing polymerase.34  The SWI/SNF chromatin remodeling 
complex is thought to regulate genes during cell differentiation, proliferation, neural development, 
hematopoietic development, malignant processes, and specifically has been identified in 
transcriptional activation of solute carrier family 11 member 1 (SLC11A1)35 and HIV-1.36  The 
SWI/SNF complexes were further shown to be recruited to target genes such as c-MYC37 and 
CCAAT/enhancer-binding protein38 or nuclear receptors39 like glucocorticoid receptor40 and 
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estrogen receptor via transcription factors.  These reports provide strong evidence for a regulatory 
role of Z-DNA in transcription.   
More recently, Mulholland et al.41 demonstrated that Z-DNA formation can occur on 
nucleosomes, contrary to previous studies that suggest that Z-DNA creates a nucleosomal 
boundary.42  Z-DNA formation within the nucleosome structure enhances the argument that Z-
DNA plays a role in gene expression as this structure may provide additional opportunities for 
protein interactions regulating gene expression even at the chromatin level.41  Regardless of 
whether Z-DNA formation prevents nucleosome reformation or initiates gene transcription, both 
can lead to overexpression of genes, a hallmark of cancer (reviewed by Santarius et al.43). 
In another system, a Z-DNA forming negative regulatory element (NRE) has been 
identified in the 5’-UTR of ADAM-12 (a disintegrin and metalloprotease).  Normal expression of 
ADAM-12 is very low but is upregulated in a number of disease states such as breast, liver, brain, 
and prostate cancer.44  In this report, the authors demonstrated that low levels of expression of 
ADAM-12 are correlated to high levels of Z-DNA-interacting protein activity with the ADAM-12 
NRE.  In contrast, low levels of Z-DNA-interacting protein activity with the NRE led to high levels 
of ADAM-12 expression.  Thus the authors suggested that there are protein(s) involved in the 
transcriptional regulation of ADAM-12.  More recently, this group confirmed the overexpression 
of ADAM-12 is correlated to the loss Z-DNA transcriptional suppression.45  These authors further 
established a novel epigenetic regulatory mechanism where a complex of three proteins, methyl-
CpG-binding protein (MeCP2) and two members of the nuclear factor 1 transcription factors 
(NF1C and NF1X), interact with the NRE in ADAM-12 thereby regulating ADAM-12 expression.  
Interestingly, nuclear factor 1 transcription factor (NF1) has been shown to target genes as well as 
Z-DNA forming regions near transcription start sites.  The NF1 was also shown to play a role in 
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the activation of the CSF1 with the above mentioned SWI/SNF remodeling complex.  Altogether 
these studies provide evidence that Z-DNA is involved in the activation of gene expression, which 
is a highly regulated, and thus when Z-DNA formation becomes dysregulated can lead to 
carcinogenic consequences. 
 
C. The Z-DNA Binding Protein Family  
 
Four proteins have been identified that belong to the Z-DNA binding protein (ZBP) family 
(ADAR1,24 ZBP1/DLM/DAI,46 PKZ,47 and E3L48).  The ZBP family of proteins all display 
specificity for the Z conformation and share structural binding motifs in the Z-DNA binding 
region.  The ZBP binding proteins have two Z-DNA binding domains, Zα and Zβ, that interact 
with the DNA backbone.  The ZBP Z-DNA binding domains contain several positively charged 
lysine and arginine residues that help to screen the negative charges of the phosphate backbone to 
stabilize the Z-DNA conformation.  Three of the ZBPs are functionally related to the interferon 
system of the innate immune response:  double stranded RNA adenosine deaminase (ADAR1), 
DNA-dependent activator of IFN-regulatory factors (DAI/ZBP1/DLM-1), and fish PKZ protein 
kinase.  ADAR1 and PKZ activity have been demonstrated as host responses to viral infections.  
For example, ADAR1 is thought to alter viral replication by deaminating the viral duplex RNA.49  
PKZ activates eIF2α to halt protein synthesis, which eventually leads to cell death.50  DAI is 
believed to be a cytosolic DNA sensor that binds foreign DNA which recruits TANK-binding 
kinase 1 (TBK1) and further activates interferon regulatory factor 3 (IRF3) and nuclear factor- κB 
(NF-κB).51-53  The fourth ZBP identified, E3L, is the virulence factor of the vaccinia virus and 
displays behavior similar to other oncogenic proteins of DNA viruses through inhibition of 
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apoptosis of the host cell.54  Since these proteins all contain structural homology, Kim and 
coworkers propose that E3L can compete with DAI to suppress gene expression of the host’s 
immune response.55   
In addition to the biological roles for these ZBP proteins, the mechanism of how ZBPs 
convert B-DNA to Z-DNA is also of great interest.  The ZBP mediated B- to Z-DNA transition, 
determined by NMR spectroscopy, was first reported for ADAR1 in 2009.56  In this report, the 
authors claim that the Zα domain of ADAR1 converted B-DNA to Z-DNA through an active-mono 
mechanism; where a single ADAR1-Zα binds to a B-DNA (d(CG)3), begins to convert it to the Z-
DNA conformation, and then a second ADAR1-Zα binds with full conversion to the Z form 
(Scheme 1.1).  A similar mechanism was suggested for E3L-Zα57, however the mechanism was 
slightly different for DAI-Zβ.58  The mechanism for DAI-Zβ proposed, instead, two DAI-Zβ 
monomers binding concurrently to convert the B-DNA structure to Z-DNA (active-di mechanism).   
 
 
More recently, studies59,60 have been performed on oligonucleotides that contain regions 
that are prone to Z-DNA formation and resistant to Z-DNA formation (i.e., non-APP B-DNA) and 
therefore a B-/Z-DNA junction can form.61  These studies provided a clearer picture of how 
ADAR1-Zα converts B-DNA into Z-DNA.  Initially, a ZBP binds to the Z-prone d(GC) repeat 
Scheme 1.1.  Proposed mechanism of the Z-DNA binding protein (ZBP) mediated B-/Z-DNA transition.  The 
currently proposed mechanism follows the red arrow and suggests that ZBPs actively induce and/or converm temp B-
DNA to the Z-DNA conformation. 
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dyad, in the B form, of the oligonucleotide.  Binding of the ZBP to the Z-DNA forming region 
causes destabilization of the adjacent portion of the oligonucleotide.  In the non-Z-DNA, B-DNA 
sequence a ‘bubble’ occurs which allows for the structural adjustments required for Z-DNA 
formation.  In particular, the purine nucleotides need to rotate about the glycosidic bond.  The 
purine nucleotides break their base pair and move outside of the helix.  The purine base then rotates 
180° (i.e., flips over) and then rotates back into the helix.  The above reports suggest that ZBPs 
bind B-DNA and actively convert it to Z-DNA, raising two intriguing questions.  First, what is the 
evolutionary advantage of producing proteins that bind selectively to Z-DNA, yet recognize 
B-DNA, only to then convert it to the Z-DNA structure?  Second, how does their biological 
function fit into their selectivity for Z-DNA structure especially in the context that the most 
common occurrence of Z-DNA arises from transcription, whether from negative supercoiling or 
nucleosome remodeling, where the ZBPs do not need to convert the B-DNA structure into the Z 
form?   
 
D. Z-DNA and Genetic Instability 
 
Genetic instability has been thought to play a role in diseases such as cancer or neurological 
disorders.  However, only recently has it been considered that the genetic instability may be the 
result from alternative, non-B-DNA structures.62  Since Z-DNA, under physiological conditions, 
is a higher energy form of DNA, Z-DNA formation has been hypothesized to be a major source of 
genetic instability.  In addition to the location of Z-DNA forming sequences at transcription start 
sites, Z-DNA forming sequences are also found near genetic ‘hotspots’ or ‘fragile sites’.  These 
regions of the genome have been shown to readily undergo double-strand breaks (DSB), 
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translocations, rearrangements and deletions.63  Initially, Z-DNA mediated genetic instability was 
observed in E. coli where incorporation of CG repeats into the bacterial DNA increased the gene 
deletion frequency.64  When CG repeats are incorporated into mammalian cells, they can stimulate 
DSBs around the Z-prone sequence which, subsequently, results in large-scale gene deletions.65  
These types of gene deletions have been found to be replication independent and therefore thought 
to be initiated by inefficient repair processes of the cleavages surrounding the Z-DNA structure.   
In addition to gene deletions, DSBs can also lead to chromosomal translocations near the 
DNA breakpoints that commonly occur in leukemia and lymphoma diseases.  Specifically these 
translocation events can occur in BCL-2,66 c-MYC67 and SCL68 genes which have been described 
as some of the most commonly translocated genes in leukemia, lymphoma, and myeloma.  Z-DNA 
forming sequences often occur at or near these breakage points on the chromosome, which are 
thought to play causative roles in acute lymphoblastic leukemia (ALL),69 non-Hodgkin’s 
lymphomas,70 chronic lymphocytic leukemia,71,72 Brukitt’s lymphomas,73 and T-cell ALL.68  
Collectively these studies provide evidence of how Z-DNA formation can lead to mutagenic 
consequences that can be correlated with several disease states.  
 
E. Chemical Modifications in the B-/Z-DNA equilibrium 
 
This review has presented evidence of Z-DNA formation in the context of biological 
events, whether it be from negative supercoiling, chromosomal remodeling via DNA unwrapping 
from the nucleosome, or stabilization from endogenous Z-DNA binding proteins.  However, 
naturally occurring or chemical modifications to the DNA bases can also alter the B-/Z-DNA 
equilibrium.  Methylation of the N7 position of guanine74 and/or C5 position of cytosine75 can 
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have a profound effect on the B-/Z-DNA equilibrium.  The methylation of N7 of guanine generates 
a positive charge which was described to help defray the negative charge repulsion in the zigzag 
phosphate backbone.  DNA with the 5-methylcytosine modifications favors the Z form which is 
mainly due to hydrophobic interactions that occur in the B form where the methyl groups protrudes 
into the surrounding aqueous environment.  In the Z form the methyl groups lie between the H1’ 
and H2’ of the adjacent 5’-guanine shielded from the solvent.   
The presence of C8-purine adducts can also cause the equilibrium to shift toward the 
Z-DNA conformer.  The DNA adducts such as bromine,76 4-aminobiphenyl,77 N-methyl-4-
aminobenzene,77 N-2-acetyl-aminofluorene78,79 or 2-aminofluorene,80 which most are formed 
from carcinogens, at the C8 position destabilize the B-DNA structure due to local steric 
interactions between the C8-adduct and the H-2’ proton of the pendant 2’-deoxyribose sugar in the 
anti-conformation.  The steric strain is alleviated in the Z-DNA conformation when the purine is 
in the syn-conformation (see Figure 1.2).  Generally, more than one of the above modifications are 
needed to destabilize the B-DNA conformation and drive Z-DNA formation.  However, a single 
base modification of C8-methylguanine81 or incorporation of a single 8-methylguanosine82 into a 
d(CG)n sequence greatly stabilizes the Z-DNA conformation.  The 8-methylguanosine 
modification stabilizes the Z conformation almost without any NaCl present.  This result was 
explained by arguing that the energy needed to stabilize the Z-DNA form was afforded by the 2’-
OH hydrogen bonding with the solvent.  In addition to the above C8-purine DNA adducts, 
alkylhydrazines and arylhydrazines can also produce DNA adducts and thus represent an important 
class of DNA adducts.  These adducts are the primary focus of the work presented here, specifically 
C8-arylguanine DNA adducts. 
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1. The Effect of Arylhydrazines on the B-/Z-DNA equilibrium 
 
Arylhydrazines are class of biologically relevant compounds and while many are known 
carcinogens it is unclear how DNA adduct formation from arylhydrazines relates to their 
carcinogenicity.83  These chemicals are important due to their potential for human exposure since 
an arylhydrazine is found in the Agaricus bisporus mushroom84-86 and related compounds are also 
found in azo dyes,87 pharmacueticals,88 and industrial areas.89  In 1996, it was proposed that C8-
arylguanine adducts can form in DNA through production of aryl radicals after reduction of the 
corresponding arenediazonium ions (Scheme 1.2).90   
 
One year later it was shown that aryl radicals are indeed the result of arylhydrazine 
metabolism, supporting the initial proposal that C8-arylguanine adduct formation occurs directly 
from aryl radicals.91  In addition, it was reported that C8-arylguanine formation can also lead to 
significant depurination92 in calf thymus DNA.  Kohda et al. showed that incorporation of the C8-
Scheme 1.2.   Mechanistic scheme for the formation of aryl radicals from arylhydrazines.  Here we will focus on the 
formation of C8-aryl-2’-deoxyguanosine modifications. 
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phenyl modification can block DNA polymerase action, however it was also demonstrated that 
GT and GC transversions can occur in addition to two-base deletions.93  In addition to the C8-
phenylguanine modification, several other C8-arylguanine DNA adducts have been found to have 
mutagenic and/or carcinogenic potential.90-92,94-97  Taken together, C8-arylguanine modifications, 
derived from exposure to arylhydrazines, bioactivation to arenediazoniums, and then to aryl 
radicals that readily react with DNA, may be related to their genotoxic and carcinogenic potential.  
However the specific mechanism(s) of action remains unclear.83 
Recently we demonstrated that the C8-arylguanine modification shift the  
B-/Z-DNA equilibrium toward the Z-DNA conformation.98-100  This modification was 
incorporated into d(CG)5 sequences (d(CGCGCG*CGCG) where G* = C8-arylguanine, Figure 
1.3).  The modified bases were shown to drive Z-DNA formation because they generate 
unfavorable steric and/or electronic interactions with the phosphate backbone when in the B-DNA 
conformation.   
 
 
Figure 1.3.  Structure of C8-aryl-2’-deoxyguanosine.  Five C8- aryl-2’-deoxyguanosine were studied in this work:  
C8-phenyl-2’-deoxyguanosine (R=H), C8-tolyl-2’-deoxyguanosine (R=CH3), C8-methoxymethylphenyl-2’-
deoxyguanosine (R=CH2OCH3), C8-hydroxymethylphenyl-2’-deoxyguanosine (R=CH2OH), and C8-
carboxyphenyl-2’-deoxyguanosine (R=COOH). 
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Our previous studies revealed several key observations.  First, C8-arylguanine modified 
bases in (CG)5 oligonucleotides significantly reduces the sodium chloride concentration required 
to observe the Z-DNA conformation, although only the C8-carboxyphenyl modification rendered 
the oligonucleotides in the Z-DNA conformation under physiological sodium chloride 
concentrations.  Second, the modified oligonucleotides displayed a much lower melting 
temperature (TM) than the unmodified (CG)5 decamer when in the B form and further exhibited 
other unique TM behaviors.  In particular, in response to increasing salt concentration the modified 
oligonucleotides displayed a further decrease in TM near the transition concentration (Tc; the salt 
concentration required to for a 1:1 B-:Z-DNA ratio).  Finally, the C8-arylguanine modified base 
stacks over the adjacent 5’-cytosine in the B form observed by noting the large upfield shifts of 
the C8-aryl protons of the modified base and the adjacent C5-H5/6 protons in the 
1H NMR 
spectrum.  Molecular dynamics simulations supported the stacking geometry between the C8-aryl 
group and C5 and also between the purine components of the two modified bases.  The latter 
interaction generates significant local distortion at the modified base step.  Taken together these 
data suggested that the C8-arylguanine modified bases produce large conformational changes in 
the oligonucleotide structure when in the B form but does not alter the Z-DNA conformation.   
The palindromic nature of these oligonucleotide sequences leads to two modified bases in 
the duplex.  Therefore, it could not be determined if the conformational preferences these 
oligonucleotides displayed are due to one C8-arylguanine modification or if two modified bases 
generate additive or synergistic conformational effects.  The work presented herein sought to 
clarify the conformational effects of the C8-arylguanine modifications. To accomplish this goal 
we utilized a DNA hairpin with the sequence 5’-CGCGCG*CGCGTTTTCGCGCGCGCG-3’, 
where G*=C8-arylguanine.  The hairpin forms an intramolecular double-stranded d(CG)5 stem 
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connected by a loop of four thymidines and was prepared such that it contained only one C8-
arylguanine modified base.  Thus, by determining the conformational preferences of this hairpin 
oligonucleotide, and in comparison to our previous work, the effect(s) of a single C8-arylguanine 
base modification can be assessed.  The section below will describe how and why a hairpin DNA 
can be utilized to effectively compare the conformational effects of a modified oligonucleotide 
with one or two C8-arylguanine modified bases. 
 
F. Hairpin DNA 
 
Investigation of hairpins has focused on their significance in tRNA and therefore most of 
what is known regarding hairpins is RNA based.5,101  Early studies concluded that hairpins were 
most stable with homonucleotide loop sizes of six or seven bases and it was proclaimed a rule for 
hairpin formation that the loop size contain greater than six nucleotides.  However, as the 
knowledge of the field progressed it became more accepted that initial conclusions were more 
likely based on a unique case rather than the prevailing rule.102   
Studies investigating DNA hairpins, initially discovered by Scheffler et al. in d(AT)n DNA 
oligomers,4 were rejuvenated as synthetic procedures for oligodeoxynucleotides evolved and 
commercially available automated DNA synthesizers became more widely available.   Subsequent 
studies were performed to investigate the thermodynamic properties of DNA hairpins and duplex-
hairpin transitions.103  Attention has been given to the role of the loop size104 and composition105 
in this dynamic process.106  Through the use of NMR spectroscopy the authors of these studies 
utilized two-dimensional techniques to determine the spatial relationships of the hairpin and 
duplex structures as well as the interconversion rates between the two forms as a function of 
temperature, salt concentration and strand concentration.107,108  It was found that DNA hairpin 
16 
 
oligonucleotides generally exhibit a two-state transition where loops with four or five bases are 
the most stable.109,110  Subsequently a series of publications by Haasnoot et al. suggested a model 
for the prediction of the loop folding and overall stability of DNA hairpins, though this particular 
model was designed for loops comprised of only thymidines.111,112  Breslauer and coworkers113 
later found that hairpins with tetraloops were most stable (i.e. TM) when the loops were comprised 
of only thymidine bases and the rank order of stability was primarily a result of steric bulk of the 
nucleotides (T > C > G > A).113  These studies further provided evidence that the presence of a 
hairpin loop does not have a significant impact on the duplex (stem) portion of the hairpin 
oligonucleotide and therefore provides a system to compare with double-stranded 
oligonucleotides.   
While there was considerable investigation into the stability of the hairpin loop with respect 
to size and composition, there were also several groups that investigated the conformational 
preferences of the stem portion of the hairpin.  In particular, Germann and van de Sande undertook 
a study to determine if the hairpin loop would provide an energy barrier that would prevent the B- 
to Z-DNA transition.114   In this study the authors determined that the hairpin (d(CG)5T4(CG)5) 
was able to undergo a B- to Z-DNA conformational change and concluded that the loop (T4) had 
only a small effect on the B-/Z-DNA equilibrium as the hairpin required slightly higher NaCl and 
MgCl2 concentrations to induce the Z-DNA conformation.  Subsequent studies by van Boom and 
coworkers,115-118 confirmed that hairpins (d(CG)3Tn(CG)3) were able to undergo a B-/Z-DNA 
transition and the presence of a T4 or T5 loops do not affect the conformational transition energy.  
Importantly their work provided a framework for quantifying the mole fractions of the major 
conformations in solution (B-, Z-, and ss-DNA).  In turn, this information can be used to accurately 
determine the thermodynamic parameters for B- to Z-DNA oligonucleotide transitions.  This 
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experimental approach will be discussed in greater detail in the subsequent experimental 
techniques section.  These reports helped further substantiate that hairpin stability is influenced 
not only by the loop composition but also by the composition of the stem sequence.107,117,119,120  
Further these reports demonstrated that the thermodynamics in the B- to Z-DNA transition 
observed in the hairpin systems were similar to the double-stranded counterparts. 
Around the time Wolk et al. determined structures for B- and Z-DNA loops by NMR,121 
Chattopadhyaya et al. were able to solve the crystal structure of a DNA hairpin, which displayed 
a Z-DNA stem.122,123  In addition, Xodo et al. measured TM, ΔH, ΔS and ΔG of the B- and Z-DNA 
forms of hairpins with loop sizes of two, three, and four thymidines and variable length CG 
palindromic stems (d(CG)nTn(CG)n).  The B and Z hairpin forms were found to be most 
energetically similar to the double-stranded forms when the loop contained four thymidines.  
Furthermore, a loop with four thymidines does not appear to alter the conformation of the double-
stranded portion when compared to same sequence lacking the loop (e.g., (d(CG)5)2 vs. 
d(CG)5T4(CG)5)).
118   Therefore, the hairpin oligonucleotides used here are expected to be a 
suitable model for determination of the conformational effects of a single base modification 
(Figure 1.4). 
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G. Summary 
 
Z-DNA has been found in many biologically relevant events that suggest a role for Z-DNA 
in gene expression that may be related to carcinogenesis and genetic instability leading to 
mutagenesis.  Further, several chemical modifications from known carcinogens can to lead to C8-
guanine adducts in DNA though it is unclear how C8-guanine DNA adduct formation relates to 
their carcinogenicity.  Here the conformational analysis of a hairpin oligonucleotide modified with 
a single C8-arylguanine and compare to previous results by our group will be described.  Further, 
these oligonucleotides are stable in the Z form near or at physiological salt conditions and therefore 
can be utilized to further clarify the Z-DNA binding protein mediated B-/Z-DNA transition 
enabling experiments that, to date, cannot and have not been performed.  Together these results 
may suggest a role for Z-DNA in arylhydrazine carcinogenesis.  Subsequent chapters will describe 
the experimental techniques used to obtain the experimental and computational results that allow 
for a discussion of how the C8-arylguanine DNA adduct drives the B-/Z-DNA equilibrium toward 
Figure 1.4.  Comparison of double-stranded (A) and hairpin (B) oligonucleotides.  The use of these two 
oligonucleotide systems enable the comparison of the conformational effects between one and two modified 
C8-arylguanine bases. 
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the Z-DNA conformation which may result in carcinogenic and/or mutagenic consequences in 
vivo.   
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Chapter 2:  Experimental Techniques and Approach 
 
C8-aryl-2’-deoxyguanine modified bases are not commercially available.  The single C8-
arylguanine modified hairpin requires synthesis beginning at the nucleoside level.  The modified 
nucleoside is subsequently converted to the functionalized C8-aryl-2’-deoxyguanine modified 
phosphoramidite used in the hairpin oligonucleotide synthesis.  In this chapter, the synthetic steps 
for production of the C8-aryl-2’-deoxyguanine modified phosphoramidite and how it is used in 
oligonucleotide synthesis by the DNA synthesizer will be described.   
After oligonucleotide synthesis, the hairpin requires purification before structural 
characterization.  In addition, the experimental techniques used to characterize the C8-arylguanine 
modified hairpin oligonucleotide including electrospray ionization-mass spectrometry (ESI-MS), 
circular dichroism (CD) and nuclear magnetic resonance (NMR) will also be described.  Using 
these techniques, one can compare the conformational effects of one versus two C8-arylguanine 
modified bases on an oligonucleotide sequence. 
The synthesis of the C8-aryl-2’-deoxyguanine modified nucleoside has been reviewed 
extensively by Thomsen et al.124  The C8-aryl-2’-deoxyguanine phosphoramidites synthesis 
begins with 2’-deoxyguanosine and in five steps is converted to the C8-aryl-2’-deoxyguanosine 
modified phosphoramidite (Scheme 2.1).125  This product is then incorporated into the  
hairpin oligonucleotide sequence.  The conversion of the 2’-deoxyguanosine to 
8-bromo-2’-deoxyguanosine (1) is achieved via reaction with N-bromosuccinimde (NBS).  
Compound (1) is then converted to C8-aryl-2’-deoxyguanosine (2) using the Suzuki coupling 
reaction.  The exocyclic amine is then converted to a N,N-dimethylformamidine to yield 3.  The 
5’-hydroxyl is protected as the dimethoxyltrityl (DMTr) ether, 4.  Finally the 3’-hydroxyl is 
phosphitylated to give the C8-aryl-2’-deoxyguanine phosphoramidite 5.  
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A. Suzuki coupling to produce the C8-aryl-2’-deoxyguanosine 
 
The C8-aryl-2’-deoxyguanosine modified base is readily produced via the Suzuki 
coupling, however this was not always the case.  Initial studies involving C8-arylguanine DNA 
modifications,90 such as the one performed by Kodha et al.,93 required the use of hazardous 
conditions to make the carcinogenic arenediazonium ions to transfer the aryl group to the 
2’-deoxyguanosine.  In this study, the benzenediazonium ion was produce via reaction of aniline 
and NaNO2, which was further reacted with the 2’-deoxyguanosine to generate the 
Scheme 2.1:  Synthesis of the C8-aryl-2’-deoxyguanosine modified phosphoramidite.  i) Arylboronic acid, 
Pd(OAc)2, TPPTS, Na2CO3, 2:1 H2O:Acetonitrile at 80 °C.  ii) N,N-Dimethylformamide dimethyl acetal in methanol. 
iii) 4,4’-Dimethoxytrityl chloride in pyridine and triethylamine.  iv) 2-Cyanoethyldiisopropylchlorophosphoramidite 
in methylene chloride and triethylamine. 
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C8-phenyl-2’-deoxyguanosine.  In addition to the necessity of working with carcinogenic 
chemicals in this synthetic route, nitrogen is a by-product making the reaction mixture difficult to 
contain due to foaming and, after workup, produced relatively low yields (< 40 %).  Further this 
procedure may not be compatible with a variety of phenyl substituted derivatives and therefore an 
alternative approach was desirable.   
It had been known from the extensive work of Suzuki and coworkers that palladium 
catalyzed cross-coupling reactions, the Suzuki126,127 coupling reaction, can be utilized to generate 
new carbon-carbon bonds.  However, this procedure was not utilized to generate modified 
nucleosides until late 1990s.  More recently, this coupling has been extensively used to site-
specifically incorporate DNA modifications into DNA sequences as a model to examine the 
carcinogenic consequences of DNA adducts.128  Since the Suzuki coupling works by connecting 
the carbon atoms between an organoboron species and organohalide species, it is expected to be 
readily applicable to the cross-coupling of a C8-halonucleoside (1) and arylboronic acid compound 
to produce our desired C8-aryl-2’-deoxyguanosine (2).  Since the synthesis of 
8-bromo-2’-deoxyguanosine has been reported129 and a variety of arylboronic acids are 
commercially, this reaction makes a logical choice for the production of  
C8-aryl-2’-deoxyguanosine nucleosides.   
The major obstacle to the success of this reaction is the proper choice of catalysts, which 
we have established through our work with collaborators at the University of Alabama.128,130   
Based on previous studies by the Shaughnessy lab131 it was determined that palladium acetate 
(Pd(OAc)2), in combination with tris-(3-sulfonatophenyl)phosphine (TPPTS) catalyst, in a 
biphasic solvent system (2:1 water: acetonitrile) at 80 °C resulted in excellent yields for a variety 
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of C8-aryl-2’-deoxyguanine modified nucleosides.  These conditions were used here in the first 
synthetic step, shown in Scheme 2.1.   
The general mechanism of the Suzuki couple reaction is depicted in Scheme 2.2.  The 
reaction cycle begins with the halonucleoside reacting with the Pd(0) catalyst by oxidative addition 
to form an aryl palladium (II) halide intermediate.  The nucleophilic base can react with the 
arylpalladium (II) halide to generate an arylpalladium (II) hydroxide.  The basic component of the 
reaction mixture, here a hydroxide, also attacks the boron of the arylboronic acid to produce an 
arylboron-ate complex.  The arylboron-ate and the arylpalladium (II) hydroxide then reacts to form 
a diarylpalladium (II) complex.  After reductive-elimination, the desired biaryl product (C8-aryl-
2’-deoxyguanosine) and results regeneration of the Pd(0) catalyst occurs and the Suzuki coupling 
catalytic cycle can begin again.   
Scheme 2.2:  The general mechanism of the Suzuki coupling used to make C8-aryl-2’-deoxyguanosine nucleosides. 
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B. C8-Aryl-2’-deoxyguanosine protection and functionalization 
 
As depicted earlier in Scheme 2.1, after adding the desired aryl group onto the C8 position 
of the 2’-deoxyguanosine there are several functional groups that need to be protected and/or 
functionalized before it can be used in the DNA synthesizer for oligonucleotide synthesis.  The 
first step protects the exocyclic amine group.  There have been several amine protecting groups 
that have been used to protect the free amine group on the guanine ring and standard guanine 
phosphoramidites use an isobutyryl moiety.  However the addition of a C8-aryl group onto the 2’-
deoxyguanosine renders the nucleoside more susceptible to acid cleavage and our group, along 
with another group, have demonstrated that protection using a N,N-dimethylformamidine100,125,130 
creates a more stable C8-aryl-2’-deoxyguanosine nucleoside, which is important in subsequent 
nucleosidic functionalization reactions as well as during DNA synthesis.  Reaction with C8-aryl-
2’-deoxyguanosine to form N2-(N,N-dimethylformamidine)-C8-aryl-2’-deoxyguanosine (3) is 
performed under inert conditions (nitrogen or argon) in dry methanol.  This reaction as well as all 
subsequent nucleoside reactions are all performed under anhydrous conditions because water can 
compete with the nucleoside for the reactants and create undesired side products decreasing the 
yield.  In this particular case, water will hydrolyze the N,N-dimethylformamide acetal reactant into 
an inactive species for the N2-amine protection reaction.  The yields of this reaction are very good 
and the product does not need further purification after solvent removal.  
After the amine protection reaction, the 5’-hydroxyl group is functionalized to a 
dimethoxytrityl (DMTr) ether compound 4.  This reaction serves a dual purpose of blocking the 
5’-OH during the next reaction (phosphitylation) as well as generating the 5’-DMTr functional 
group that is customary in DNA synthesis.  The 5’-hydroxyl protection follows a SN1 mechanism, 
where the nucleoside hydroxyl group is the nucleophile that attacks the electrophilic carbon of the 
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DMTr-Cl compound replacing the Cl atom to produce the 5’-DMTr-N2-dimethylformamidine-
C8-aryl-2’-deoxyguanosine (4).  Since the by-product is HCl, this reaction is conducted in the 
basic solvents, pyridine and triethylamine (TEA), to neutralize the acid that would otherwise 
destroy the C8-aryl-2’-deoxyguanine derivative.  In addition, both of these solvents are dried and 
purified from lithium aluminum hydride (LAH) to remove any residual water that can also react 
with the DMTr-Cl reactant reducing the yield of the desired DMTr-C8-aryl-2’-deoxyguanosine 
product.  The progress of the reaction is monitored by neutral alumina thin layer chromatography 
(TLC) where one can observe the formation of the DMTr-C8-aryl-2’-deoxyguanine by washing 
the TLC strip with HCl which renders the DMTr-C8-aryl-2’-deoxyguanine spot an orange color.  
The orange spot is likely due to the formation of DMTr-OH, since the DMTr- moiety is susceptible 
to acid cleavage.  The reaction is deemed complete when the N2-dimethylformamidine-C8-aryl-
2’-deoxyguanine spot disappears and only the DMTr-C8-aryl-2’-deoxyguanosine spot is present 
on the TLC.  After the reaction is complete the excess of DMTr-Cl is inactivated with the addition 
of methanol and then the solvents are removed in vacuo to yield the crude 5’-DMTr protected C8-
aryl-2’-deoxyguanosine (4).   
Unlike the previous two reactions in the C8-aryl-2’-deoxyguanine phosphoramidite 
synthetic scheme, this reaction product requires purification before the phosphitylation reaction.  
The DMTr-C8-aryl-2’-deoxyguanosine is purified using column chromatography on basic 
alumina as the stationary phase.  Alumina is chosen over the more commonly used silica stationary 
phase because the acidic nature of the silica leads to breakdown of the C8-aryl-2’-deoxyguanosine 
base and the yields are much lower versus the alumina stationary phase.  The mobile phase used 
in the purification is a mixture of methylene chloride and methanol (CH2Cl2:CH3OH).  Initially 
99:1 CH2Cl2:CH3OH is used to separate the less polar DMTr-OH from the DMTr-C8-aryl-2’-
26 
 
deoxyguanosine, which requires a greater percentage of methanol to elute from the column.  
Typically after column purification the DMTr protected C8-aryl-2’-deoxyguanosine nucleosides 
are obtained in 40 to 60 % yields (two steps). 
The final step of the C8-aryl-2’-deoxyguanine phosphoramidite synthesis functionalizes, 
forming compound (5), the 3’-hydroxyl into the phosphoramidite using the 2-cyanoethyl 
N,N-diisopropylchlorophosphoramidite phosphitylating agent.132-134  The nucleophilic 3’-
hydroxyl reacts on the electrophilic nitrogen of the phosphoramidite reactant displacing the Cl 
atom.  Again, this reaction must occur under anhydrous conditions because of the high reactivity 
of the phosphitylating agent with water which can inactivate the reagent for the phosphitylation 
reaction.  The reaction is performed in CH2Cl2 with TEA so that the HCl produced throughout the 
course of the reaction is neutralized.  The reaction progress is monitored by the TLC, monitoring 
the disappearance of the DMTr-C8-aryl-2’-deoxyguanosine spot from the reaction mixture.  While 
the modified phosphoramidite can be purified via column chromatography, this purification step 
is not necessary, and generally tends to lead to product degradation.  Further, purification does not 
enhance the overall yield of the phosphoramidite coupling in DNA synthesis.  Instead, the TEA-
hydrochloride salts are precipitated from the C8-aryl-2’-deoxyguanine phosphoramidite using a 
4:1 benzene: tetrahydrofuran solvent mixture that can be filtered from solution.  The C8-aryl-2’-
deoxyguanine phosphoramidite is obtained after solvent removal and is further dried by washing 
with dry benzene.  Finally, before the modified phosphoramidite is used in DNA synthesis, the 
desired product is dried in vacuo over phosphorus pentoxide (P2O5).   
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C. C8-Arylguanine modified hairpin oligonucleotide synthesis 
 
Single C8-arylguanine modified hairpin oligonucleotide synthesis was conducted on an 
ABI 394 DNA synthesizer using phosphoramidite chemistry pioneered by Caruthers and 
coworkers.135,136  This method has become the method of choice and the standard chemistry, 
phosphoramidite chemistry, utilized by commercial DNA synthesizers.  The standard 
phosphoramidites along with the synthesized C8-aryl-2’-deoxyguanine phosphoramidites are 
depicted in Figure 2.1.  Although the C8-aryl-2’-deoxyguanine modified phosphoramidites require 
multi-step synthesis before use in the DNA synthesizer, the other phosphoramidites, in this case 
dG CE-PA, dC CE-PA, and dT CE-PA, are commercially available.  In this section the chemistry 
of DNA synthesis will be reviewed (and references therein).137   
 
Figure 2.1.  Structures of the phosphoramidites used in the single modified C8-arylguanine hairpin 
oligonucleotide synthesis. 
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Although a complex macromolecule, the chemistry of DNA synthesis is quite simple.  
DNA sequences are written and read in the 5’ to 3’ direction, however synthesis occurs in the 3’ 
to 5’ direction.  Synthesis begins on a controlled pore glass (CPG) solid support with the 
3’-nucletoide already attached to the column.  Oligonucleotide synthesis occurs one monomer 
nucleotide unit at time through a four-step synthetic cycle (Scheme 2.3).  After each step in the 
cycle excess reactants are removed, which is another advantage in the design of the CPG support, 
so purification is not necessary.  In addition, each step in the oligonucleotide synthesis occurs 
under anhydrous conditions, to minimize side reactions, by washing the growing oligonucleotide 
chain with anhydrous acetonitrile and then dried under a stream of argon.   
 
Scheme 2.3:  The synthetic cycle of DNA synthesis. 
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The first step in DNA synthesis begins with detritylation of the DMTr moiety of the 
nucleoside (1) attached to the CPG support by treatment with trichloroacetic acid (TCA) in 
CH2Cl2.  Cleavage of the acid labile DMTr generates a free, nucleophilic 5’-OH (2).  After the 
removal of any residual TCA with an acetonitrile (ACN) wash, the next base in the desired 
sequence is delivered to the column simultaneously with the tetrazole activator.  Tetrazole 
protonates the nitrogen of the incoming phosphoramidite which renders this phosphoramidite 
moiety more electrophilic and thus more susceptible to nucleophilic attack.  Tetrazole attacks the 
phosphoramidite producing a tetrazolyl phosphoramidite intermediate, which then reacts with the 
5’-OH of the nucleoside on the CPG support.  Since there is still a DMTr group on the incoming 
phosphoramidite, the reaction is directed towards coupling the 5’-OH on the CPG to the 3’-
phosphoramidite creating an internucleotide linkage (3).   
The coupling reaction is not 100% efficient and therefore the third step in the synthetic 
cycle inactivates any free 5’-OH from participating in any further chain extension reactions (4).  
This step is necessary to prevent the accumulation of undesired oligonucleotide products which 
ultimately makes DNA synthesis more efficient.  The 5’-OH is ‘capped’ using acetic anhydride in 
the presence of methylimidazole to produce a 5’-acetylated group that is inactive in any further 
synthetic cycles.  After the capping reaction the trivalent phosphite internucleotide linkage is 
oxidized to the pentavalent phosphodiester linkage characteristic of DNA (5).  Iodine is used as 
the oxidizing agent and water as the oxygen donor from a solution of aqueous iodine, pyridine and 
tetrahydrofuran.   
Now that the growing oligonucleotide chain has been extended by one base, this base can 
begin the next synthetic cycle again via detritylation of the 5’-DMTr of the oligonucleotide.  This 
four step process is repeated until the desired sequence has been synthesized, which is controlled 
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by the user.  Using these conditions the addition of each base addition is ~ 98% efficient, and 
therefore automated DNA synthesis is an ideal technique in the study of synthetic oligonucleotide 
sequences.  Afterwards, the oligonucleotide can be cleaved from the CPG support using aqueous 
ammonium hydroxide (30 % NH3) and the exocyclic protecting groups, shown in Figure 2.1, are 
removed by heating the ammonium hydroxide solution at 55 °C overnight (≤ 18h) 
 
D. Purification of C8-arylguanine modified hairpin oligonucleotide 
 
There are several factors that can affect the efficiency of the C8-arylguanine modified 
hairpin oligonucleotide synthesis, including the purity of the aforementioned  
C8-aryl-2’-deoxyguanine phosphoramidite, degradation of the modified oligonucleotide during 
synthesis, and/or inefficient coupling of the phosphoramidite to the growing oligonucleotide chain.  
Therefore it is necessary to purify the unmodified and modified hairpin oligonucleotides before 
structural characterization and determination of the conformational effects of the C8-arylguanine 
modified base.  The method used in this study was Fast Protein Liquid Chromatography (FPLC), 
an application of High Performance Liquid Chromatography (HPLC). 
FPLC is typically used to purify proteins, however it has also been utilized to purify DNA.  
FPLC uses aqueous buffers and separates its analyte of interest via ion-exchange,138 since both 
DNA and proteins are charged species.  Ion-exchange chromatography is a convenient 
methodology to purify DNA since the phosphate backbone is negatively charged and can separate 
the DNA based on charge and, therefore, also on chain length.  This is especially important in our 
hairpin oligonucleotides used in this study because both inefficient coupling and product 
degradation leads to two major products in the crude oligonucleotide solution forming.  One is the 
18-mer, where the C8-aryl-2’-deoxyguanine does not get coupled to the oligonucleotide chain, and 
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the other is the full length 24-mer hairpin oligonucleotide (Figure 2.2).  The longer 24-mer hairpin 
oligonucleotide is more negatively charged and will absorb to the positively charged stationary 
phase more strongly than the 18-mer thus the 24-mer will have a longer retention time than the 18-
mer.  In addition to the charge separation in the ion-exchange chromatography there is also some 
dependence of retention time on the hydrophobicity of the individual nucleosides that comprise an 
oligonucleotide, especially after incorporation of the C8-aryl modification, where the increase in 
hydrophobicity decreases the retention time of the oligonucleotide relative to the unmodified 
oligonucleotide.   
 
Anion exchange chromatography requires a cationic stationary phase.  The 
diethylaminoethyl (DEME) modified resin used here to purify the hairpin oligonucleotides 
contains a quaternary ammonium ion.138  The quaternary ammonium ion requires a counter ion, 
here hydroxide ion, to maintain the electrical neutrality of the stationary phase.  When the hairpin 
oligonucleotides are loaded onto the column, the negatively charged residues of the 
Figure 2.2.  Structures of the major synthetic products of the C8-arylguanine modified hairpins.  A) Displays 
the acetylated (capped) 18-mer structure and B) depicts the full length 24-mer structure. 
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oligonucleotide phosphate backbone will bind more tightly to the DEME matrix and replaces the 
counter ions.  The mobile phase used to elute the oligonucleotides (mobile phase B) is comprised 
of sodium hydroxide and sodium chloride solutions.  Increasing the concentration of the Cl- atoms 
causes the oligonucleotides to elute from the DEME stationary phase.  The full-length 
oligonucleotide sequence will have the longest sequence in the crude mixture and, consequently, 
will have the longest retention time.  DNA purification is monitored using an ultraviolet (UV) 
detector at 260 nm where nucleic acids typically have the highest absorbtivities. 
After the desired full-length oligonucleotide is obtained, the oligonucleotides must be 
desalted to remove the sodium chloride salts present in the eluent solution.  This final desalting 
step is accomplished using reverse-phase C18 solid phase extraction (SPE) cartridges.  The 
hydrophobic purine and pyrimidine components of the oligonucleotides will interact with the 
lipophilic hydrocarbon chain of the stationary phase of the SPE more strongly than the more polar 
salts.  Therefore the salts can be removed from the oligonucleotides after washing the SPE 
cartridge with water and the oligonucleotides can be eluted from the SPE cartridge with aqueous 
methanol.  After removing the solvent, the purity of the modified oligonucleotides can be 
determined by a single peak in the FPLC chromatogram.   
 
E. Mass spectrometry  
 
Mass spectrometry (MS) is an analytical technique that can be used to determine the 
molecular weight of molecule of interest.  During MS measurements the sample is ionized and 
may also break down into ionized fragments.139  These ionized products are produced in a vacuum 
and separated by a magnetic or electric field based on their mass to charge ratio (m/z).  The ions 
are directed towards a detector which can convert the number of ions into a signal that is reported 
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in the mass spectrum.  Some techniques produce the ionized molecule with electrons in electron 
ionization (EI) or with other ions such as a protonated methane (CH5
+) or ammonium ion (NH4
+) 
in chemical ionization (CI).  However, these techniques were not reliable and/or sufficient for 
analysis of large, high molecular weight biomolecules, such as proteins or DNA, that are non-
volatile and thermally unstable.140  Electrospray ionization (ESI) provides a solution to this 
problem that has enabled tremendous advancement of the field of mass spectrometry for the 
investigation of DNA.141 
In ESI, a solution of analyte is injected into the mass spectrometer through a capillary tube 
that is held a high potential.142  This produces a mist or ion spray of charged solution droplets 
which are directed towards the mass analyser.  As the analyte droplets flow down a potential and 
pressure gradient the droplets become smaller due to evaporation of the solvent, eventually 
resulting in ‘Coulomb explosion’ (solvent droplets shrink in size).  Solvent evaporation is aided 
by a nebulizer gas which is typically nitrogen.140  In general, the process employed in ESI can be 
described in three stages:  droplet formation, droplet shrinkage and gaseous ion formation. 
ESI is a desorption technique that produces multiply charged, quasi-molecular ions without 
fragmentation and therefore allows for the characterization of significantly larger molecules of 
interest that have a much higher molecular weight than the mass detector but the resultant ions 
have m/z  values within the detector range.  In the case of DNA, this allows for the characterization 
of DNA samples with molecular weights between 200 Da to 200 kDa.141  In ESI, the mass spectrum 
of a DNA sample contains a series of peaks that result from several different charge states 
associated with the DNA molecule. 
DNA ionization is typically observed in the negative ion mode due to the polyanionic 
nature of the phosphodiester backbone (pKa ~ 1).  To assist with the ionization of the DNA sample 
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volatile counter ions (e.g. NH4
+) are used to replace the more common non-volatile counter ions 
(e.g. Na+ or K+).  In addition, non-volatile solvents and salts are typically avoided to prevent their 
accumulation which will lead to decreased resolution and may lead to machine malfunction.  To 
ensure non-volatile salts are not in the sample, several methods have been used for inline desalting.  
For example, the ESI-MS can be coupled to an HPLC system (LC-MS or LC-MS/MS).  However, 
prior desalting with C18 SPE and direct injection analysis, used here, provided excellent results 
and confirmed the identity of the synthetic products of the unmodified and C8-arylguanine 
modified hairpin oligonucleotides. 
 
F. Circular Dichroism  
 
Circular dichroism (CD) is an optical spectroscopic technique that uses circularly polarized 
right- (εR) and left-handed (εL) light.  Optically active molecules absorb right- and left-handed 
light differently and that difference is called CD (Δε= εL – εR).143  CD has been mathematically 
predicted though the computational result does not always correlate with the experimental CD 
spectrum.  A CD spectrum is generally referred to as a characteristic spectrum, especially in the 
case for the spectrum of DNA.  The purine and pyrimidine components of nucleic acids are 
chromophoric due to the aromaticity of their π systems, however their planar sp2 system renders 
them optically inactive and thus CD inactive.  The base-pendant deoxyribose sugars, on the other 
hand, are chiral and therefore active in CD.  However, given that the chromophoric and chiral unit 
are attached, the CD intensity of a nucleoside is low.  Fortunately the interactions within the double 
helix of a DNA molecule, such as hydrogen bonding, base stacking, hydrophobic and electronic 
interactions, provide a super asymmetric molecule with a high CD intensity.143   
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CD was used here to distinguish between the right-handed (B) and the left-handed (Z) 
tertiary DNA structures.  CD can differentiate between B- and Z-DNA since B-DNA has 
characteristic positive ellipticity around 280 nm and negative ellipticity around 250 nm whereas 
Z-DNA has negative ellipticity at approximately 295 nm with positive ellipticity at approximately 
250 nm (Figure 2.3).12  CD has been used to characterize the B- to Z-DNA transition in several 
different studies including modified oligonucleotides as well as hairpin oligonucleotides.12,114,117  
In general, increasing salt concentration, typically NaCl or NaClO4, will drive the B-/Z-DNA 
equilibrium favor the Z-DNA conformation at approximately 3 M Na+.  Divalent cations144 such 
as Mg2+ and other polycationic species such as the polyamines spermine21 and spermidine22 are 
more effective at stabilizing the Z-DNA conformation at significantly lower salt concentrations 
and, in some cases, within the range of physiological conditions. This is especially important in 
the work discussed here to examine the conformational effects of the C8-arylguanine modified 
base on the B-/Z-DNA equilibrium. 
Figure 2.3.  CD spectrum of B-DNA (black) and Z-DNA (red) conformations of the hairpin oligonucleotides. 
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The CD spectra can be used to estimate the magnitude of the conformational effects caused 
by the C8-arylguanine modified base where a lower salt concentration required to drive Z-DNA 
formation is indicative of the relative amount the modified base destabilizes B-DNA and/or 
stabilizes Z-DNA.  This can be accomplished by acquiring CD data as a function of salt 
concentration.  Acquiring CD at a single temperature will provide data appropriate for an initial 
estimation of the effects on the B-/Z-DNA equilibrium.  A more accurate method to compare the 
conformational effects between the unmodified and modified hairpin oligonucleotides requires the 
quantitation of the mole fractions of the DNA conformations (B-, Z-, and ss-DNA) in solution.  
Therefore by acquiring CD data as a function of both salt concentration and temperature one can 
make a quantitative determination of the effect on conformation by the C8-aryl modification. 
1. Mole Fraction Calculations 
 
The conformational effects of the C8-arylguanine modified base(s) can be quantitated by 
determining the molar fractions of B- (fB), Z- (fZ), and ss-DNA (fss) as a function of temperature 
and salt concentration.  This analysis enables a more accurate evaluation of the conformational 
effects of the C8-arylguanine modification on the hairpin oligonucleotide stability in comparison 
to the unmodified hairpin.  The mathematical determination of the mole fractions with respect to 
the B-/Z-DNA equilibrium was first developed by Xodo et al.117  This approach assumes that the 
only DNA conformations in solution are the B-, Z- and ss-DNA forms and that they are rapidly 
equilibrating.  Thus, at all wavelengths acquired in the CD spectrum, the total molar ellipticity 
(Δε) is equal to the sum of the molar ellipticities of all the oligonucleotide conformations in 
solution, weighted by the mole fraction of each species (eq 2.1).  Since the CD at 295 nm correlates 
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strongly with the Z-DNA but not the B-DNA conformation, the Δε 295 is used to determine fB, fZ 
and fSS.  Therefore, for each temperature data were acquired, eqs 2.1 and 2.2 apply: 
 
 
where f is the mole fraction of one of the three possible oligonucleotide conformations and Δε is 
the corresponding ellipticity of the oligonucleotide in that particular conformation.  However the 
mole fractions cannot be determined solely from eqs 2.1 and 2.2 and thus eq 2.1 is modified to eq 
2.3. 
 
 
The Δε values for each of the three possible conformations were estimated from the CD at a) low 
salt (0 – 250 mM NaCl) at 30 °C (ΔεB), b) high salt (1000 – 4000 mM NaCl) at 10 °C (ΔεZ), and 
c) low salt (0 – 500 mM NaCl) at 99 °C (ΔεSS).  However to determine CB and CZ, one must first 
determine Css.   
An isosbestic point was observed at 274 nm corresponding to the case where Δε for the B 
and Z forms are equal (ΔεB = ΔεZ = Δεds).  Therefore eqs 2.4 and 2.5 can be used to determine fss 
and fds. 
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As with eq 2.3, eq 2.4 is modified to eq 2.6 however the observed UV absorbance (A274) was used 
rather than CD.  
 
 
The molar absorptivities of ds- and ss-DNA can be estimated in a similar manner as ΔεB and ΔεZ.  
At low temperatures (10 °C) εds274 can be estimated and at high temperatures (99 °C) εss274 can be 
estimated.  However the concentration of ds-DNA (Cds) requires additional calculations based on 
the ss-DNA and ds-DNA equilibrium.  While the amount of ss-DNA and ds-DNA varies based on 
the conditions, the total amount of DNA (Ctotal) remains constant and, therefore, at the lowest 
temperature at which experiments were conducted (10 °C), one can assume that DNA denaturation 
is minimal and all DNA is in the double-stranded form.  Thus, to quantitate the ds-DNA and ss-
DNA equilibrium eqs 2.7 and 2.8 are applied:  
 
 
Substitution of Cds with eq 2.8, Css can be determined from eq 2.13 derived below:   
 
 
 
 
 
 
Eq 2.3 can be manipulated to solve for CB when substituting Cds – CB for CZ since  
Cds = CB + CZ.  This provides eq 2.19, derived below: 
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CZ can be determined from Cds – CB once CB is determined; and once CB, CZ and Css have been 
calculated the mole fractions fB, fZ and fSS can be calculated from eqs 2.20-2.22. 
 
 
 
The mole fraction data from the variable temperature and salt concentration CD 
experiments allows for a quantitative comparison amongst the hairpin (unmodified vs. modified) 
oligonucleotides.  This data can also be used to compare the hairpin to double-stranded (single vs. 
doubly modified) oligonucleotides.  The mole fraction plots can also be used to determine the 
melting temperature (TM) of the C8-arylguanine modified oligonucleotides where the temperature 
that corresponds to (fB + fZ)/fSS = 1 was taken as the TM.   
 
2. Thermodynamic Parameters 
 
The mole fraction data can also be used to derive thermodynamic data of the 
C8-arylguanine modified oligonucleotides including the transition concentration (Tc), transition 
free energy (ΔGt), ΔG, ΔH, and ΔS.  The Tc is the concentration of salt required such that the B-
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/Z-DNA ratio is 1.  This can be estimated by interpolation from the CD data and the ratios obtained 
by the methods described above.   
An alternative method to determine the transition salt concentration has been described and 
was also used here.145  The effect of salt on the B-/Z-DNA transition can be described as written 
in eq 2.23: 
 
 
where c[NaCl] represents the interactions of salt between the B- and Z-DNA conformations and c 
stands for the transition specific constant coefficient.  The observed equilibrium constant (Kobs) 
(calculated from fZ/fB), for a given salt concentration, is defined as shown in eqs 2.24 and 2.25. 
 
 
A plot of ln(Kobs) versus ln[NaCl] yields the values of c and ln (Keq), determined from the slope 
and y-intercept.  In turn, the transition energy can be calculated from eq 2.26. 
 
 
Finally ΔG, ΔH, and ΔS can be determined by fitting the data to the van’t Hoff equation.118  CD 
spectroscopy is an extremely useful technique to evaluate the conformational effects of the C8-
arylguanine modified bases on the oligonucleotide stability for the hairpin or double-stranded 
oligonucleotides as well as comparison between the single and double modified systems. 
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G. Nuclear Magnetic Resonance spectroscopy  
 
Nuclear Magnetic Resonance (NMR) is a powerful technique for the structural 
characterization of chemical compounds and, in this case, the B- and Z-DNA structures of the 
C8-arylguanine modified hairpin oligonucleotides.146,147  While CD is an excellent technique for 
the conformational analysis of the C8-arylguanine modified oligonucleotides, CD only provides 
information on the global structure of the hairpin oligonucleotides, whereas, NMR provides 
detailed structural information of the local conformation of the C8-arylguanine modified base.  
NMR was used here to confirm the conformation of the hairpin oligonucleotides seen in the CD 
experiments and to examine the local environment of the modified base.  The principles of NMR 
and how NMR has been used previously to study the B- and Z-DNA conformation are discussed 
below. 
 
1. Basic Theory of NMR 
 
Atomic nuclei may have magnetic properties, the physical characteristic required for the 
NMR phenomenon.  The general requirement for nuclei to be magnetically active is they must 
have the property called spin.  Nuclei will have spin if it does not have an even atomic mass and 
even number of neutrons.  A spinning charge generates a magnetic field and the magnetic spin 
properties are characterized by the spin quantum number I.  The atomic nuclei that have spin most 
important in DNA NMR have a spin = ½ (I = ½) such as 1H, 13C, 31P, and in some cases 15N.  
Atomic nuclei with I = ½ give the simplest spectra because when placed in a magnetic field (B0) 
the nuclei will orient themselves either with (parallel) or against (antiparallel) the external 
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magnetic field.  In turn, this gives rise to two possible spin or energy states, + ½ and – ½.  These 
two spin states are separated by an energy difference (ΔE) shown in Figure 2.4.   
 
An observable signal in NMR occurs when the nuclei from the lower energy state are 
excited to the higher energy state and if there is a difference in the number of electrons occupying 
the two spin states.  This can also be described as a spin flip where the nuclei reorient themselves 
relative to the direction of B0.  The Larmor equation (eq 2.27) can be used to calculate the energy 
gap between the two energy states of the nuclei which is based on the Larmor or rotation frequency 
(v0) of the nuclei relative to the gyromagnetic ratio (γ) and the external magnetic field strength 
(B0).   
 
When the electromagnetic frequency is tuned to match the value of v0 for a given nuclei like 
1H or 
13C then the nuclei can be promoted from the lower energy state to the higher energy state are 
come into resonance, which is where the terminology NMR is derived.  Using a programmable 
Figure 2.4.  Energy levels of nuclei with I = ½ and relationship of ΔE and external magnetic field strength.   
I = quantum spin number, B0 = external magnetic field, h = Planck’s constant, and v0 = Larmor frequency. 
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radio frequency (RF in MHz for NMR) transmitter, one can adjust the frequency from the RF (v) 
to bring the nuclei under study into resonance.  As the nuclei from the higher energy state transition 
back to the lower energy state the absorption energy can be detected and translated into the NMR 
peaks of the NMR spectrum. 
The relationship above describes the effect of nuclei in an applied magnetic field under the 
assumption that all the nuclei in a molecule are identical.  However, nuclei of the same type in a 
molecule will have slightly different chemical environments that arise from the electron cloud 
density of a given nuclei.  These nuclei absorb energy at slightly different frequencies and, when 
compared to a reference sample (e.g., tetramethylsilane (TMS) for 1H), the difference in resonance 
frequency between the resonance of interest and TMS, is termed the chemical shift (δ) (eq 2.28).  
The resonance frequency difference between the reference resonance and the resonance of interest 
divided by the NMR spectrometer frequency yields the chemical shift in parts per million (ppm).  
In NMR the absorption peaks or signals are plotted in the form of intensity as a function of their 
chemical shift.  Finally, the peak area is proportional to the number of nuclei giving rise to the 
peak.  
 
 
Another important phenomenon seen in NMR occurs when a nucleus in the sample interact 
with nearby nuclei.  Spin-spin coupling occurs when a particular nucleus has a magnetic moment 
induced from the applied RF and then transfers the energy to other nuclei in the same molecule.  
This interaction can result in splitting of the NMR signal that produces a multiplicity of the 
absorption peak separated by the coupling constant (J-coupling).  In particular, for nuclei with  
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I = ½ scalar coupling follow the 2nI + 1 rule where n is the number of magnetically equivalent 
nuclei surrounding the nucleus of interest.  For example, when a nucleus has only one neighboring 
nucleus a doublet is observed.  The most commonly studied nuclei in NMR are 1H and 13C because 
all organic molecules contain these nuclei and since I = ½ produce spectra that are relatively 
straightforward to analyze.  Thus, by acquiring 1H and 13C spectra and determining from them 
peak areas (integrations), chemical shifts, multiplicities and coupling constants, one can assign the 
structure and conformation of a compound. 
Normally, one dimensional (1D) 1H and 13C spectra acquisition is sufficient to determine 
the structure of simple organic molecules.  Macromolecules, such as proteins or DNA, require 
additional experiments to determine structure as there is usually insufficient dispersion to resolve 
all the signals.  In particular, 2D experiments, such correlation spectroscopy (COSY) and nuclear 
Overhauser effect correlation spectroscopy (NOESY), provide additional information relevant to 
the structure determination of a molecule of interest.  These experiments, provide additional 
information making it possible to assign the many NMR signals of proteins or DNA by utilizing 
additional dimensions.  COSY experiments provide through bond connectivities from spin 
coupling and NOESY provides through space information arising from dipole-dipole interactions. 
The proton-proton coupling correlation, 1H-1H COSY, experiment reveals the bond 
connectivities of a molecule.  In a COSY spectra, the diagonal corresponds to the 1D 1H spectrum, 
which is typically displayed on both the top and side of the spectral plot.  The off-diagonal signals 
represent J–coupling correlations and are used to determine which nuclei are adjacent to each other 
in the molecule.  COSY spectra were used here in this study to assign the nucleoside protons (e.g., 
H1’ to H2’ and H2”) as well as the pyrimidine protons, dC H6 to H5 and dT H6 to CH3. 
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NOESY is based on the nuclear Overhauser effect (NOE) which provides information of 
protons interacting through space and in close proximity (< ~ 4 Å).148,149  In NOESY, when the 
protons promoted to the higher energy relax back to lower energy state they interact with nearby 
protons through dipole-dipole interactions which results in an enhancement of the NMR signal.  
Similar to COSY, the diagonal in a NOESY plot corresponds to the 1H reference spectrum where 
off-diagonal correlations are due to spatial interactions of the protons in the sample.  The intensity 
of the cross-peaks that form are distance dependent and are proportional to the inverse of r-6 where 
r is the distance between interacting protons.  NMR experiments (1H, gCOSY and NOESY) were 
used in this study to confirm the presence of the C8-arylguanine modified base and its local 
geometry in the hairpin oligonucleotides, aid in the assignment of the spectra, and to corroborate 
the CD results relative to the B-/Z-DNA equilibrium.   
 
2. NMR of B- and Z-DNA  
 
DNA is a polymer composed of many monomeric units (dA, dG, dC, or dT nucleobases) 
and in the hairpin oligonucleotide studied here, 10 dG, 10 dC, and four dT bases are present.  
Although each dG, dC or dT bases has the same atomic identity, the NMR data show each base 
has a slightly different chemical environment resulting in slightly different chemical shifts of the 
same nuclei.  This results in the 1H spectrum of the hairpin oligonucleotides with many overlapping 
signals (Figure 2.5) and hence there is a need for 2D experiments to derive structural information 
of the C8-arylguanine modified base in the B- and Z-DNA conformation.  There have been several 
NMR studies comparing the NMR of the B and Z forms of the same sequence that provide the 
framework for the conformational and therefore spectral differences observed by NMR 
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spectroscopy.  These reports guided our assignment of the NMR of the C8-arylguanine modified 
hairpin oligonucleotides studied in this work.120,121,150,151 
 
Patel and coworkers150 were the first to observe the effect of conformational changes of an 
alternating dG-dC oligonucleotide (B- to Z-DNA) in high salt solution using NMR, at that time 
this sequence was still referred to as ‘alternating B-DNA’.  In this work the authors demonstrated 
that as the salt concentration was increased to 4 M NaCl the H1’ proton of the dG residues shifted 
downfield, this corresponds to less influence from adjacent base-pairs (shielding) and a change in 
glycosidic torsional angle.  However the exact identity of which H1’ was most affected could not 
ascertained from the 1D 1H spectrum alone.  Three years later Patel and another group of 
coworkers151 used 2D NOESY experiments to confirm that this H1’ proton belonged to the dG 
base through NOE correlations between H8 and H1’, indicative of the syn-glycosidic bond 
Figure 2.5.  1H NMR spectrum of the hairpin oligonucleotide d(5’-CGCGCGCGCGTTTTCGCGCGCGCG-3’).  
The sugar proton resonances of the nucleotide bases overlap extensively and are not resolved.  To fully assign the 
protons of each individual nucleotide, more advanced 2D (COSY and NOESY) experiments are required. 
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conformation.  Further it was demonstrated that NOEs were seen only under high salt conditions 
(i.e., Z-DNA conformation) and were not present under conditions where only the B-DNA 
conformation was present.  Therefore, using NOESY, combined with COSY 2D data, one can 
often assign the nucleoside protons as well as distinguish between the B- and Z-DNA 
conformations. 
In the early 1980s, two groups established a set of rules for the sequential assignment of 
the non-exchangeable protons of DNA bases.152,153  In DNA, the only aromatic scalar coupled 
protons are the H6 and H5 of dC, although it is possible to see four bond coupling between the H6 
and CH3 of dT bases, and therefore are readily identifiable in the COSY spectra of an 
oligonucleotide.  Hare and Reid153 demonstrated that every H8 and H6 proton will display NOEs 
to their own H1’ and with the H1’ of the 3’-base in the sequence (n+1).  In addition, the H8/H6 
base protons are also close enough to display NOEs to the H2” of the 5’-base, which is scalar 
coupled to the H1’ of the 5’-base.  This provides a checkpoint where the COSY spectra can be 
used to verify the NOEs seen in the NOESY spectra.  In addition, this work also demonstrated that 
the H5 of the pyrimidines will have NOEs to the H6 or H8 of the 3’-base and the H1’ of any base 
will have an NOE to H5 proton of a 5’-pyrimidine.  Further these authors explained that in a 
NOESY spectrum the H2” should always have a stronger intensity cross-peak with the H1’ of the 
same base than with the H2’ since the H2” is always closer in space than the H2’.153  Scheek et 
al.152 reported a similar assignment procedure where the resonance signals of the 
purine/pyrimidine components of the nucleotides do not display direct NOEs to adjacent bases, 
however the H1’, H2’ and H2” of any given nucleotide should display NOEs cross-peaks to both 
their own base (purine/pyrimidine) proton(s) and also to the 3’-base proton(s).  Using these two 
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reports, one can follow their assignment procedures to readily assign the base and nucleoside 
protons of any DNA sequence in the B-DNA conformation (Figure 2.6).   
 
 
The structural differences between B-DNA and Z-DNA are substantial and arise from the 
glycosidic bond conformation which alternates from syn for the purine bases to anti for the 
pyrimidines in the Z-DNA conformation whereas in B-DNA, all the nucleotides have the 
Figure 2.6.  Intranucleotide and internucleotide assignment procedure for oligonucleotides in the B-DNA 
conformation.  The red double-tip arrows show the protons that can be assigned from the COSY spectra:  dC H6 to 
H5, H1’ to H2’ and H1’ to H2”.  The blue single-tip arrows show the NOE correlations that can be assigned from the 
NOESY spectra:  H1’ to the 5’-base protons (H8/H6/H5) and H2’/H2” to the 5’-base protons. 
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anti-glycosidic bond conformation.  As a result there is also a substantial difference in the 1H NMR 
spectrum, which has the most effect on the chemical shift of the H1’ proton.151,154-156  One of the 
most important characteristics of the Z-DNA conformation in the NOESY spectra is a strong NOE 
cross-peak between the H8 proton of purines, here dG bases, and their own H1’ proton (see Figure 
2.6).  The syn-conformation brings the H8 proton significantly closer in space than when in the 
anti-conformation and is therefore diagnostic of the Z-DNA conformation.  This is also useful in 
the study described here where the aromatic protons of the C8-arylguanine modified base show 
strong NOE correlations to its H1’ proton, which has also been observed for C8-methylguanine 
modified oligonucleotides.157,158   
NMR is a very powerful technique to determine the conformational effects of the 
C8-arylguanine modified base on the hairpin oligonucleotide as well as for comparison to the 
previously studied doubly modified double-stranded oligonucleotide.  The combination of the 
COSY and NOESY NMR experiments can be used to assign the resonances of the B-DNA and 
Z-DNA conformations of C8-arylguanine modified hairpin oligonucleotides in a fashion similar 
to previously studied double-stranded oligonucleotides.98,100  Hairpin oligonucleotides have also 
been studied in both the B- and Z-DNA conformations120,121 and have been shown to behave 
similarly to their double-stranded oligonucleotides without a loop (e.g., (d(CG)n)2 vs. 
d(CG)nT4(CG)n)).  Therefore using hairpin oligonucleotides similar to those previous studies 
provide a good system for comparison one and two C8-arylguanine modified bases. 
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Chapter 3:  Experimental Techniques and Results 
 
It is well known that DNA base modifications in alternating purine-pyrimidine (APP) 
sequences can shift the B-/Z-DNA equilibrium toward the Z-DNA conformation.16,159  In addition 
many of these C8-purine modifications are derived from carcinogens.77,83,88,90  APP sequences 
have been shown to play a role in gene expression, specifically in relation to these sequences being 
able to adopt Z-DNA.  Therefore, it is possible that the base modifications that drive Z-DNA 
formation in a region of the genome that regulates gene expression may amplify the role of Z-
DNA in gene expression.  Therefore it is important to understand how base modifications can alter 
the B-/Z-DNA equilibrium to drive Z-DNA formation. 
Previous work in our laboratory has investigated the conformational effects of C8-
arylguanine modified bases on the B-/Z-DNA equilibrium.98-100  In addition our group has also 
demonstrated expertise in the synthesis of C8-aryl-2’-deoxyguanine modified nucleoside to 
produce C8-aryl-2’-deoxyguanine analogs with various para-substituents on the C8-aryl 
modification that can be incorporated into oligonucleotide sequences.125  In general, the C8-aryl-
2’-deoxyguanine modified nucleoside synthesis begins with 8-bromo-2’-deoxyguanosine 
synthesis prepared from 2’-deoxyguanosine and NBS which is further used in the Suzuki coupling 
reaction with an arylboronic acid to make C8-aryl-2’-deoxyguanosine.  Subsequently, the 
exocyclic amine is converted to a dimethylformamidine and then the 5’-hydroxyl is converted to 
the dimethoxy trityl ether.  Finally, the 3’-hydroxyl group was converted to the phosphoramidite 
and used in the modified hairpin oligonucleotide synthesis (see Scheme 2.1). 
Although we have confirmed that the presence of the C8-arylguanine modified base shifts 
the B-/Z-DNA equilibrium towards the Z-DNA conformation in d(CG)5 oligonucleotides, our 
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previous studies used oligonucleotides that contained two modified bases, one on each strand and 
in successive base pairs.98,100  Consequently, we could not determine if the conformational effects 
of the doubly modified d(CG)5 oligonucleotides were due to the modifications acting 
independently or in combination.  Further, since it is unlikely that two adducts would form adjacent 
to one another in vivo, we sought to determine the effect of a single C8-arylguanine modification 
on the B-/Z-DNA equilibrium.  To accomplish this goal we utilized a DNA hairpin with the 
sequence 5’-CGCGCG*CGCGTTTTCGCGCGCGCG-3’, where G*=C8-arylguanine (see Figure 
1.4).  Thus, by determining the conformational preferences of this hairpin oligonucleotide we can 
determine the effect of a single modification directly.  In turn, by comparison to our previous work, 
the effect of a double modification can be assessed as to whether the effect is additive or that the 
two modifications are acting independently.100  This also allows us determine if, when multiple 
adducts are present, their effects are independent of one another.   
In this section the experimental procedures and results of the synthesis of the 
C8-aryl-2’-deoxyguanine modified nucleosides will be reported.  In addition the modified hairpin 
oligonucleotide synthesis and purification will be presented.  Finally a detailed description of the 
conformational analysis experiments (NMR and CD) will be provided.   
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Part I:  C8-Aryl-2’-deoxyguanine Modified Nucleoside and  
Hairpin Oligonucleotide Synthesis 
 
A. C8-Aryl-2’-deoxyguanosine Nucleosides and Phosphoramidite Synthesis 
1. General 
 
All chemicals used were purchased from Aldrich (Milwaukee, WI) unless otherwise noted.  
4-Carboxyphenyl boronic acid (4-CPhBA) and 4-methoxymethylphenyl boronic acid 
(4-MMPhBA) were purchased from Frontier Scientific (Logan, UT).  Tris-(3-sulfantophenyl) 
phosphine (TPPTS) was purchased from Strem Chemicals (Newburyport, MA).  Other than the 
Suzuki coupling reaction, the following reactions en route to the production of the 
C8-aryl-2’-deoxyguanine phosphoramidite require anhydrous conditions and thus the solvents 
were dried and distilled before use.  Methanol (CH3OH) and dimethylformamide (DMF) were 
dried over molecular sieves (3 Å).  Methylene chloride (CH2Cl2) was dried by distillation from 
phosphorus pentoxide (P2O5).  Benzene and toluene were dried by distillation from calcium 
hydride.  Triethylamine (TEA), tetrahydrofuran (THF), and pyridine were dried by distillation 
from lithium aluminum hydride.  The structure of the synthetic C8-aryl-2’-deoxyguanine modified 
nucleosides (structures shown in Appendix B) were consistent with 1H NMR spectra obtained on 
either a Varian 300 or 600 spectrometers (Palo Alto, CA) and are displayed in Appendix C.   
 
2. Synthesis 
 
8-Bromo-2’-deoxyguanosine, C10H12O4N5Br (1):  2’-Deoxyguanosine (dG; 2.86 g, 10 mmol) 
was suspended in a 4:1 mixture of acetonitrile (ACN) and water (125 mL).  N-Bromosuccinimide 
(NBS) (freshly recrystallized from water and hot filtration) was added to the dG suspension (2.67 
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g, 15 mmol) which resulted in a yellow-orange precipitate.  The reaction mixture was stirred for 
30 min at rm temp and then filtered.  The filter cake was resuspended in acetone (50 mL), stirred 
from 2h, sealed and then stored at -20 °C freezer overnight.  The precipitate was isolated by 
vacuum filtration and dried in a vacuum desiccator for additional 24h (2.94 g, 8.5 mmol, 85 % 
yield). 
 
1H NMR (300 MHz, DMSO-d6):  δ ppm 10.78 (1H, s, NH), 6.47 (2H, s, NH2), 6.16 (1H, t, J = 7.5 
Hz, H1’), 5.23 (1H, d, J = 6.0 Hz 3’-OH), 4.83 (1H, s, 5’-OH), 4.39 (1H, m, H3’), 3.80 (1H, m, 
H4’), 3.62 and 3.50 (2H, m, H5’/5”), 3.16 (1H, m, H2”) and 2.10 (1H, ddd, J = 3.0, 6.0, 9.0 Hz, 
H2’).   
 
4-(tert-butyldimethylsilyl-O-methyl)-phenyl bromide, C12H21OSiBr (2): 4-Bromobenzyl 
alcohol (756 mg, 4.0 mmol), tert-butyldimethylsilyl (TBS) chloride (1.30 mg, 8.0 mmol), and 
imidazole (freshly sublimed, 605 mg, 8.8 mmol) were dissolved in DMF (10 mL).  The reaction 
was stirred at rm temp for 24h under argon.  The reaction solvent was removed using Rotovap 
with heating at 90 °C.  The residue was extracted with hexane (30 mL), the hexane then washed 
with water (3 x 30 mL), and the organic layer dried over sodium sulfate.  The desired product, 2, 
was isolated after solvent removal and further dried in vacuo overnight in a desiccator.   
 
1H NMR (300 MHz, CDCl3-d1):  δ ppm 7.46 (2H, d, J = 9.0 Hz, aryl), 7.21 (2H, d, J = 9.0 Hz, 
aryl), 4.69 (2H, s, CH2), 0.95 (9H, s, t-butyl), and 0.11 (6H, s, dimethylsilyl).   
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4-(TBS-O-methyl)-phenyl boronic acid, C13H23O3BSi (3):  A previously reported procedure160 
of this compound was modified and used here.  Compound 2 (5 g, 16.6 mmol) was dissolved in 
dry THF (50 mL) and toluene (10 mL) and combined with triisopropyl borate (5.5 mL, 23.8 mmol).  
The organic mixture was sparged with nitrogen at -78 °C (acetone and dry ice bath) for 30 min 
and then n-butyl lithium (1.6 M in hexane, 20 mL, 32 mmol) added, over 20 min, through an 
addition funnel.  The reaction was stirred for 10 min, the dry ice bath was removed and replaced 
with a wet ice bath, and the temperature raised from -78 °C to 0 °C over 30 min.  Concentrated 
HCl was then added (17.5 mL, 2 M), the mixture stirred for 30 min, ethyl acetate (27.5 mL) added 
and stirring for additional 30 min.  The organic layer was collected and washed with a 5 % sodium 
bicarbonate and 10 % sodium chloride solution (25 mL), dried over magnesium sulfate, filtered 
and concentrated to dryness in vacuo.  The crude product was suspended in ACN and collected by 
filtration to yield the final TBS-protected boronic acid 3. 
 
1H NMR (300 MHz, CDCl3-d1):  δ ppm 8.23 (2H, d, J = 7.5 Hz, aryl), 7.48 (2H, d, J = 7.8 Hz, 
aryl), 4.86 (2H, s, CH2), 0.99 (9H, s, t-butyl), and 0.14 (6H, s, dimethylsilyl). 
 
8-(Phenyl)-2’-deoxyguanosine C16H17O4N5 (4):  Phenylboronic acid (301 mg, 2.47 mmol), 1 
(692 mg, 2.0 mmol), Na2CO3 (421 mg, 3.97 mmol), TPPTS (80 mg, 0.14 mmol) were added to the 
reaction flask and sparged with argon for 5 min.  Then, palladium (II) acetate (Pd(OAc)2; 11.6 mg, 
0.053 mmol) was added to the reaction flask and sparged with argon for an additional 10 min.  The 
reactants were dissolved in aqueous ACN (2:1 H2O:ACN, 20 mL), sparged with argon for 30 min 
and then heated at 80 °C.  The reaction was stirred for 2.5 h or until reverse-phase TLC (RP-TLC; 
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C18, 1:1 H2O:CH3OH, UV detection) indicated complete consumption of 1, which typically was 
accompanied by the reaction mixture changing from a clear, yellowish color to an opaque, black 
color.  The reaction mixture was cooled to rm temp by the addition of ice and diluted with H2O 
(10 mL) and further cooled with an ice bath.  The pH was adjusted to 6-7 by the drop-wise addition 
of 10% HCl.  The resulting precipitate was isolated via vacuum filtration and the filter cake was 
dried in vacuo to yield 4 (665 mg, 1.94 mmol, 96.9 % yield).   
 
1H NMR (300 MHz, DMSO-d6):  δ ppm 10.80 (1H, s, NH), 7.65 (2H, m), 7.53 (3H, m), 6.40 (2H, 
s, NH2), 6.05 (1H, t, J = 6.8 Hz, H1’), 5.12 (1H, brs, 3’-OH), 4.99 (1H, brs, 5’-OH), 4.34 (1H, m, 
H3’), 3.79 (1H, m, H4’), 3.65 and 3.54 (2H, m, H5’/H5”), 3.17 (1H, m, H2”), and 2.03 (1H, ddd, 
J = 3.0, 6.0, 9.0 Hz, H2’).  
 
8-p-Tolyl-2’-deoxyguanosine C17H18O4N5 (5):  p-Tolylboronic acid (336 mg, 2.47 mmol), 1 (692 
mg, 2.0 mmol), Na2CO3 (421 mg, 3.97 mmol), TPPTS (80 mg, 0.14 mmol) were added to the 
reaction flask and sparged with argon for 5 min.  Then Pd(OAc)2 (11.6 mg, 0.053 mmol) was 
added to the reaction flask and sparged with argon for an additional 10 min.  The reactants were 
dissolved in aqueous ACN (2:1 H2O:ACN, 20 mL) sparged with argon for 30 min and then heated 
at 80 °C.  The reaction was stirred for 2.5 h or until reverse-phase TLC (RP-TLC; C18, 1:1 
H2O:CH3OH, UV detection) indicated complete consumption of 1, which typically was 
accompanied by the reaction mixture changing from a clear, yellowish color to an opaque, black 
color.  The reaction mixture was cooled to rm temp by the addition of ice and diluted with H2O 
(10 mL) and further cooled with an ice bath.  The pH was adjusted to 6-7 by the drop-wise addition 
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of 10% HCl.  The precipitate was isolated via vacuum filtration and the filter cake was dried in 
vacuo to yield 5 (704 mg, 1.84 mmol, 92.0 %).   
 
1H NMR (300 MHz, DMSO-d6):  δ ppm 7.52 (2H, d, J = 8.1 Hz, aryl), 7.34 (2H, d, J = 8.1 Hz, 
aryl), 6.70 (2H, brs, NH2), 6.07 (1H, dd, J = 8.6, 6.3 Hz, H1’), 5.69 (1H, brs, 3’-OH), 4.13 (1H, 
brs, 5’-OH), 4.36 (1H, m, H3’), 3.82 (1H, m, H4’), 3.68 and 3.55 (2H, m, H5’/H5”), 3.17 (1H, m, 
H2”), 2.39 (3H, s, CH3), and 2.02 (1H, ddd, J = 2.7, 6.0, 88 Hz, H2’).  
 
8-(4-(TBS-O-methyl)phenyl)-2’-deoxyguanosine C23H33O5N5Si (6):  Compound 3 (293 mg, 
1.10 mmol), 1 (346 mg, 1.0 mmol), Na2CO3 (292 mg, 2.75 mmol), TPPTS (80 mg, 0.14 mmol) 
were added to the reaction flask and sparged with argon for 5 min.  Then Pd(OAc)2 (22 mg, 0.10 
mmol) was added to the reaction flask and sparged with argon for an additional 10 min.  The 
reactants were dissolved in aqueous ACN (2:1 H2O: ACN, 10 mL) sparged with argon for 30 min 
and then heated to 80 °C.  The reaction was stirred for 2.5 h or until reverse-phase TLC (RP-TLC; 
C18, 1:1 H2O:CH3OH, UV detection) indicated complete consumption of 1, which typically was 
accompanied by the reaction mixture changing from a clear, yellowish color to an opaque, black 
color.  The reaction mixture was cooled to rm temp, diluted with H2O (5 mL) and further cooled 
with an ice bath.  The pH was not adjusted unlike the other C8-aryl-2’-deoxyguanosine derivatives 
and the precipitate was isolated via vacuum filtration, washed with water and then ethyl acetate, 
and the filter cake was dried in vacuo to yield 6 (365 mg, 0.75 mmol, 74.9 %).   
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1H NMR (300 MHz, DMSO-d6):  δ ppm 7.60 (2H, d, 8.4 Hz), 7.45 (2H, d, 8.1 Hz), 6.65 (2H, s, 
NH2), 6.08 (1H, t, J = 7.5 Hz, H1’), 5.83 (1H, brs, 3’-OH), 5.12 (1H, brs, 5’-OH), 4.80 (2H, s, CH2 
4.37 (1H, m, H3’), 3.83 (1H, m, H4’), 3.67 and 3.54 (2H, m, H5’/H5”), 3.15 (1H, m, H2”), and 
2.03 (1H, dd, J = 6.0, 12.0 Hz, H2’), 0.94 (9H, s, t-butyl), and 0.12 (6H, s, dimethylsilyl).  
 
8-(4-Methoxymethylphenyl)-2’-deoxyguanosine C18H21O5N5 (7):  4-MPhBA (410 mg, 2.47 
mmol), 1 (692 mg, 2.0 mmol), Na2CO3 (421 mg, 3.97 mmol), TPPTS (80 mg, 0.14 mmol) were 
added to the reaction flask and sparged with argon for 5 min.  Then Pd(OAc)2 (11.6 mg, 0.053 
mmol) was added to the reaction flask and sparged with argon for an additional 10 min.  The 
reactants were dissolved in aqueous ACN (1:1 H2O:ACN, 20 mL) sparged with argon for 30 min 
and then heated to 80 °C.  The reaction was stirred for 2.5 h or until reverse-phase TLC (RP-TLC; 
C18, 1:1 H2O:CH3OH, UV detection) indicated complete consumption of 1, which typically was 
accompanied by the reaction mixture changing from a clear, yellowish color to an opaque, black 
color.  The reaction mixture was cooled to rm temp by the addition of ice and diluted with H2O 
(10 mL) and further cooled with an ice bath.  The pH was adjusted to 6-7 by the drop-wise addition 
of 10% HCl.  The precipitate was isolated via vacuum filtration and the filter cake was dried in 
vacuo to 7 (708 mg, 1.83 mmol, 91.5 % yield).   
 
1H NMR (300 MHz, DMSO-d6):  δ ppm 10.76 (1H, s, NH), 7.64 (2H, d, 9.0 Hz), 7.47 (2H, d, 9.0 
Hz), 6.39 (2H, s, NH2), 6.07 (1H, t, J = 7.5 Hz, H1’), 5.12 (1H, d, J = 6.0 Hz, 3’-OH), 4.99 (1H, 
d, J = 6.0 Hz, 5’-OH), 4.33 (1H, m, H3’), 3.78 (1H, m, H4’), 3.65 and 3.54 (2H, m, H5’/H5”), 3.32 
(3H, s, OCH3), 3.15 (1H, m, H2”), and 2.02 (1H, ddd, J = 3.0, 6.0, 9.0 Hz, H2’).  
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8-(4-Carboxyphenyl)-2’-deoxyguanosine C17H17O6N5 (8):  4-CPhBA (410 mg, 2.47 mmol), 1 
(8-Br2dG; 692 mg, 2.0 mmol), Na2CO3 (421 mg, 3.97 mmol TPPTS (80 mg, 0.14 mmol) were 
added to the reaction flask and sparged with argon for 5 min.  Then Pd(OAc)2 (11.6 mg, 0.053 
mmol) was added to the reaction flask and sparged with argon for an additional 10 min.  The 
reactants were dissolved in aqueous ACN (1:1 H2O:ACN, 20 mL) sparged with argon for 30 min 
and then heated to 80 °C.  The reaction was stirred for 2.5 h or until reverse-phase TLC (RP-TLC; 
C18, 1:1 H2O:CH3OH, UV detection) indicated complete consumption of 1, which typically was 
accompanied by the reaction mixture changing from a clear, yellowish color to an opaque, black 
color.  The reaction mixture was gradually cooled to rm temp without an ice bath before diluted 
with H2O (10 mL) and the pH was adjusted to 6-7 by the drop-wise addition of 10% HCl.  The 
precipitate was isolated via vacuum filtration and the filter cake was dried in vacuo to yield 8 (704 
mg, 1.84 mmol, 92.0 %).   
 
1H NMR (300 MHz, DMSO-d6):  δ ppm 10.83 (1H, s, NH), 8.07 (2H, d, 8.3 Hz), 7.80 (2H, d, 8.4 
Hz), 6.49 (2H, s, NH2), 6.10 (1H, t, J = 7.5 Hz, H1’), 5.12 (1H, brs, 3’-OH), 4.95 (1H, brs, 5’-OH), 
4.34 (1H, m, H3’), 3.80 (1H, m, H4’), 3.66 and 3.55 (2H, m, H5’/H5”), 3.11 (1H, m, H2”), and 
2.04 (1H, ddd, J = 3.0, 6.0, 9.0 Hz, H2’).  
 
N2-(N,N-Dimethylformamidine)-8-phenyl-2’-deoxyguanosine, C19H22O6N6 (9):  Compound 4 
(350 mg, 1.02 mmol) was suspended in methanol (7 mL) and N,N-dimethylformamide dimethyl 
acetal (625 µL, 5.0 mmol) was added to the reaction.  The suspension was stirred at rm temp for 
59 
 
24-48 h.  The solvent was removed in vacuo to yield 9 which was used without further purification 
(382 mg, 0.96 mmol, 94.0 % yield) 
 
1H NMR (300 MHz, DMSO-d6):  δ ppm 11.48 (1H, s, NH), 8.53 (1H, s, HC=N), 7.68 (2H, m), 
7.58 (3H, m), 6.14 (1H, t, J = 7.4 Hz, H1’), 5.23 (1H, brs, 3’-OH), 4.94 (1H, brs, 5’-OH), 4.46 
(1H, m, H3’), 3.84 (1H, m, H4’), 3.70 and 3.61 (2H, m, H5’/H5”), 3.23 (1H, m, H2”), 3.17 and 
3.07 (3H each, s, N(CH3)2) and 2.08 (1H, ddd, J = 3.0, 6.0, 9.0 Hz, H2’).  
 
N2-(N,N-Dimethylformamidine)-8-p-tolyl-2’-deoxyguanosine, C20H24O4N6 (10):  Compound 
5 (365 mg, 1.02 mmol) was suspended in methanol (7 mL) and N,N-dimethylformamide dimethyl 
acetal (625 µL, 5.0 mmol) was added to the reaction mixture.  The suspension was stirred at rm 
temp for 24-48 h.  The solvent was removed in vacuo to yield 10 which was used without further 
purification (405 mg, 0.98 mmol, 96.3 % yield) 
 
1H NMR (300 MHz, DMSO-d6):  δ ppm 11.44 (1H, s, NH), 8.50 (1H, s, HC=N), 7.54 (2H, d, J = 
8.0 Hz, aryl), 7.58 (2H, d, J = 8.0 Hz, aryl), 6.10 (1H, t, J = 7.4 Hz, H1’), 5.20 (1H, brs, 3’-OH), 
4.98 (1H, brs, 5’-OH), 4.43 (1H, m, H3’), 3.81 (1H, m, H4’), 3.67 and 3.56 (2H, m, H5’/H5”), 
3.22 (1H, m, H2”), 3.15 and 3.05 (3H each, s, N(CH3)2), 2.40 (3H, s, CH3), and 2.08 (1H, ddd, J 
= 2.7, 6.6, 9.2 Hz, H2’).  
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N2-(N,N-Dimethylformamidine)-8-(4-(TBS-O-methyl)phenyl-2’-deoxyguanosine, 
C26H38O5N6Si (11):  Compound 6 (497 mg, 1.02 mmol) was suspended in methanol (7 mL).  The 
addition of N,N-dimethylformamide dimethyl acetal (625 µL, 5.0 mmol) created the reaction 
solution, which was stirred at rm temp for 24-48 h.  The solvent was removed in vacuo to yield 11 
and was used without further purification (485 mg, 0.89 mmol, 84.6 % yield) 
 
1H NMR (300 MHz, DMSO-d6):  δ ppm 8.51 (1H, s, HC=N), 7.63 (2H, d, J = 8.0 Hz, aryl), 7.58 
(2H, d, J = 8.0 Hz, aryl), 6.10 (1H, t, J = 7.2 Hz, H1’), 4.81 (2H, s, CH2), 4.44 (1H, m, H3’), 3.81 
(1H, m, H4’), 3.66 and 3.57 (2H, m, H5’/H5”), 3.24 (1H, m, H2”), 3.15 and 3.05 (3H each, s, 
N(CH3)2) and 2.08 (1H, ddd, J = 3.0, 6.0, 9.0 Hz, H2’) 0.94 (9H, s, t-butyl), and 0.12 (6H, s, 
dimethylsilyl).  
 
N2-(N,N-Dimethylforamidine)-8-(4-methoxymethylphenyl)-2’-deoxyguanosine, C21H26O5N6 
(12):  Compound 7 (395 mg, 1.02 mmol) was suspended in methanol (7 mL) and N,N-
dimethylformamide dimethyl acetal (625 µL, 5.0 mmol) was added to the reaction mixture.  The 
suspension was stirred at rm temp for 24-48 h.  The solvent was removed in vacuo to yield 12 and 
was used without further purification (430 mg, 0.97 mmol, 95.2 % yield) 
 
1H NMR (300 MHz, DMSO-d6):  δ ppm 11.44 (1H, s, NH), 8.49 (1H, s, HC=N), 7.63 (2H, d, J = 
8.3 Hz, aryl), 7.49 (2H, d, J = 8.3 Hz, aryl), 6.11 (1H, t, J = 7.5 Hz, H1’), 5.20 (1H, brs, 3’-OH), 
4.50 (2H, s, CH2), 4.43 (1H, m, H3’), 3.82 (1H, m, H4’), 3.66 and 3.58 (2H, m, H5’/H5”), 3.35 
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(3H, s, OCH3), 3.22 (1H, m, H2”), 3.14 and 3.04 (3H each, s, N(CH3)2) and 2.08 (1H, ddd, J = 3.0, 
6.0, 9.0 Hz, H2’).  
 
N2-(N,N-Dimethylformamidine)-8-(4-carboxyphenyl)-2’-deoxyguanosine, C20H22O6N6 (13):  
Compound 8 (395 mg, 1.02 mmol) was suspended in methanol (7 mL).  The addition of N,N-
dimethylformamide dimethyl acetal (625 µL, 5.0 mmol) created the reaction solution, which was 
stirred at rt for 24-48h.  The solvent was removed in vacuo to yield 13 and used without further 
purification (422 mg, 0.95 mmol, 93.5 % yield) 
 
1H NMR (300 MHz, DMSO-d6):  δ ppm 8.57 (1H, s, HC=N), 8.03 (2H, d, J = 8.3 Hz, aryl), 7.62 
(dH, d, J = 8.3 Hz, aryl), 6.18 (1H, t, J = 7.9 Hz, H1’), 4.52 (1H, m, H3’), 3.85 (1H, m, H4’), 3.71 
and 3.62 (2H, m, H5’/H5”), 3.22 (1H, m, H2”), 3.14 and 3.06 (3H each, s, N(CH3)2) and 2.14 (1H, 
ddd, J = 3.0, 6.0, 9.0 Hz, H2’).  
 
5’-O-(4,4’-Dimethoxytrityl)-N2-(N,N-dimethylformamidine)-8-phenyl-2’-deoxyguanosine, 
C40H40O6N6 (14):  Compound 9 (398 mg, 1.0 mmol) was dissolved in pyridine (8 mL) and then 
4,4’-dimethoxytrityl chloride (DMTr-Cl; 501 mg, 1.48 mmol) was added, which resulted in a deep 
red reaction mixture.  TEA (0.175 mL) was then added to the reaction vessel, the reaction was 
stirred at rm temp, under argon, and the reaction progress was monitored by normal phase TLC 
(neutral alumina, 5 % CH3OH:CH2Cl2).  TLC confirmed complete consumption of 9 (10 % HCl 
solution to develop the TLC) indicated by an orange spot on the TLC strip.  Once the reaction is 
complete, methanol (8 mL) was added to the reaction mixture to destroy the remaining DMTr-Cl.  
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The solvents were removed in vacuo and the product dried in a desiccator (P2O5).  Crude 14 was 
purified by low pressure column chromatography (neutral alumina, 0-5% CH3OH:CH2Cl2) to give 
the pure 14 (350 mg, 0.5 mmol, 50.0 % yield).   
 
1H NMR (300 MHz, DMSO-d6):  δ ppm 11.42 (1H, s, NH), 8.30 (1H, s, HC=N), 7.75 (2H, m), 
7.33 (3H, m), 7.33-6.73 (13H, m, DMTr-H), 6.17 (1H, dd, J = 5.3, 7.8 Hz, H1’), 5.27 (1H, d, J = 
4.8 Hz, 3’-OH), 4.58 (1H, m, H3’), 3.92 (1H, m, H4’), 3.71 and 3.70 (3H each, s, OCH3), 3.31 and 
3.14 (2H, m, H5’/H5”), 3.22 (1H, m, H2”), 3.03 and 2.98 (3H each, s, N(CH3)2) and 2.18 (1H, m, 
H2’).  
 
5’-O-(4,4’-Dimethoxytrityl)-N2-(N,N-dimethylformamidine)-8-p-tolyl-2’-deoxyguanosine, 
C41H42O6N6 (15):  Compound 10 (412 mg, 1.0 mmol) was dissolved in pyridine (8 mL) and then 
DMTr-Cl (501 mg, 1.48 mmol) was added to the reaction solution, which resulted in a deep red 
reaction mixture. TEA (0.175 mL) was then added to the reaction vessel, the reaction was stirred 
at rm temp, under argon, and the reaction progress was monitored by normal phase TLC (neutral 
alumina, 5 % CH3OH:CH2Cl2).  TLC confirmed complete consumption of 10 (10 % HCl solution 
to develop the TLC) indicated by an orange spot on the TLC strip.  Once the reaction was complete, 
methanol (8 mL) was added to the reaction mixture to destroy the remaining DMTr-Cl.  The 
solvents were removed in vacuo and the product dried in a desiccator (P2O5). Crude 15 was purified 
by low pressure column chromatography (neutral alumina, 0-5% CH3OH:CH2Cl2) (341 mg, 0.49 
mmol, 48.5% yield).   
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1H NMR (300 MHz, DMSO-d6):  δ ppm 11.40 (1H, s, NH), 8.30 (1H, s, HC=N), 7.64 (2H, d, J = 
7.8 Hz, aryl), 7.33 (4H, m, aryl/DMTr-H), 7.20-6.72 (11H, m, DMTr-H), 6.15 (1H, dd, J = 5.1, 
7.8 Hz, H1’), 5.27 (1H, d, J = 5.1 Hz, 3’-OH), 4.57 (1H, m, H3’), 3.91 (1H, m, H4’), 3.71 and 3.70 
(3H each, s, OCH3), 3.28 and 3.14 (2H, m, H5’/H5”), 3.21 (1H, m, H2”), 3.02 and 2.97 (3H each, 
s, N(CH3)2), 2.39 (3H, s, CH3), and 2.16 (1H, m, H2’).  
 
5’-O-(4,4’-Dimethoxytrityl)-N2-(N,N-dimethylformamidine)-8-(4-(TBS-O-methyl)phenyl-
2’-deoxyguanosine, C51H56O7N6Si (16):  Compound 11 (543 mg, 1.0 mmol) was dissolved in 
pyridine (8 mL) and then DMTr-Cl (501 mg, 1.48 mmol) was added to the reaction solution, which 
resulted in a deep red reaction mixture.  TEA (0.175 mL) was then added to the reaction vessel, 
the reaction was stirred at rm temp, under argon, and the reaction progress was monitored by 
normal phase TLC (neutral alumina, 5 % CH3OH:CH2Cl2).  TLC confirmed complete 
consumption of 11 (10 % HCl solution to develop the TLC) indicated by an orange spot on the 
TLC strip.  Once the reaction was complete, methanol (8 mL) was added to the reaction mixture 
to destroy the remaining DMTr-Cl.  The solvents were removed in vacuo and the product dried in 
a desiccator (P2O5). Crude 16 was purified by low pressure column chromatography (neutral 
alumina, 0-5% CH3OH:CH2Cl2) (332 mg, 0.32 mmol, 39.3 % yield).   
 
1H NMR (300 MHz, DMSO-d6):  δ ppm 11.43 (1H, s, NH), 8.33 (1H, s, HC=N), 7.75 (2H, d, J = 
7.8 Hz, aryl), 7.48 (2H, d, J = 7.8 Hz, aryl), 7.35-6.74 (13H, m, DMTr-H), 6.19 (1H, t, J = 6.2 Hz, 
H1’), 5.29 (1H, d, J = 4.7 Hz, 3’-OH), 4.83 (2H, s, CH2), 4.59 (1H, m, H3’), 3.94 (1H, m, H4’), 
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3.73 and 3.72 (3H each, s, OCH3), 3.31 and 3.17 (2H, m, H5’/H5”), 3.24 (1H, m, H2”), 3.05 and 
3.00 (3H each, s, N(CH3)2), 2.19 (1H, m, H2’), 0.99 (9H, s, t-butyl), and 0.14 (6H, s, dimethylsilyl).  
 
5’-O-(4,4’-Dimethoxytrityl)-N2-(N,N-dimethylformamidine)-8-(4-methoxymethylphenyl)-
2’-deoxyguanosine, C42H44O7N6 (17):  Compound 12 (442 mg, 1.0 mmol) was dissolved in 
pyridine (8 mL) and then DMTr-Cl (501 mg, 1.48 mmol) was added to the reaction solution, which 
resulted in a deep red reaction mixture.  TEA (0.175 mL) was then added to the reaction vessel, 
the reaction was stirred at rm temp, under argon, and the reaction progress was monitored by 
normal phase TLC (neutral alumina, 5 % CH3OH:CH2Cl2).  TLC confirmed complete 
consumption of 12 (10 % HCl solution to develop the TLC) indicated by an orange spot on the 
TLC strip.  Once the reaction was complete, methanol (8 mL) was added to the reaction mixture 
to destroy the remaining DMTr-Cl.  The solvents were removed in vacuo and the product dried in 
a desiccator (P2O5). Crude 17 was purified by low pressure column chromatography (neutral 
alumina, 0-5% CH3OH:CH2Cl2, 399 mg, 0.54 mmol, 53.5 % yield).   
 
1H NMR (300 MHz, DMSO-d6):  δ ppm 11.41 (1H, s, NH), 8.30 (1H, s, HC=N), 7.74 (2H, d, J = 
8.1 Hz, aryl), 7.33 (2H, d, J = 8.1 Hz, aryl), 7.33-6.72 (13H, m, DMTr-H), 6.17 (1H, dd, J = 5.3, 
8.0 Hz, H1’), 5.27 (1H, d, J = 4.8 Hz, 3’-OH), 4.55 (1H, m, H3’), 4.50 (2H, s, CH2), 3.91 (1H, m, 
H4’), 3.71 and 3.70 (3H each, s, OCH3), 3.50 (3H, s, OCH3), 3.30 and 3.16 (2H, m, H5’/H5”), 
3.22 (1H, m, H2”), 3.03 and 2.98 (3H each, s, N(CH3)2) and 2.17 (1H, m, H2’).  
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5’-O-(4,4’-Dimethoxytrityl)-N2-(N,N-dimethylformamidine)-8-(4-carboxyphenyl)-2’-
deoxyguanosine, C41H40O8N6 (18):  Compound 13 (398 mg, 1.0 mmol) was dissolved in pyridine 
(8 mL) and then DMTr-Cl (501 mg, 1.48 mmol) was added to the reaction solution, which resulted 
in a deep red reaction mixture.  TEA (0.175 mL) was then added to the reaction vessel, the reaction 
was stirred at rt, under argon, and the reaction progress was monitored by reverse-phase TLC (C18, 
5 % CH3OH:CH2Cl2).  TLC confirmed complete consumption of 13 (10 % HCl solution to develop 
the TLC) indicated by an orange spot on the TLC strip.  Once the reaction was complete, methanol 
(8 mL) was added to the reaction mixture to destroy the remaining DMTr-Cl.  The solvents were 
removed in vacuo and the product dried overnight in a desiccator (P2O5). The crude DMTr-
8CPh2dG was suspended in freshly distilled CH2Cl2 (100 mL) and stored at -20 °C for 24-48h.  
The precipitate was isolated via vacuum filtration and the filtrate was stored at -20 °C for additional 
24h.  This process was repeated again to maximize yield of the final DMTr-protected 18 (505 mg, 
0.68 mmol, 67.8 % yield).   
 
1H NMR (300 MHz, DMSO-d6):  δ ppm 11.46 (1H, s, NH), 8.32 (1H, s, HC=N), 8.07 (2H, d, J = 
8.3 Hz, aryl), 7.89 (2H, d, J = 8.3 Hz, aryl), 7.33-6.72 (13H, m, DMTr-H), 6.20 (1H, dd, J = 5.4, 
7.8 Hz, H1’), 5.20 (1H, brs, 3’-OH), 4.59 (1H, m, H3’), 3.92 (1H, m, H4’), 3.71 and 3.70 (3H each, 
s, OCH3), 3.30 and 3.14 (2H, m, H5’/H5”), 3.19 (1H, m, H2”), 3.03 and 2.99 (3H each, s, N(CH3)2) 
and 2.20 (1H, m, H2’).  
 
3’-O-[2-Cyanoethoxy)(diisopropylamino)phosphine]-5’-O-(4,4’-dimethoxytrityl)-N2-(N,N-
dimethylformamidine)-8-phenyl-2’-deoxyguanosine, C49H57O7N8P (19):  Compound 14 (203 
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mg, 0.29 mmol) was dissolved in CH2Cl2 (3 mL) and TEA (80 µL) before 2-cyanoethyl 
diisopropylchlorophosphoramidite (CEDCIP; 65 µL, 0.29 mmol) was added.  The reaction was 
allowed to stir at rm temp for 30 min and then another aliquot of CEDCIP (14 µL, 0.14 mmol) was 
added and stirred for 30 min at rm temp.  The reaction progress was monitored with normal phase 
TLC (neutral alumina, 5 % CH3OH:CH2Cl2) and once TLC indicated complete consumption of 14 
the reaction solvents were removed in vacuo.  Then, benzene:THF (4:1, 4 mL) was added, briefly 
mixed, and filtered under argon.  The filtrate was concentrated in vacuo in individual vials (~250 
µL/vial) to produce 19, which is ready for DNA synthesis.   
 
3’-O-[2-Cyanoethoxy)(diisopropylamino)phosphine]-5’-O-(4,4’-dimethoxytrityl)-N2-(N,N-
dimethylformamidine)-8-p-tolyl-2’-deoxyguanosine, C50H59O7N8P (20):  Compound 15 (207 
mg, 0.29 mmol) was dissolved in CH2Cl2 (3 mL) and TEA (80 µL) before 2-cyanoethyl 
diisopropylchlorophosphoramidite (CEDCIP; 65 µL, 0.29 mmol) was added.  The reaction was 
allowed to stir at rm temp for 30 min and then another aliquot of CEDCIP (14 µL, 0.14 mmol) was 
added and stirred for 30 min at rm temp.  The reaction progress was monitored with normal phase 
TLC (neutral alumina, 5 % CH3OH:CH2Cl2) and once TLC indicated complete consumption of 15 
the reaction solvents were removed in vacuo.  Then, benzene:THF (4:1, 4 mL) was added, briefly 
mixed, and filtered under argon.  The filtrate was concentrated in vacuo in individual vials (~250 
µL/vial) to produce 20, which is ready for DNA synthesis.   
 
3’-O-[2-Cyanoethoxy)(diisopropylamino)phosphine]-5’-O-(4,4’-dimethoxytrityl)-N2-(N,N-
dimethylformamidine)-8-(4-(TBS-O-methyl)phenyl)-2’-deoxyguanosine, C56H73O8N8SiP 
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(21):  Compound 16 (245 mg, 0.29 mmol) was dissolved in CH2Cl2 (3 mL) and TEA (80 µL) 
before 2-cyanoethyl diisopropylchlorophosphoramidite (CEDCIP; 65 µL, 0.29 mmol) was added.  
The reaction was allowed to stir at rm temp for 30 min and then another aliquot of CEDCIP (14 
µL, 0.14 mmol) was added and stirred for 30 min at rm temp.  The reaction progress was monitored 
with normal phase TLC (neutral alumina, 5 % CH3OH:CH2Cl2) and once TLC indicated complete 
consumption of 16 the reaction solvents were removed in vacuo.  Then, benzene:THF (4:1, 4 mL) 
was added, briefly mixed, and filtered under argon.  The filtrate was concentrated in vacuo in 
individual vials (~250 µL/vial) to produce 21, which is ready for DNA synthesis.   
 
3’-O-[2-Cyanoethoxy)(diisopropylamino)phosphine]-5’-O-(4,4’-dimethoxytrityl)-N2-(N,N-
dimethylformamidine)-8-(4-methoxymethylphenyl)-2’-deoxyguanosine, C49H57O7N8P (22):  
Compound 17 (216 mg, 0.29 mmol) was dissolved in CH2Cl2 (3 mL) and TEA (80 µL) before 2-
cyanoethyl diisopropylchlorophosphoramidite (CEDCIP; 65 µL, 0.29 mmol) was added.  The 
reaction was allowed to stir at rm temp for 30 min and then another aliquot of CEDCIP (14 µL, 
0.14 mmol) was added and stirred for 30 min at rm temp.  The reaction progress was monitored 
with normal phase TLC (neutral alumina, 5 % CH3OH:CH2Cl2) and once TLC indicated complete 
consumption of 17 the reaction solvents were removed in vacuo.  Then, benzene:THF (4:1, 4 mL) 
was added, briefly mixed, and filtered under argon.  The filtrate was concentrated in vacuo in 
individual vials (~250 µL/vial) to produce 22, which is ready for DNA synthesis.   
 
3’-O-[2-Cyanoethoxy)(diisopropylamino)phosphine]-5’-O-(4,4’-dimethoxytrityl)-N2-(N,N-
dimethylformamidine)-8-(4-carboxyphenyl)-2’-deoxyguanosine, C50H57O9N8P (23):  
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Compound 18 (216 mg, 0.29 mmol) was suspended in CH2Cl2 (3 mL) and TEA (80 µL).  The 
addition of 2-cyanoethyl diisopropylchlorophosphoramidite (CEDCIP; 65 µL, 0.29 mmol) created 
the reaction solution.  The reaction was allowed to stir at rm temp for 30 min and then another 
aliquot of CEDCIP (14 µL, 0.14 mmol) was added and stirred for 30 min at rm temp.  The reaction 
progress was monitored with reverse phase TLC (C18, 5 % CH3OH:CH2Cl2) and once TLC 
indicated complete consumption of 18 the reaction solvents were removed in vacuo.  Then, 
benzene:THF (4:1, 4 mL) was added, briefly mixed, and filtered under argon.  The filtrate was 
concentrated in vacuo in individual vials (~250 µL/vial) to produce 23, which is ready for DNA 
synthesis.   
 
B. Synthesis, Purification and Structure Confirmation of Hairpin Oligonucleotides 
 
1. General  
 
The unmodified hairpin oligonucleotide dG (HP-CG) and modified hairpin 
oligonucleotides (C8-phenyl- (HP-CG8Ph), C8-tolyl- (HP-CG8Tol), C8-hydroxymethylphenyl- 
(HP-CG8HMPh), C8-methoxymethylphenyl- (HP-CG8MMPh), and C8-carboxyphenylguanine 
(HP-CG8CPh)) were synthesized on an ABI-394 DNA synthesizer (Foster City, CA).  DNA 
synthesizer phosphoramidites (dG CE-PA, dC CE-PA and dT CE-PA) and CPG (dG, 1 µmol, 500 
Å pore size) columns were purchased from Glen Research (Sterling, VA).  DNA synthesizer 
reagents:  phosphoramidite diluent (anhydrous ACN), activator (0.45 M tetrazole in ACN), cap 
mix A (THF, pyridine, and acetic anhydride), cap mix B (16 % 1-methylimidazole in THF), 
oxidizing solution (0.02 M I2 in THF, pyridine, and water), and deblocking mix (3 % 
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trichloroacetic acid (TCA) in CH2Cl2) were also purchased from Glen Research. Anhydrous 
acetonitrile (4 L) was purchased from Fisher Scientific (Waltham, MA). 
The FPLC system used in the purification of the synthetic hairpin oligonucleotides 
employed a Waters U6K loop injector, HPLC 510 pump, and a 2487 dual absorbance detector 
(Milford, MA).  The anion exchange columns (DEAE-5PW) were purchased from Tosoh 
Bioscience (Montgomeryville, PA).  Maxi-Clean™ reversed-phase solid phase extraction (SPE) 
cartridges were purchased from Fisher Scientific (Waltham, MA).  The amount of hairpin 
oligonucleotide in the crude and purified samples were quantified using a Beckman DU640 
spectrophotometer (Somerset, NJ) and the OD, measured at 260 nm, was converted into a 
concentration using OligoCalc.161  ESI-MS spectra were recorded on a Q-Exactive (Thermo 
Scientific, West Palm Beach, FL).   
 
2. DNA Synthesis 
 
The hairpin oligonucleotides (unmodified and modified) were synthesized on a 1 µmol 
scale.  Reagents were used according to the shelf life specified by the ABI DNA synthesizer 
manual.  DNA synthesis is performed 3’ to 5’ and therefore the C8-aryl-2’-deoxyguanine modified 
base was located closer to the 5’-end of the hairpin sequence 
(d(5’-CGCGCG*CGCGTTTTCGCGCGCGCG-3’)) to minimize exposure of the 
C8-aryl-2’-deoxyguanine modified base to TCA, used in the detritylation step in base extension.  
In general, the synthesis followed standard protocols for the 1.0 µM CE cycle using the four major 
steps of detritylation, coupling, capping, and oxidation (see Scheme 2.3).  The major exception 
here is the C8-aryl-2’-deoxyguanine modified base was manually coupled to the growing 
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oligonucleotide chain because the C8-aryl-2’-deoxyguanine phosphoramidites form insoluble 
gels, rapidly, after dissolution with ACN. 
Compounds 19 – 23 were used to make HP-CG8Ph, HP-CG8Tol, HP-CG8HMPh, HP-CG8MMPh, 
or HP-CG8CPh, respectively.  After detritylation of the 3’-dC base (C7 , 18th base) the synthesizer 
was paused and the column was removed from the DNA synthesizer and sealed with Luer-Lok (3 
mL) syringes, previously purged with argon to prevent the exposure of the growing 
oligonucleotide chain to air or moisture.  Using a 1 mL syringe, the activator solution (100 µL) 
was placed in the Luer-Lok fitting above the dG CPG synthesis column.  The C8-aryl-2’-
deoxyguanine modified phosphoramidites (15 – 25 mg, 15 – 25 µmol) were dissolved in anhydrous 
ACN (100 µL), drawn up into a 1 mL syringe, and then fitted to the bottom Luer-Lok fitting below 
the dG-CPG synthesis column.  The activator solution was pushed through the synthesis column 
into the C8-arylguaine phosphoramidite solution, briefly mixed, before returning the solution back 
into the CPG column.  The C8-aryl-2’-deoxyguanine solution is mixed repeatedly back and forth 
(above and below) through the CPG column by pushing and pulling the top and bottom syringes 
connected to the CPG column.  This process was repeated 3 times every 5 min (15 min total) for 
the first addition of the C8-aryl-2’-deoxyguanine phosphoramidite.  After 15 min, the solution was 
removed and the CPG column was washed with fresh activator (0.5 mL).  Then fresh activator 
(100 µL) was placed above the column in a 1 mL syringe and the second addition of modified 
phosphoramidite (15 – 25 mg, 15 – 25 µmol) was dissolved in anhydrous ACN (100 µL), drawn 
up into a 1 mL syringe, and fitted below the CPG column.  Again the activator is pushed through 
the CPG column to the phosphoramidite solution below the column, mixed, and the activated 
phosphoramidite solution is added back to the CPG column.  The solution is repeatedly mixed 
above and below the column before allowing to remain in the column for 5 min and the process is 
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repeated three more times (15 min total).  After the reaction is complete, the phosphoramidite 
solution is removed from the column the column is washed and rinsed with fresh anhydrous ACN 
(1 mL) before returning the column back to the DNA synthesizer.  Once placed back on the DNA 
synthesizer the coupling steps are skipped resuming with the capping step in the DNA synthetic 
cycle.   
Once DNA synthesis is complete, the hairpin oligonucleotides are cleaved from the CPG 
column using ammonium hydroxide (30 % NH3, 1 mL).  Cleavage occurs by pushing the 
ammonium hydroxide (0.3 mL) from syringe above the CPG column into the syringe below the 
column every 20 min (1 h total).  The cleaved oligonucleotides were transferred to a centrifuge 
tube and deprotected by heating the ammonium hydroxide solution at 55 °C overnight (≤ 18h).  
After deprotection, the centrifuge tube is cooled to rm temp and then concentrated to dryness in 
the SpeedVac™ to yield the crude hairpin oligonucleotide. 
 
3. FPLC Purification  
 
The crude hairpin oligonucleotides contain unwanted products which are mainly 
incomplete oligonucleotide sequences but may also contain residual protecting groups that will 
confound the conformational analysis experiments (Figure 3.1).  Therefore, all of the hairpin 
oligonucleotides require purification before characterization and conformational analysis.  The 
crude hairpins (100 OD) were dissolved in deionized (DI) water (500 µL) and purified using a 
gradient of 50%-80% mobile phase B over 30 min (mobile phase: A: 10 mM NaOH, mobile phase 
B: 10 mM NaOH/ 1M NaCl) at a flow rate of 6 mL/min on the DEAE-5PW preparative column 
(21.5 mm ID x 15 cm).  Oligonucleotide separation was monitored by UV detection at 260 nm and 
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the major peaks of the crude solution were collected (Figure 3.2).  The majority of the time the 
signal that gives the largest absorbance is the desired sequence of interest. 
 
 
 
Figure 3.1.  FPLC chromatogram of the HP-CG8Ph hairpin oligonucleotide before purification. 
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After purification, the collected fractions need to be desalted to remove the salt used in the 
mobile phase.  The fractions were desalted using C18 SPE cartridges rinsed with methanol (6 mL) 
and then conditioned with water (6 mL).  The desired fraction was loaded on the SPE under 
conditions where the hairpin oligonucleotide is absorbed to the C18 packing material and the 
sodium chloride is not.  The SPE was washed with water (6 mL) to rinse off the salts, and the 
hairpin oligonucleotide was eluted from the SPE cartridge using aqueous methanol (60 %, 4 x 1.5 
mL).  The samples were concentrated to dryness in a SpeedVac™ to give the pure hairpin 
oligonucleotide. 
The success of the purification was confirmed by FPLC using an analytical DEAE-5PW 
column (5.0 mm ID x 5 cm).  The major objective of this experiment is to demonstrate that the 
purified hairpin oligonucleotide sample contains a single peak in the FPLC chromatogram.  The 
hairpin sample (~ 1 OD in deionized water) was injected into the FPLC and run using a gradient 
Figure 3.2.  FPLC chromatogram of the HP-CG8Ph oligonucleotide purification run. 
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of 30 – 90 % mobile phase B over 30 or 60 min.  The existence of a single peak in the 
chromatogram verifies that there was only one oligonucleotide species detected in the purified 
sample solution (Figure 3.3).  The retention times of all the hairpin oligonucleotides are presented 
in Table 3.1 and the FPLC chromatograms for the purified hairpin oligonucleotides are presented 
in Appendix C.  
 
 
 
Figure 3.3.  FPLC chromatogram of the HP-CG8Ph after purification. 
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4. ESI-MS Analysis 
 
The FPLC analysis is consistent with the hairpin oligonucleotide samples containing a 
single molecule but do not unequivocally confirm the identity of the DNA synthesis and 
purification products.  Therefore, the purified synthetic hairpin oligonucleotides was verified using 
by ESI-MS in negative ion mode.  Before analysis, however, samples were further desalted using 
Poly-Pak (Glen Research) C18 SPE cartridges.  The SPE cartridges were rinsed with ACN (2 mL) 
and conditioned with triethylammonium acetate (TEAA; 2 mL, 2 M).  Then the hairpin 
oligonucleotides are loaded onto the SPE column in water (< 50 OD).  The SPE column was 
washed with TEAA (3 mL, 0.1 M) and then the oligonucleotides were eluted with 50 % aqueous 
ACN (1 mL).  The samples were concentrated to dryness in a SpeedVac™.  The desalted 
oligonucleotide samples (25 µM) were dissolved in ammonium acetate (300 µM) in methanol and 
water (1:1).  Samples were analyzed via direct injection of solution of the oligonucleotide at a rate 
of 5 µL/min and with a scan range of 600–2,000 m/z.  Spectra were consistent with the desired 
 
Oligonucleotide   Retention Time (min) 
HP-CG   18.68 
HP-CG8Ph   19.16 
HP-CG8Tol   19.64 
HP-CG8HMPh   19.37 
HP-CG8MMPh   19.37 
HP-CG8CPh   20.20 
aRetention time determined using FPLC gradient 30 – 90 % mobile 
phase B over 30 min at 1 mL/min. 
Table 3.1.  FPLC Analysis of Hairpin Oligonucleotidesa 
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products (< 0.01 % error), which confirms the synthesis of the C8-arylguanine hairpin 
oligonucleotides (Table 3.2).  ESI-MS spectra for all the hairpin oligonucleotides are displayed in 
Appendix C.   
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Part II:  Conformational Analysis of C8-Arylyguanine Modified  
Hairpin Oligonucleotides by Circular Dichroism 
  
After the hairpin oligonucleotide (unmodified and C8-arylguanine modified) had been 
synthesized, purified and the structures confirmed, the hairpin oligonucleotides were analyzed 
using circular dichroism (CD) and nuclear magnetic resonance spectroscopy (NMR) (see Part III).  
Using these two techniques, the conformational preferences of the single C8-arylguanine modified 
hairpin oligonucleotides, in comparison to the unmodified hairpin oligonucleotide were 
determined, as a function of variety of sample conditions.  This section will focus on the CD 
experiments.  In addition, the conformational effects of a single or double modified 
oligonucleotides will be compared and this will be presented in the Discussion section.   
Previous work in our group has demonstrated that the C8-aryguanine modifications shift 
the B-/Z-DNA equilibrium toward the Z-DNA conformation.98,100  Our previous studies examined 
d(CGCGCG*CGCG) sequences where G* is the C8-arylguanine modified base (G8Ph, G8Tol, 
G8HMPh, G8MMPh, or G8CPh).  Since the previous oligonucleotides are palindromes, the resulting 
duplex structure contains two modified bases and, therefore, it was unclear whether the two 
modified bases produced conformational effects independent of one another or if the effects were 
additive or synergistic.  To clarify this ambiguity, hairpin oligonucleotides can be designed to 
contain the d(CG)5 structure correspond to the ds-DNA, and synthesized to contain only one 
modified base since they are derived from one DNA strand.  Finally the original duplex 
oligonucleotides were analyzed by CD and NMR and the same techniques were used here and the 
data used to compare the conformational effects between one and two C8-arylguanine modified 
bases.   
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A. CD Measurement of the Hairpin Oligonucleotides 
1. General 
 
CD of the hairpin oligonucleotide samples (25 µM) of HP-CG, HP-CG8Ph, HP-CG8Tol, HP-
CG8HMPh, HP-CG8MMPh, and HP-CG8CPh were acquired in sodium phosphate (10 mM, pH 7.0) as a 
function of sodium chloride (0-4000 mM) and temperature (0–99 °C) or on oligonucleotide 
solutions (25 µM) in physiological salt conditions (pH 7.4):  NaCl (10 mM), KCl (140 mM), MgCl2 
(2 or 10 mM) with or without spermine (1 mM).  Hairpin oligonucleotides were annealed at 90 °C 
for 5 min then slowly cooled to rt over 1.5 h.  CD spectra were acquired on hairpin oligonucleotide 
samples using a Jasco J-810 spectropolarimeter (Easton, MD) and data were smoothed using the 
Jasco Spectra Analysis software.  CD spectra were measured from 350 to 220 nm using the 
continuous scanning mode (50 nm/min).  In addition, the CD spectra were recorded with a band 
width of 1 nm, a response rate of 1 sec and at a data pitch of 1 nm. CD data are reported as an 
average of triplicate experiments.  CD spectra obtained as function of salt concentration and 
temperature were acquired using a temperature pitch of 1 °C/min. 
 
2. Wavelength Scans  
 
CD is an excellent technique to distinguish between the tertiary structures of B- and 
Z-DNA.  The CD spectrum of B-DNA exhibits positive ellipticity at approximately 280 nm and 
negative ellipticity at approximately 250 nm.  The CD spectrum of Z-DNA exhibits negative 
ellipticity at approximately 295 nm and positive ellipticity at approximately 250 nm.  The CD 
spectra of the unmodified hairpin and the C8-arylguanine modified hairpin oligonucleotides were 
acquired at 37 °C at various sodium chloride concentrations (0, 25, 50, 100, 250, 500, 1000, 2000 
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and 4000 mM) are presented in Figures 3.4-3.9.  At low salt concentrations the B-DNA 
conformation is the predominant form in solution, however as the salt concentration is increased 
the amount Z-DNA also increases.   
The CD results here with the hairpin oligonucleotides are in good agreement with our 
previous studies98,100 as well as other studies with CG oligomers12 and hairpins.114  The unmodified 
hairpin (Figure 3.4) transition from B-DNA to Z-DNA between 2 M NaCl and 4 M NaCl whereas 
the C8-arylguanine modified hairpins require significantly less NaCl for the Z form to become 
predominant.  The CD spectra for HP-CG8Ph (Figure 3.5), HP-CG8Tol (Figure 3.6), HP-CG8HMPh 
(Figure 3.7), HP-CG8MMPh (Figure 3.8), and HP-CG8CPh (Figure 3.9) indicate that the transition 
from B-DNA to Z-DNA occurs between 500-1000 mM NaCl.  The CD at a single temperature 
with varying NaCl concentrations demonstrate the C8-arylguanine modified hairpins shift the B-
/Z-DNA equilibrium toward the Z-DNA conformation better than the unmodified hairpin.  
However, to make a quantitative comparison between the hairpin oligonucleotides or with the 
double-stranded oligonucleotides, the mole fractions must be calculated (see Chapter 2.F.1). 
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Figure 3.4.  CD spectra of HP-CG with 0 (black), 25 (gold), 50 (violet), 100 (light blue), 250 (indigo), 500 
(blue), 1000 (green), 2000 (orange), and 4000 (red) mM NaCl at 37 °C. 
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Figure 3.5.  CD spectra of HP-CG8Ph with 0 (black), 25 (gold), 50 (violet), 100 (light blue), 250 (indigo), 500 
(blue), 1000 (green), 2000 (orange), and 4000 (red) mM NaCl at 37 °C. 
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Figure 3.6.  CD spectra of HP-CG8Tol with 0 (black), 25 (gold), 50 (violet), 100 (light blue), 250 (indigo), 500 
(blue), 1000 (green), 2000 (orange), and 4000 (red) mM NaCl at 37 °C. 
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Figure 3.7.  CD spectra of HP-CG8HMPh with 0 (black), 25 (gold), 50 (violet), 100 (light blue), 250 (indigo), 500 
(blue), 1000 (green), 2000 (orange), and 4000 (red) mM NaCl at 37 °C. 
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Figure 3.8.  CD spectra of HP-CG8MMPh with 0 (black), 25 (gold), 50 (violet), 100 (light blue), 250 (indigo), 500 
(blue), 1000 (green), 2000 (orange), and 4000 (red) mM NaCl at 37 °C. 
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Figure 3.9.  CD spectra of HP-CG8CPh with 0 (black), 25 (gold), 50 (violet), 100 (light blue), 250 (indigo), 500 
(blue), 1000 (green), 2000 (orange), and 4000 (red) mM NaCl at 37 °C. 
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3. Mole Fraction Calculations and Z-DNA Quantitation 
 
When CD spectra are acquired using variable NaCl concentrations and variable 
temperatures, along with the assumption that the only conformations of DNA in solution are B-,  
Z-, and ss-DNA and that they are rapidly equilibrating, the mole fractions of each can be 
determined.117  The approach utilizes eqs 3.1 and 3.2:   
 
 
 
where f is the mole fraction of one of the three possible oligonucleotide conformations and Δε is 
the corresponding ellipticity of the oligonucleotide in that particular conformation.  The Δε values 
corresponding to each of the three possible conformations were estimated from CD data obtained 
at a) low salt at room temperature (30 °C) (ΔεB), b) high salt and low temperature (10 °C)  (ΔεZ), 
and c) low salt and high temperature (99 °C) (ΔεSS).  An isosbestic point was observed at 274 nm 
corresponding to the case where Δε for the B and Z forms are equal and therefore 
 fB + fZ = fds.  Thus, fSS could be determined using equations 3.3 and 3.4 and then fB and fZ were 
solved from equations 3.1, 3.2, and fSS. 
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The fB, fZ, and fSS for all the hairpin oligonucleotides are shown in Tables 3.3-3.8.  The data 
in these tables were used to generate the mole fraction plots (Figure 3.10-3.15).  The mole fraction 
plots were consistent with the known behavior of DNA where the B-DNA conformation is 
predominate at low salt concentrations and elevated temperatures while the Z-DNA conformation 
is favored at high salt concentrations and lower temperatures.  As the temperature increases the B-
DNA or ss-DNA form is favored.  Depending on the particular temperature in relation to the 
melting temperature (TM) either the B-DNA or ss-DNA will predominate.   
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Table 3.3.  Mole fractions of B-DNA, Z-DNA, and ss-DNA of HP-CG with 0-4000 mM NaCl 
at temperatures 10-99 °C. 
NaCl 
(mM) 
fB at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 1.00 1.00 1.00 0.97 0.91 0.87 0.76 0.59 0.07 0.00 
25 1.00 0.96 0.91 0.90 0.82 0.80 0.70 0.59 0.25 0.00 
50 1.00 0.95 0.88 0.88 0.83 0.81 0.73 0.66 0.34 0.00 
100 1.00 0.95 0.89 0.91 0.83 0.84 0.78 0.72 0.46 0.00 
250 0.98 0.91 0.86 0.81 0.76 0.72 0.63 0.57 0.37 0.00 
500 0.96 0.90 0.83 0.80 0.80 0.78 0.71 0.59 0.40 0.00 
1000 1.00 0.94 0.83 0.81 0.73 0.78 0.62 0.53 0.36 0.00 
2000 0.89 0.86 0.83 0.78 0.75 0.74 0.69 0.55 0.36 0.00 
4000 0.00 0.06 0.12 0.14 0.21 0.29 0.32 0.31 0.19 0.00 
 
          
NaCl 
(mM) 
fZ at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 
25 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
50 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
100 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
250 0.02 0.02 0.01 0.02 0.00 0.00 0.00 0.00 0.00 0.00 
500 0.04 0.02 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 
1000 0.00 0.00 0.04 0.02 0.02 0.04 0.01 0.01 0.00 0.00 
2000 0.11 0.10 0.08 0.09 0.07 0.05 0.04 0.04 0.02 0.00 
4000 1.00 0.92 0.82 0.77 0.71 0.59 0.51 0.39 0.24 0.00 
 
          
NaCl 
(mM) 
fSS at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.00 0.00 0.00 0.03 0.09 0.13 0.24 0.41 0.90 1.00 
25 0.00 0.04 0.09 0.10 0.18 0.20 0.30 0.41 0.75 1.00 
50 0.00 0.05 0.11 0.12 0.17 0.19 0.27 0.34 0.66 1.00 
100 0.00 0.05 0.11 0.09 0.17 0.16 0.22 0.28 0.54 1.00 
250 0.00 0.07 0.14 0.17 0.25 0.28 0.37 0.43 0.63 1.00 
500 0.00 0.08 0.16 0.20 0.20 0.22 0.29 0.40 0.60 1.00 
1000 0.00 0.06 0.12 0.18 0.25 0.02 0.37 0.47 0.64 1.00 
2000 0.00 0.05 0.10 0.13 0.18 0.21 0.28 0.42 0.62 1.00 
4000 0.00 0.02 0.06 0.09 0.08 0.12 0.17 0.30 0.56 1.00 
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Figure 3.10.  Mole fraction plots of the HP-CG calculated at 0, 25, 50, 100, 250, 500, 1000, 2000, and 4000 mM 
NaCl (A-I) over 10–99 °C.  B-DNA is displayed in the blue circles, Z-DNA in red squares and ss-DNA in black 
triangles.  
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Table 3.4.  Mole fractions of B-DNA, Z-DNA, and ss-DNA of HP-CG8Ph with 0-4000 mM 
NaCl at temperatures 10-99 °C. 
NaCl 
(mM) 
fB at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.96 0.93 0.89 0.85 0.76 0.66 0.38 0.11 0.02 0.00 
25 1.00 0.96 0.91 0.87 0.77 0.70 0.51 0.21 0.05 0.00 
50 0.98 0.96 0.92 0.87 0.85 0.78 0.60 0.28 0.05 0.00 
100 0.94 0.88 0.85 0.85 0.83 0.80 0.63 0.26 0.04 0.00 
250 0.94 0.88 0.82 0.80 0.71 0.61 0.51 0.32 0.09 0.00 
500 0.70 0.71 0.73 0.75 0.76 0.75 0.69 0.46 0.14 0.00 
1000 0.17 0.24 0.30 0.37 0.46 0.54 0.51 0.46 0.16 0.00 
2000 0.00 0.00 0.02 0.05 0.11 0.14 0.20 0.18 0.08 0.00 
4000 0.00 0.00 0.03 0.07 0.08 0.13 0.14 0.09 0.01 0.00 
                      
NaCl 
(mM) 
fZ at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.04 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 
25 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
50 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
100 0.06 0.04 0.02 0.00 0.00 0.00 0.00 0.00 0.01 0.00 
250 0.06 0.04 0.03 0.02 0.00 0.00 0.00 0.00 0.00 0.00 
500 0.30 0.25 0.20 0.15 0.11 0.05 0.00 0.00 0.00 0.00 
1000 0.83 0.76 0.69 0.61 0.50 0.40 0.28 0.14 0.03 0.00 
2000 1.00 0.99 0.93 0.91 0.83 0.76 0.63 0.47 0.18 0.00 
4000 1.00 1.00 0.96 0.90 0.87 0.77 0.70 0.56 0.33 0.00 
                      
NaCl 
(mM) 
fSS at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.00 0.06 0.11 0.15 0.24 0.34 0.62 0.89 0.97 1.00 
25 0.00 0.04 0.09 0.13 0.23 0.30 0.49 0.79 0.95 1.00 
50 0.00 0.03 0.08 0.13 0.15 0.22 0.40 0.72 0.95 1.00 
100 0.00 0.08 0.13 0.15 0.17 0.20 0.37 0.75 0.95 1.00 
250 0.00 0.08 0.15 0.18 0.29 0.39 0.49 0.68 0.91 1.00 
500 0.00 0.04 0.07 0.09 0.13 0.20 0.30 0.54 0.87 1.00 
1000 0.00 0.00 0.01 0.02 0.04 0.06 0.21 0.41 0.80 1.00 
2000 0.00 0.01 0.04 0.04 0.06 0.10 0.18 0.35 0.74 1.00 
4000 0.00 0.00 0.01 0.03 0.05 0.11 0.16 0.36 0.66 1.00 
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Figure 3.11.  Mole fraction plots of the HP-CG8Ph calculated at 0, 25, 50, 100, 250, 500, 1000, 2000, and 4000 mM 
NaCl (A-I) over 10–99 °C.  B-DNA is displayed in the blue circles, Z-DNA in red squares and ss-DNA in black 
triangles.  
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Table 3.5.  Mole fractions of B-DNA, Z-DNA, and ss-DNA of HP-CG8Tol with 0-4000 mM 
NaCl at temperatures 10-99 °C. 
NaCl 
(mM) 
fB at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.98 1.00 1.00 1.00 0.95 0.88 0.53 0.13 0.02 0.00 
25 0.96 0.97 0.93 0.94 0.86 0.83 0.65 0.27 0.04 0.00 
50 0.96 0.94 0.94 0.90 0.80 0.82 0.63 0.22 0.02 0.00 
100 0.93 0.91 0.90 0.88 0.86 0.86 0.73 0.31 0.05 0.00 
250 0.86 0.86 0.87 0.84 0.83 0.85 0.77 0.53 0.14 0.00 
500 0.63 0.68 0.70 0.73 0.76 0.80 0.75 0.57 0.21 0.00 
1000 0.17 0.24 0.28 0.37 0.52 0.62 0.64 0.54 0.19 0.00 
2000 0.00 0.00 0.00 0.04 0.09 0.14 0.27 0.26 0.14 0.00 
4000 0.00 0.01 0.04 0.07 0.12 0.20 0.19 0.16 0.05 0.00 
                      
NaCl 
(mM) 
fZ at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 
25 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
50 0.04 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.02 0.00 
100 0.07 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 
250 0.14 0.11 0.07 0.08 0.00 0.00 0.00 0.00 0.00 0.00 
500 0.37 0.29 0.24 0.18 0.12 0.04 0.00 0.00 0.00 0.00 
1000 0.83 0.74 0.71 0.63 0.46 0.34 0.22 0.10 0.04 0.00 
2000 1.00 0.97 0.96 0.91 0.82 0.75 0.59 0.41 0.13 0.00 
4000 1.00 0.98 0.92 0.86 0.82 0.76 0.72 0.58 0.32 0.00 
                      
NaCl 
(mM) 
fSS at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.00 0.00 0.00 0.00 0.05 0.12 0.47 0.87 0.97 1.00 
25 0.00 0.03 0.07 0.06 0.15 0.17 0.35 0.73 0.96 1.00 
50 0.00 0.04 0.06 0.10 0.20 0.18 0.37 0.78 0.96 1.00 
100 0.00 0.06 0.09 0.12 0.14 0.14 0.27 0.69 0.94 1.00 
250 0.00 0.03 0.06 0.09 0.17 0.15 0.23 0.47 0.86 1.00 
500 0.00 0.03 0.07 0.09 0.12 0.16 0.25 0.43 0.79 1.00 
1000 0.00 0.02 0.01 0.01 0.02 0.04 0.14 0.37 0.78 1.00 
2000 0.00 0.03 0.04 0.05 0.09 0.10 0.14 0.32 0.73 1.00 
4000 0.00 0.01 0.04 0.07 0.06 0.05 0.09 0.26 0.63 1.00 
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Figure 3.12.  Mole fraction plots of the HP-CG8Tol calculated at 0, 25, 50, 100, 250, 500, 1000, 2000, and 4000 
mM NaCl (A-I) over 10–99 °C.  B-DNA is displayed in the blue circles, Z-DNA in red squares and ss-DNA in 
black triangles.  
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Table 3.6.  Mole fractions of B-DNA, Z-DNA, and ss-DNA of HP-CG8HMPh with 0-4000 mM 
NaCl at temperatures 10-99 °C. 
NaCl 
(mM) 
fB at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 1.00 1.00 0.96 1.00 0.95 0.73 0.25 0.08 0.00 0.00 
25 1.00 0.96 0.93 0.88 0.73 0.64 0.43 0.04 0.00 0.00 
50 0.96 0.92 0.87 0.84 0.79 0.74 0.62 0.29 0.06 0.00 
100 0.99 0.93 0.90 0.86 0.78 0.76 0.65 0.34 0.07 0.00 
250 0.88 0.88 0.86 0.83 0.75 0.74 0.64 0.43 0.08 0.00 
500 0.73 0.76 0.75 0.75 0.74 0.74 0.66 0.46 0.16 0.00 
1000 0.21 0.26 0.32 0.36 0.44 0.51 0.47 0.40 0.16 0.00 
2000 0.00 0.00 0.03 0.04 0.13 0.16 0.23 0.19 0.11 0.00 
4000 0.00 0.00 0.00 0.01 0.01 0.09 0.06 0.05 0.00 0.00 
                      
NaCl 
(mM) 
fZ at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 
25 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
50 0.04 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 
100 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 
250 0.12 0.08 0.07 0.07 0.00 0.00 0.00 0.00 0.00 0.00 
500 0.27 0.21 0.17 0.14 0.09 0.03 0.00 0.00 0.00 0.00 
1000 0.79 0.72 0.66 0.59 0.46 0.38 0.27 0.14 0.03 0.00 
2000 1.00 0.97 0.94 0.91 0.79 0.72 0.61 0.45 0.14 0.00 
4000 1.00 1.00 0.96 0.93 0.87 0.72 0.65 0.52 0.28 0.00 
                      
NaCl 
(mM) 
fSS at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.00 0.00 0.04 0.00 0.05 0.27 0.75 0.92 0.97 1.00 
25 0.00 0.04 0.07 0.12 0.27 0.36 0.57 0.96 1.00 1.00 
50 0.00 0.07 0.13 0.16 0.21 0.26 0.38 0.71 0.94 1.00 
100 0.00 0.06 0.10 0.14 0.22 0.24 0.35 0.66 0.93 1.00 
250 0.00 0.04 0.08 0.10 0.25 0.26 0.36 0.57 0.92 1.00 
500 0.00 0.03 0.08 0.11 0.18 0.23 0.34 0.54 0.84 1.00 
1000 0.00 0.02 0.00 0.00 0.00 0.10 0.27 0.46 0.81 1.00 
2000 0.00 0.03 0.04 0.05 0.08 0.12 0.16 0.36 0.75 1.00 
4000 0.00 0.00 0.04 0.06 0.12 0.19 0.29 0.43 0.72 1.00 
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Figure 3.13.  Mole fraction plots of the HP-CG8HMPh calculated at 0, 25, 50, 100, 250, 500, 1000, 2000, and 4000 
mM NaCl (A-I) over 10–99 °C.  B-DNA is displayed in the blue circles, Z-DNA in red squares and ss-DNA in 
black triangles. 
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Table 3.7.  Mole fractions of B-DNA, Z-DNA, and ss-DNA of HP-CG8MMPh with 0-4000 mM 
NaCl at temperatures 10-99 °C. 
NaCl 
(mM) 
fB at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 1.00 1.00 1.00 1.00 0.96 0.87 0.58 0.21 0.08 0.00 
25 1.00 0.98 0.94 0.94 0.87 0.88 0.71 0.31 0.07 0.00 
50 0.92 0.92 0.94 0.89 0.90 0.85 0.72 0.34 0.05 0.00 
100 0.93 0.92 0.91 0.91 0.87 0.87 0.76 0.47 0.10 0.00 
250 0.83 0.84 0.83 0.81 0.80 0.77 0.72 0.53 0.15 0.00 
500 0.60 0.66 0.69 0.72 0.76 0.77 0.74 0.58 0.24 0.00 
1000 0.16 0.23 0.30 0.37 0.50 0.59 0.65 0.55 0.20 0.00 
2000 0.00 0.00 0.02 0.06 0.11 0.17 0.18 0.20 0.10 0.00 
4000 0.00 0.00 0.03 0.06 0.10 0.15 0.17 0.15 0.07 0.00 
                      
NaCl 
(mM) 
fZ at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
25 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
50 0.08 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 
100 0.07 0.05 0.02 0.00 0.00 0.00 0.00 0.00 0.01 0.00 
250 0.17 0.12 0.08 0.08 0.00 0.00 0.00 0.00 0.00 0.00 
500 0.40 0.32 0.27 0.22 0.15 0.09 0.00 0.00 0.00 0.00 
1000 0.84 0.76 0.71 0.64 0.50 0.40 0.26 0.13 0.04 0.00 
2000 1.00 0.98 0.95 0.91 0.83 0.75 0.64 0.44 0.17 0.00 
4000 1.00 0.98 0.93 0.90 0.84 0.78 0.74 0.58 0.33 0.00 
                      
NaCl 
(mM) 
fSS at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.00 0.00 0.00 0.00 0.04 0.13 0.42 0.79 0.93 1.00 
25 0.00 0.02 0.06 0.06 0.13 0.12 0.29 0.69 0.93 1.00 
50 0.00 0.02 0.06 0.11 0.10 0.15 0.28 0.66 0.93 1.00 
100 0.00 0.03 0.07 0.09 0.13 0.13 0.24 0.53 0.90 1.00 
250 0.00 0.04 0.09 0.12 0.20 0.23 0.28 0.47 0.85 1.00 
500 0.00 0.02 0.04 0.06 0.10 0.14 0.26 0.42 0.76 1.00 
1000 0.00 0.01 0.00 0.00 0.00 0.01 0.09 0.33 0.76 1.00 
2000 0.00 0.02 0.02 0.03 0.06 0.08 0.18 0.36 0.73 1.00 
4000 0.00 0.02 0.04 0.04 0.06 0.07 0.09 0.24 0.60 1.00 
 
 
97 
 
 
 
 
  
 
Figure 3.14.  Mole fraction plots of the HP-CG8MMPh calculated at 0, 25, 50, 100, 250, 500, 1000, 2000, and 
4000 mM NaCl (A-I) over 10–99 °C.  B-DNA is displayed in the blue circles, Z-DNA in red squares and 
ss-DNA in black triangles.  
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Table 3.8.  Mole fractions of B-DNA, Z-DNA, and ss-DNA of HP-CG8CPh with 0-4000 mM 
NaCl at temperatures 10-99 °C. 
NaCl 
(mM) 
fB at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.96 0.97 1.00 0.97 0.91 0.82 0.49 0.14 0.04 0.00 
25 0.98 0.97 0.93 0.91 0.85 0.80 0.62 0.18 0.04 0.00 
50 0.93 0.91 0.89 0.86 0.83 0.80 0.66 0.27 0.04 0.00 
100 0.91 0.90 0.91 0.89 0.87 0.86 0.70 0.24 0.04 0.00 
250 0.81 0.84 0.86 0.81 0.76 0.75 0.69 0.48 0.10 0.00 
500 0.50 0.57 0.61 0.63 0.62 0.65 0.61 0.47 0.14 0.00 
1000 0.09 0.15 0.18 0.24 0.33 0.41 0.38 0.36 0.14 0.00 
2000 0.00 0.00 0.04 0.04 0.08 0.13 0.17 0.18 0.12 0.00 
4000 0.00 0.04 0.08 0.13 0.11 0.17 0.17 0.15 0.05 0.00 
                      
NaCl 
(mM) 
fZ at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.04 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
25 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
50 0.07 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
100 0.09 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
250 0.19 0.12 0.07 0.10 0.04 0.00 0.00 0.00 0.00 0.00 
500 0.50 0.42 0.35 0.29 0.23 0.14 0.09 0.06 0.01 0.00 
1000 0.91 0.83 0.77 0.70 0.60 0.52 0.41 0.27 0.08 0.00 
2000 1.00 0.93 0.87 0.88 0.81 0.76 0.69 0.56 0.27 0.00 
4000 1.00 0.90 0.83 0.77 0.75 0.66 0.61 0.53 0.35 0.00 
                      
NaCl 
(mM) 
fSS at temperature (°C) 
10 20 30 37 50 60 70 80 90 99 
0 0.00 0.01 0.00 0.03 0.09 0.18 0.51 0.86 0.96 1.00 
25 0.00 0.03 0.07 0.09 0.15 0.20 0.38 0.82 0.96 1.00 
50 0.00 0.06 0.11 0.14 0.17 0.20 0.34 0.73 0.96 1.00 
100 0.00 0.06 0.09 0.11 0.13 0.14 0.30 0.76 0.96 1.00 
250 0.00 0.04 0.07 0.09 0.20 0.25 0.31 0.52 0.90 1.00 
500 0.00 0.02 0.04 0.07 0.15 0.21 0.30 0.47 0.85 1.00 
1000 0.00 0.02 0.04 0.06 0.07 0.07 0.21 0.37 0.78 1.00 
2000 0.00 0.07 0.08 0.08 0.10 0.11 0.14 0.26 0.61 1.00 
4000 0.00 0.06 0.09 0.10 0.13 0.17 0.22 0.32 0.60 1.00 
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Figure 3.15.  Mole fraction plots of the HP-CG8CPh calculated at 0, 25, 50, 100, 250, 500, 1000, 2000, and 4000 
mM NaCl (A-I) over 10–99 °C.  B-DNA is displayed in the blue circles, Z-DNA in red squares and ss-DNA in 
black triangles.  
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The CD spectra can be used to show that the single C8-arylguanine modification shifts the 
B-/Z-DNA equilibrium toward the Z-DNA conformation. However, acquiring CD spectra at only 
a single temperature provides data that can only be used to qualitatively determine the 
conformational effects of the C8-arylguanine modified base.  Quantitation requires CD spectra to 
be acquired over a range of salt concentrations and temperatures and then the mole fractions of B-
, Z-, and ss-DNA, in solution, be calculated.   
The mole fraction data can be used, also, to estimate and/or calculate the transition 
concentration (Tc; the salt concentration required such that the B-/Z-DNA ratio is 1). The 
calculation of the transition salt concentration begins by considering the equilibrium in eq 3.5  
 
where c[NaCl] represents the interactions of salt between the B- and Z-DNA conformations and 
c stands for the transition specific constant coefficient.145  The observed equilibrium constant 
(Kobs) (calculated from fZ/fB), for a given salt concentration, is defined as shown by eqs 3.6 and 
3.7. 
 
 
Fitting a plot of ln(Kobs) versus ln[NaCl] yields the values of c and Keq, determined from the 
slope (c) and y-intercept (ln(Keq)).  In turn, the transition energy can be calculated from eq 3.8. 
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The rank-order (Table 3.9) for the hairpin oligonucleotides with respect to the Tc is HP-CG
8CPh < 
HP-CG8Tol < HP-CG8MMPh < HP-CG8HMPh < HP-CG8Ph << HP-CG.  The mole fraction calculations 
demonstrate that the C8-arylguanine modified hairpin oligonucleotides require much less NaCl to 
drive Z-DNA formation.  In addition the mole fraction data can also be used to determine 
thermodynamic data for the hairpin oligonucleotides (ΔG, ΔH, and ΔS). 
 
 
4. Thermodynamic Parameters 
 
Using the mole fraction data, the thermodynamic parameters (ΔG, ΔH, and ΔS) which can 
be used to quantitatively compare the C8-arylguanine modified hairpins to the unmodified hairpin 
as well to the previously studied doubly modified double-stranded (CG)5 oligonucleotides (see 
Discussion).  The van’t Hoff equation has been previously used to calculate the thermodynamic 
parameters for the B-/Z-DNA equilibrium and was also used here.117,157,158  The van’t Hoff 
equation can be derived using the Gibbs free energy (eq 3.9) combined with the Gibbs free energy 
Table 3.9.  Transition concentration of the hairpin oligonucleotides at 37 °C 
Hairpin 
Transition Concentration  
ΔGta 
(mM NaCl) 
CG 2978 18.4 
CG8Ph 822 12.7 
CG8Tol 708 10.9 
CG8HMPh 744 11.1 
CG8MMPh 730 10.0 
CG8CPh 621 9.9 
  aCalculated for T= 310 K, KB/Z=1.  ΔGt are in kcal mol-1 
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isotherm equation (eq 3.10) to yield the van’t Hoff equation, eq 3.11.  The van’t Hoff equation can 
be modified, replacing Keq with fZ/fB resulting in eq. 3.12 or, by multiplying through by -1, to 
provide eq 3.13.  The mole fraction data can then be fit to the van’t Hoff equation to yield the ΔG, 
ΔH, and ΔS (Figure 3.16).  The values of ΔGt, ΔG, ΔH, and ΔS for the hairpin oligonucleotides 
are listed in Table 3.10.   
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Figure 3.16.  Van’t Hoff plot of the hairpin mole fraction vs. temperature. Displayed are the unmodified 
HP-CG (black circles), HP-CG
8Ph
 (blue squares), HP-CG
8Tol
 (green triangles), HP-CG
8HMPh
 (red circles), 
HP-CG
8MMPh
 (orange diamonds) and HP-CG
8CPh 
(purple stars) in sodium phosphate (10 mM, pH 7.0) in 
2000 mM NaCl for the unmodified hairpin and 1000 mM NaCl for the C8-arylguanine modified hairpins. 
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5. Melting Temperature 
 
The melting temperature (TM) of the unmodified and C8-arylguanine modified hairpins 
were determined from the mole fraction data.  TM is the temperature at which ([B-DNA] + [Z-
DNA])/[ss-DNA] = 1, or, equivalently, when (fB + fZ)/fss = 1 .  The TM data was measured as 
function of the concentration of sodium chloride are presented in Figure 3.17.  The C8-arylguanine 
modification reduced the TM (up to 16 °C) relative to the unmodified hairpin when in the B-DNA 
conformation.  The differences observed in TM diminished as the salt concentration increased and 
the Z form became the dominant species.   
 
 
 
Table 3.10.  Thermodynamic parameters for the hairpin oligonucleotides 
Hairpin ΔGa ΔHa ΔSa 
CG 1.4 -2.1 -11.4 
CG8Ph -0.58 -6.99 -21.5 
CG8Tol -0.52 -8.08 -25.4 
CG8HMPh -0.50 -6.07 -18.7 
CG8MMPh -0.60 -7.63 -23.6 
CG8CPh -0.92 -7.30 -21.4 
aThermodynamic parameters were obtained from 
oligonucleotide solutions (25 µM) in sodium 
phosphate (10 mm, pH 7.0) and NaCl (1000 mM 
(modified hairpins) and 2000 mM (unmodified 
hairpin)) at 298 K.  ΔG and ΔH are in kcal mol-1 
K-1 and ΔS is in cal mol-1 K-1. 
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Figure 3.17.  Melting temperature profile for unmodified and C8-arylguanine modified hairpin oligonucleotides as 
a function of salt concentration (mM NaCl).  The melting temperature at the corresponding salt concentration for 
unmodified HP-CG (black circles), HP-CG8Ph (blue squares), HP-CG8Tol (green triangles), HP-CG8HMPh (red 
hexagons), HP-CG8MMPh (orange diamonds), and HP-CG8CPh (purple stars) modified hairpins (25 µM) were 
acquired in solutions of sodium phosphate (10 mM, pH=7.0) and the indicated NaCl concentration over a 
temperature range of 10 – 99 °C.   
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6. Conformational Preferences of the B-/Z-DNA Equilibrium under 
Physiological Conditions 
 
The conformational effects of the C8-arylguanine modifications were examined in 
physiological salt conditions.23,162-164  In particular, CD spectra were obtained on the unmodified 
and the C8-arylguanine modified hairpins in the presence of MgCl2, KCl, NaCl, and spermine.  In 
samples containing 10 mM MgCl2, 10 mM NaCl, and 140 mM KCl, with or without spermine, the 
CD indicated the C8-arylguanine modified hairpin (Figure 3.19, HP-CG8Ph; Figure 3.20, 
HP-CG8Tol; Figure 3.21, HP-CG8HMPh; Figure 3.22, HP-CG8MMPh; Figure 3.23, HP-CG8CPh) was in 
~100% Z-DNA conformation.  Reducing the MgCl2 concentration (10 to 2 mM) in the presence 
of spermine had no effect on the B-/Z-DNA equilibrium and the modified hairpin oligonucleotides 
remained in the Z-DNA conformation.  In contrast, the unmodified hairpin (Figure 3.18) was 
unaffected by any of these conditions and remained in the B-DNA conformation. 
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Figure 3.18.  Unmodified hairpin HP-CG CD spectra under physiological salt conditions.  CD spectra of the 
unmodified hairpin (25 µM) at 37 °C (pH 7.4) in 2 mM MgCl2, 10 mM NaCl and 140 mM KCl (black), 10 mM 
MgCl2, 10 mM NaCl, 140 mM KCl (blue), 2 mM MgCl2, 10 mM NaCl, 140 KCl and 1 mM spermine (green) and 10 
mM MgCl2, 10 mM NaCl, 140 mM KCl and 1 mM spermine (red). 
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Figure 3.19.  Modified hairpin HP-CG8Ph CD spectra under physiological salt conditions.  CD spectra of the 
unmodified hairpin (25 µM) at 37 °C (pH 7.4) in 2 mM MgCl2, 10 mM NaCl and 140 mM KCl (black), 10 mM 
MgCl2, 10 mM NaCl, 140 mM KCl (blue), 2 mM MgCl2, 10 mM NaCl, 140 KCl and 1 mM spermine (green) and 10 
mM MgCl2, 10 mM NaCl, 140 mM KCl and 1 mM spermine (red). 
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Figure 3.20.  Modified hairpin HP-CG8Tol CD spectra under physiological salt conditions.  CD spectra of the 
unmodified hairpin (25 µM) at 37 °C (pH 7.4) in 2 mM MgCl2, 10 mM NaCl and 140 mM KCl (black), 10 mM 
MgCl2, 10 mM NaCl, 140 mM KCl (blue), 2 mM MgCl2, 10 mM NaCl, 140 KCl and 1 mM spermine (green) and 10 
mM MgCl2, 10 mM NaCl, 140 mM KCl and 1 mM spermine (red). 
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Figure 3.21.  Modified hairpin HP-CG8HMPh CD spectra under physiological salt conditions.  CD spectra of the 
unmodified hairpin (25 µM) at 37 °C (pH 7.4) in 2 mM MgCl2, 10 mM NaCl and 140 mM KCl (black), 10 mM 
MgCl2, 10 mM NaCl, 140 mM KCl (blue), 2 mM MgCl2, 10 mM NaCl, 140 KCl and 1 mM spermine (green) and 10 
mM MgCl2, 10 mM NaCl, 140 mM KCl and 1 mM spermine (red). 
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Figure 3.22.  Modified hairpin HP-CG8MMPh CD spectra under physiological salt conditions.  CD spectra of the 
unmodified hairpin (25 µM) at 37 °C (pH 7.4) in 2 mM MgCl2, 10 mM NaCl and 140 mM KCl (black), 10 mM 
MgCl2, 10 mM NaCl, 140 mM KCl (blue), 2 mM MgCl2, 10 mM NaCl, 140 KCl and 1 mM spermine (green) 
and 10 mM MgCl2, 10 mM NaCl, 140 mM KCl and 1 mM spermine (red). 
112 
 
 
 
 
 
 
  
Figure 3.23.  Modified hairpin HP-CG8CPh CD spectra under physiological salt conditions.  CD spectra of the 
unmodified hairpin (25 µM) at 37 °C (pH 7.4) in 2 mM MgCl2, 10 mM NaCl and 140 mM KCl (black), 10 mM 
MgCl2, 10 mM NaCl, 140 mM KCl (blue), 2 mM MgCl2, 10 mM NaCl, 140 KCl and 1 mM spermine (green) and 10 
mM MgCl2, 10 mM NaCl, 140 mM KCl and 1 mM spermine (red). 
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Part III:  NMR Analysis of the Hairpin Oligonucleotides 
 
The CD experiments described in Part II provide partial information regarding the 
conformational preferences for the B-/Z-DNA conformation preferences of the C8-arylguanine 
modified hairpin oligonucleotides relative to the unmodified hairpin.  However, CD data only 
provides information about the global conformation of the oligonucleotides in solution and, 
therefore, to determine the local environment of the C8-arylguanine modification, NMR was used.  
NMR has been extensively used to determine the conformation of nucleic acids primarily through 
two-dimensional (2D) techniques such as COSY and NOESY.121,150,151  We have applied these 
techniques to examine the B- and Z-DNA conformations of the C8-arylguanine modified 
oligonucleotides.98,100   The techniques used here follow the previously reported assignment 
procedures of the non-exchangeable protons in oligonucleotides by Scheek et al.152 and Hare and 
Reid.119,153   
 
A. General 
 
NMR spectra were acquired on samples containing deuterated sodium phosphate (10 mM, 
apparent pD 7.0, 0.5 mL) in D2O on a Varian 600 MHz spectrometer (Paolo Alto, Ca).  Deuterated 
sodium phosphate solutions were prepared by drying down the sodium phosphate in vacuo in a 
SpeedVac™ and then re-dissolving the solute in an equal volume of “100 %” deuterium oxide 
(D2O, 99.996%, 0.5 mL).  This process was repeated three times to prepare the deuterated sodium 
phosphate.  The hairpin oligonucleotides (~1.5 mM) were dissolved in deuterated sodium 
phosphate (10 mM) and sodium chloride (25 mM) for the B form and the addition of MgCl2 (50 
mM) was used for the Z form.  Hairpin oligonucleotides samples were annealed at 90 °C for 5 min 
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then slowly cooled to rt over 1.5h.  Samples were filtered using Fisherbrand™ syringe filters 
(Nylon, pore size: 0.45 µm, Waltham, MA) then transferred to a Shigemi NMR tube (5 mm, 
Allison Park, PA).  NMR spectra were acquired at rt (25 °C).  1H NMR spectra (1D) were obtained 
acquiring 128 transients (nt).  1H-1H gCOSY spectra were collected with 16 nt and 512 t1 
increments.  Data were zero-filled by transforming the data with 2048 t2 complex points.  NOESY 
spectra were acquired with mixing time of 100 ms (B form) and 600 ms (Z form) and data collected 
with 512 t1 increments, 16 nt each.  Data was transformed with 2048 t2 complex points. 
 
B. Non-exchangeable Proton Assignment for B-DNA 
 
The non-exchangeable protons of the hairpin oligonucleotides in the B-DNA conformation 
were assigned using data from 1H 1D NMR, gCOSY and NOESY 2D NMR experiments.  1D 
spectra of the hairpin oligonucleotides can be used to determine the general location of the base 
and sugar protons of the individual nucleotides in the hairpin.  The non-exchangeable protons of 
the oligonucleotides are found in the 0-9 ppm range of the 1H NMR spectrum; where the base 
protons are the most downfield (5.30 – 8.0 ppm) and the sugar protons exhibit a broad chemical 
shift range (1.46 – 6.20 ppm).  The C8-aryl protons are also downfield in the aromatic region (7.52 
– 8.07 ppm).  The base, the C8-aryl protons, and the dT- CH3 protons can be loosely assigned 
based on their relative location and multiplicity in the 1H spectrum.  The dG-H8 and dT-H6 protons 
exhibit singlets in the aromatic region (~6.0 – 8.0 ppm) where the dC-H6 protons (7.01 – 7.68 
ppm) should appear as doublets in this region and the dC-H5 protons are upfield (5.23 – 5.97 ppm).  
The C8-aryl protons, except the C8-phenylguanine derivative, also exhibit doublets in the aromatic 
region.  Unfortunately, the deoxyribose sugar protons have a similar chemical environment relative 
to the other identical deoxyribose residues in the hairpin oligonucleotide sequence (10 dG, 10 dC, 
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and four dT) and are not well resolved.  This is a problem also shared by the base protons which 
leads to large clusters of multiplets or otherwise unresolved peaks.  Complete assignment of the 
chemical shifts in the 1D 1H spectral data was generally possible using a combination of the 2D 
gCOSY and NOESY data.   
gCOSY (gradient COSY) (see Experimental 2.G) provides J-coupling correlations based 
on scalar coupling (i.e., on adjacent nuclei).  In the case of the hairpin oligonucleotides, only the 
dC-H6/H5 protons and the protons of the C8-arylguanine group show scalar coupling in the 
aromatic region.  The H6-H5 coupling exhibit correlations further from the diagonal since the H6 
and H5 1H chemical shift differences are larger.  The C8-arylguanine protons are the only protons 
that give rise to correlations between 7 – 8 ppm.  In addition, the dT-H6 and dT-CH3 exhibit unique 
four-bond coupling and off-diagonal correlations can be see between these protons and are in a 
region where no other protons will have correlations (1.65 to 7.60 ppm).  The H1’H2’/H2” 
correlations can also be observed and assigned in the gCOSY spectra because their relatively large 
chemical shift difference.  However these proton resonances cannot be assigned to a particular 
nucleotide in the sequence and therefore one must also acquire NOESY spectra for assignment of 
these protons to a particular base in the sequence. 
NOESY spectra shows correlations between protons that are close in space (~ 4 Å) which 
is very useful in the assignment of the non-exchangeable protons in the hairpin oligonucleotides 
because several protons within the same nucleotide such as ArH/H8/H5/6H1’, 
ArH/H8/H5/6H2’ and ArH/H8/H5/6H2” can be observed, which were used to confirm the 
assignments made for the gCOSY spectra.  In addition, several of the protons of any given 
nucleotide are close enough to show NOEs to the adjacent nucleotide(s).  Thereby, using these 
NOE correlations with the already determined intranucleotide resonances, one can sequentially 
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assign the protons of one nucleotide to the adjacent nucleotide(s) in the sequence.  Figure 3.24 
summarizes the assignment procedure for the hairpin oligonucleotides used here.   
 
The assignment procedure of the non-exchangeable protons will be described for the 
HP-CG8MMPh as a representative model for the unmodified and other C8-arylguanine modified 
hairpins in the B-DNA conformation (NMR spectra (1H, gCOSY, NOESY) for the other hairpin 
oligonucleotides are shown in Appendix C).  Initial inspection of the 1H spectrum between 5.2 – 
8.1 ppm (Figure 3.25) reveals extensive signal overlap, especially between 5.72 – 6.22 ppm, which 
Figure 3.24.  NMR assignment procedure for the hairpin oligonucleotides.  The arrows show the NOEs used for the 
assignment of the intranucleotide and internucleotide resonances.   
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likely corresponds to 24 H1’ protons and a couple dC-H5 protons.  The five furthest downfield 
peaks and probably correspond to nine dG-H8 protons.  Between 7.63 – 7.83 ppm are a series of 
multiplets, which correspond to the C8-aryl-dG6 protons as well as a couple of dC-H6 protons.  
The four singlets (7.42 – 7.61 ppm) are likely the dT-H6 resonances as they are expected to be 
further upfield than the dG-H8 singlets.  The remaining series of peaks between (7.02 – 7.38 ppm) 
can be then assumed to correspond to the remaining dC-H6 protons that mostly likely correlate to 
the series of peaks between (5.27 – 5.51 ppm).  At this point the 1H spectrum can only be used to 
further locate the C8-MMPh-OCH3 at δ 3.51 ppm and the dT-CH3 protons at δ 1.65, 1.76, 1.84 
and 1.85 ppm (Figure 3.26).  Therefore one must use the gCOSY spectra to assign the dC-H6-H5, 
dT-H6-CH3, and all the H1’-H2’/H2” pairs.   
 
 
Figure 3.25.  Expansion of the aromatic region of the 1H NMR spectrum.  The dG-H8, dG-C8-aryl (ArH), 
dT-H6, dC-H6/H5 and the H1’ are labeled above and below the frequency axis (ppm). 
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The gCOSY spectra support the initial assumptions made in the 1H spectrum.  The furthest 
downfield singlets do not show any correlations with other protons, which confirms these singlets 
correspond to dG-H8 protons.  The multiplets at 7.77 and 7.82 ppm show correlations to 7.67 and 
7.54 ppm, respectively, and are most likely the C8-MMPh aromatic protons (Figure 3.27a).  
Further the multiplet at 7.64 – 7.69 ppm show correlations to 5.97 and 5.87 ppm, which correspond 
to dC-H6-H5 protons.  The series of peaks between δ 7.02 – 7.38 ppm show correlations to 5.27 – 
5.51 ppm confirming our initial assumption that these resonances belong to the dC nucleotides 
(H6-H5 pairs).  The final two unique upfield doublets in the δ 7 – 8 ppm range exhibit correlations 
5.39 to 7.23 ppm and 5.27 to 7.01 ppm (Figure 3.27b).  The four singlets at 7.41, 7.52, 7.53 and 
7.60 ppm show correlations to the upfield singlets at 1.76, 1.65, 1.85 and 1.84 ppm, respectively, 
confirming these resonances are due to the dT nucleotides (Figure 3.27c).  Finally Figure 3.27d 
shows the H1’ to H2’/H2’’ correlations.  The 24 H1’ protons correlate to 24 H2’ and 24 H2” over 
Figure 3.26.  Expansion of the upfield region of the 1H NMR spectrum.  The dG-MMPh-OCH3 and dT-CH3 are 
labeled above the spectrum. 
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the range of 1.46 – 2.81 ppm.  The gCOSY spectra was used to assign the J correlated resonances 
such as the dG6-MMPh-Ar/Ar, dC-H6/H5 and dT-H6/CH3 however, deoxyribose sugar proton 
resonances cannot be assigned to a particular nucleotide.  Using the NOESY spectra the H1’ can 
be assigned to either a dG, dC or dT nucleotide.   
 
 
 
 
Figure 3.27.  Expansion of the HP-CG8MMPh gCOSY spectra.  The boxed areas show a) G6-MMPh Ar/Ar b) dC-
H6/H5 correlations c) dT-H6/CH3 and d) H1’/H2’H2” cross-peaks. 
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The H1’ of any given nucleotide is close enough in space (~ 3 – 5 Å) to show NOE 
correlations to H8 of dG, H6 of dC or the C8-aryl protons in the same nucleotide (Figure 3.28).  
Therefore the 24 H1’ protons observed from the gCOSY spectra can be assigned to their respective 
nucleotide residues.  Further, the H1’, H2’ and H2” also show NOE correlations to each other 
which can be used to confirm the assignments made in the gCOSY spectra.  The combination of 
the gCOSY and NOESY spectra allow for assignment of the H8, H6, or C8-aryl  H1’  H2’  
H2” of all 24 nucleotides in the hairpin oligonucleotides.  These assignments can then be used to 
Figure 3.28.  NOESY expansion of the HP-CG8MMPh. The lines from the letters a, b, or c show the a) dG-H8-H1’or dG-
Ar-H1’, b) dT-H6-H1’ and c) dC-H6-H1’ correlations. 
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determine the cross-peaks in the NOESY spectra that correspond to the internucleotide 
connectivities that can be used in the sequential resonance assignments of the hairpin 
oligonucleotides. 
In our previous studies with the doubly modified double-stranded oligonucleotide the C1 
residue was generally the starting point given that its H6 resonance is furthest downfield in 
comparison to the dC residues, here it is actually easier to start the assignment procedures at the 
T4 loop because T11 will have a correlation(s) with only G10 and T14 will have a correlation(s) with 
only C15 (C1G2C3G4C5G6*C7G8C9G10T11T12T13T14C15G16C17G18C19G20C21G22C23G24).  This easily 
distinguishes the 5’ and 3’ dT residues of the T4 loop.  Then, the remaining d(CG)5 stem component 
of the hairpin oligonucleotides can be sequentially assigned.   
Starting from T11, the dT-H6 δ 7.41 ppm shows J correlations to its CH3 at 1.76 ppm (Figure 
3.29A, the ‘A’ refers to the correlation labeled ‘A’), which was further used to assign the G10 based 
on the observed NOE correlation to 7.87 ppm (Figure 3.29B).  The H1’, H2’ and H2” (5.76, 2.27, 
and 1.74 ppm, respectively) of C9 are correlated to G10-H8 (Figure 3.29D).  The H1’/H2’ of G8 
correlate to the C9-H5 (Figure 3.29F), and, in addition, the G8 displays cross-peaks with the C7 
H2’/H2” (Figure 3.29H).  The C7-H5 shows NOE correlations to the H1’ and H2” of the MMPh-
G6 (Figure 3.29J).  The modified MMPh-G6 H2’ and H2” protons are further correlated to the 
H5/H2’/H2” of C5 which is easily distinguishable because the H2” protons of C5 is the furthest 
signal upfield (Figure 3.29L).  The C5-H6 is correlated to the H2’/H2” of G4 (Figure 3.29N).  G4 
shows correlations to C3 from NOEs between the G4-H1’ and C3-H6 and of G4-H8 and C3-H2” 
(Figure 3.29P).  C3 shows NOEs from its H2’/H2” protons to the G2-H8 (Figure 3.29R), which 
shows correlations to the H1’/H2’/H2” of C1 (5.82/2.46/2.02 ppm) (Figure 3.29T).  This completes 
the assignment of one strand of the d(CG)5 stem. 
122 
 
Beginning at T11, the T12-CH3 as well as T12-H2” show NOE correlations to T11-H6 (Figure 
3.29V).  The T12-H2’ and T12-CH3 show correlations to the T13-H6 (Figure 3.29X).  T12 shows a 
NOE correlation to T13-CH3 which distinguishes T13-H6 and T14-H6 (7.52 and 7.53 ppm).  Further, 
T14 can be assigned based on its NOEs to C15 where the T14 shows a NOE to C15-H1’ and C15 
shows a NOE to T14-H2’ and to T14-CH3.  G16-H8 is assigned from the NOE to the distinct C15-
H1’ (Figure 3.29CC).  C17 is assigned through correlations to G16-H1’ and NOEs from G16-H8 to 
C17-H2”.  G18 is assigned via NOEs between C17-H1’ and –H5.  C19 is assigned through NOEs 
with G18-H2’/H2” and a NOE from G18-H1’ to C19.  C19-H1’/H2’/H2” shows correlations to 
G20-H8 and C21 shows correlations to the G20-H1’.  C21-H5 show a correlation to the G22-H8 and 
G22-H8 shows a NOE to C23-H5, that also shows a NOE to G22-H1’.  Finally the G24-H8 can be 
assigned through a NOE to C23-H1’.  Figure 3.28 shows the NOE cross-peaks that were used in 
the assignment procedure.  Using this assignment procedure the individual nucleotides 
(H8/H6/C8-aryl  H1’  H2’  H2”) of unmodified and modified hairpins can be sequentially 
assigned (Table 3.11 – 3.16). 
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Figure 3.29.  NOESY expansion of the HP-CG8MMPh in the B-DNA conformation.  The blue letters 
correspond to the intranucleotide correlations and the red letters correspond to the correlations that are 
internucleotide.  The assignment labels begin with T11 (A) through C1 (U).  The T4 loop is also labeled starm 
temping from T11 (A) to T12 (V) as well as C15 (CC). 
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Table 3.11.  Non-exchangeable proton assignment of the unmodified HP-CG in the B forma 
base no. 
1H Chemical Shifts (ppm) 
H8/H6 H5/CH3 H1' H2' H2" 
C1 7.67 5.96 5.83 2.46 2.02 
G2 8.00   5.96 2.75 2.72 
C3 7.33 5.43 5.77 2.44 2.03 
G4 7.92   5.97 2.75 2.73 
C5 7.30 5.37 5.70 2.39 2.01 
G6 7.91   5.91 2.75 2.64 
C7 7.35 5.42 5.78 2.38 2.02 
G8 7.92   5.91 2.75 2.64 
C9 7.24 5.41 5.74 2.26 1.75 
G10 7.87   6.04 2.68 2.63 
T11 7.41 1.77 6.03 2.43 2.13 
T12 7.60 1.84 6.12 2.40 2.14 
T13 7.52 1.66 5.96 2.30 2.07 
T14 7.53 1.86 6.16 2.56 2.38 
C15 7.64 5.85 5.44 2.43 2.24 
G16 7.96   5.99 2.77 2.74 
C17 7.33 5.39 5.71 2.39 1.99 
G18 7.98   5.98 2.72 2.70 
C19 7.38 5.40 5.80 2.36 1.92 
G20 7.91   5.90 2.71 2.67 
C21 7.37 5.44 5.82 2.44 2.05 
G22 7.93   5.93 2.75 2.67 
C23 7.36 5.48 5.76 2.38 1.94 
G24 7.98   6.20 2.64 2.40 
aNMR spectra (1H, gCOSY and NOESY) were acquired on 
oligonucleotide solutions (~ 1.5 mM) in deuterated sodium phosphate (10 
mM, pD 7.0) and sodium chloride (25 mM) and at 25 °C. 
 
125 
 
 
 
  
Table 3.12.  Non-exchangeable proton assignment of the modified HP-CG8Ph in the B forma 
base no. 
1H Chemical Shifts (ppm) 
H8/H6 H5/CH3 H1' H2' H2" 
C1 7.68 5.96 5.81 2.46 2.02 
G2 8.00   5.94 2.76 2.68 
C3 7.37 5.43 5.79 2.41 2.02 
G4 7.87   5.89 2.65 2.60 
C5 7.01 5.24 5.88 2.40 1.55 
G6 7.84, 7.52, 7.74 ,7.68, 7.62 5.95 2.44 2.29 
C7 7.33 5.39 5.75 2.40 1.95 
G8 7.91   5.92 2.76 2.64 
C9 7.22 5.39 5.74 2.40 1.95 
G10 7.87   6.05 2.65 2.41 
T11 7.41 1.75 6.02 2.43 2.13 
T12 7.60 1.84 6.12 2.40 2.14 
T13 7.53 1.66 6.17 2.55 2.34 
T14 7.54 1.85 5.96 2.30 2.07 
C15 7.65 5.86 5.44 2.44 2.26 
G16 7.98   6.00 2.80 2.71 
C17 7.37 5.43 5.79 2.41 2.02 
G18 7.94   5.91 2.74 2.69 
C19 7.38 5.50 5.81 2.48 2.08 
G20 7.93   5.97 2.80 2.72 
C21 7.33 5.39 5.75 2.33 1.95 
G22 7.91   5.92 2.80 2.74 
C23 7.37 5.43 5.80 2.36 1.93 
G24 7.98   6.20 2.63 2.40 
a NMR spectra (1H, gCOSY and NOESY) were acquired on oligonucleotide solutions 
(~ 1.5 mM) in deuterated sodium phosphate (10 mM, pD 7.0) and sodium chloride (25 
mM) and at 25 °C. 
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Table 3.13.  Non-exchangeable proton assignment of the modified HP-CG8Tol in the B forma 
base no. 
1H Chemical Shifts (ppm) 
H8/H6 H5/CH3 H1' H2' H2" 
C1 7.68 5.96 5.82 2.46 2.02 
G2 8.01   5.94 2.76 2.72 
C3 7.38 5.41 5.76 2.46 2.04 
G4 7.87   5.88 2.61 2.42 
C5 7.01 5.24 5.89 2.42 1.53 
G6b 7.81, 7.53, 7.65 5.39 2.66 2.42 
C7 7.33 5.41 5.76 2.39 1.97 
G8 7.91   5.93 2.76 2.65 
C9 7.23 5.39 5.74 2.26 1.75 
G10 7.87   6.05 2.65 2.40 
T11 7.42 1.77 6.04 2.44 2.14 
T12 7.60 1.84 6.13 2.41 2.14 
T13 7.52 1.66 5.96 2.32 2.07 
T14 7.53 1.86 6.18 2.58 2.34 
C15 7.66 5.87 5.45 2.45 2.27 
G16 7.98   6.00 2.80 2.70 
C17 7.38 5.44 5.78 2.35 1.95 
G18 7.95   5.96 2.81 2.72 
C19 7.33 5.39 5.72 2.39 2.02 
G20 7.99   5.44 2.45 2.27 
C21 7.38 5.50 5.81 2.37 1.94 
G22 7.95   5.92 2.75 2.68 
C23 7.38 5.50 5.82 2.42 2.04 
G24 7.99   6.20 2.65 2.41 
a NMR spectra (1H, gCOSY and NOESY) were acquired on oligonucleotide solutions 
(~ 1.5 mM) in deuterated sodium phosphate (10 mM, pD 7.0) and sodium chloride 
(25 mM) and at 25 °C. bC8-Tol-CH3 = 2.55 ppm. 
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Table 3.14.  Non-exchangeable proton assignment of the modified HP-CG8HMPh in the B forma 
base no. 
1H Chemical Shift (ppm) 
H8/H6 H5/CH3 H1' H2' H2" 
C1 7.68 5.96 5.82 2.46 2.02 
G2 8.01   5.93 2.78 2.69 
C3 7.37 5.45 5.76 2.42 2.04 
G4 7.88   5.90 2.67 2.61 
C5 7.02 5.24 5.90 2.35 1.56 
G6a 7.84/7.73, 7.67/7.53 6.21 2.65 2.43 
C7 7.33 5.39 5.76 2.40 2.00 
G8 7.90   5.93 2.79 2.65 
C9 7.23 5.39 5.75 2.26 1.76 
G10 7.88   6.05 2.65 2.39 
T11 7.42 1.77 6.05 2.45 2.14 
T12 7.60 1.85 6.13 2.42 2.13 
T13 7.52 1.67 5.97 2.33 2.07 
T14 7.53 1.86 6.18 2.57 2.34 
C15 7.65 5.86 5.45 2.44 2.26 
G16 7.98   6.00 2.81 2.71 
C17 7.38 5.49 5.82 2.46 1.94 
G18 7.95   5.96 2.81 2.72 
C19 7.33 5.43 5.78 2.38 1.98 
G20 7.92   5.94 2.74 2.71 
C21 7.37 5.40 5.78 2.46 2.02 
G22 7.95   5.99 2.75 2.70 
C23 7.38 5.49 5.82 2.49 2.10 
G24 7.99   6.20 2.65 2.41 
a NMR spectra (1H, gCOSY and NOESY) were acquired on oligonucleotide solutions 
(~ 1.5 mM) in deuterated sodium phosphate (10 mM, pD 7.0) and sodium chloride 
(25 mM) and at 25 °C. 
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Table 3.15.  Non-exchangeable proton assignment of the modified HP-CG8MMPh in the B forma 
base no. 
1H Chemical Shifts (ppm) 
H8/H6 H5/CH3 H1' H2' H2" 
C1 7.68 5.96 5.82 2.46 2.02 
G2 8.01   5.93 2.78 2.69 
C3 7.37 5.45 5.76 2.42 2.04 
G4 7.88   5.90 2.67 2.61 
C5 7.02 5.24 5.90 2.35 1.56 
G6b 7.84/7.73, 7.67/7.53 6.21 2.65 2.43 
C7 7.33 5.39 5.76 2.40 2.00 
G8 7.90   5.93 2.79 2.65 
C9 7.23 5.39 5.75 2.26 1.76 
G10 7.88   6.05 2.65 2.39 
T11 7.42 1.77 6.05 2.45 2.14 
T12 7.52 1.67 5.97 2.33 2.07 
T13 7.53 1.86 6.18 2.57 2.34 
T14 7.60 1.85 6.13 2.42 2.13 
C15 7.65 5.86 5.45 2.44 2.26 
G16 7.98   6.00 2.81 2.71 
C17 7.38 5.49 5.82 2.46 1.94 
G18 7.95   5.96 2.81 2.72 
C19 7.33 5.43 5.78 2.38 1.98 
G20 7.92   5.94 2.74 2.71 
C21 7.37 5.40 5.78 2.46 2.02 
G22 7.95   5.99 2.75 2.70 
C23 7.38 5.49 5.82 2.49 2.10 
G24 7.99   6.20 2.65 2.41 
a NMR spectra (1H, gCOSY and NOESY) were acquired on oligonucleotide solutions 
(~ 1.5 mM) in deuterated sodium phosphate (10 mM, pD 7.0) and sodium chloride 
(25 mM) and at 25 °C. bC8-MMPh-OCH3 = 3.51 ppm. 
 
a 
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Table 3.16.  Non-exchangeable proton assignment of the modified HP-CG8CPh in the B forma 
base no. 
1H Chemical Shifts (ppm) 
H8/H6 H5/CH3 H1' H2' H2" 
C1 7.68 5.97 5.83 2.46 2.02 
G2 8.01   5.95 2.75 2.72 
C3 7.37 5.43 5.77 2.42 2.27 
G4 7.88   5.88 2.66 2.60 
C5 7.06 5.32 5.90 2.43 1.46 
G6 8.03/7.84, 7.76/7.56 6.01 2.51 2.27 
C7 7.32 5.41 5.74 2.38 1.99 
G8 7.91   5.94 2.77 2.63 
C9 7.23 5.39 5.75 2.27 1.75 
G10 7.88   6.05 2.65 2.45 
T11 7.43 1.77 6.04 2.44 2.14 
T12 7.61 1.85 6.13 2.41 2.14 
T13 7.54 1.87 5.97 2.32 2.09 
T14 7.53 1.67 6.17 2.57 2.34 
C15 7.65 5.87 5.46 2.45 2.25 
G16 7.99   6.00 2.80 2.70 
C17 7.39 5.50 5.81 2.38 1.94 
G18 7.95   5.92 2.81 2.65 
C19 7.39 5.46 5.82 2.47 2.07 
G20 7.95   5.96 2.78 2.68 
C21 7.35 5.45 5.73 2.33 1.94 
G22 7.93   5.92 2.77 2.67 
C23 7.37 5.43 5.78 2.44 2.04 
G24 7.99   6.20 2.65 2.41 
a NMR spectra (1H, gCOSY and NOESY) were acquired on oligonucleotide solutions 
(~ 1.5 mM) in deuterated sodium phosphate (10 mM, pD 7.0) and sodium chloride 
(25 mM) and at 25 °C. 
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C. Non-exchangeable Proton Assignment for Z-DNA 
The non-exchangeable protons of the Z-DNA conformation of the C8-arylguanine 
modified hairpin oligonucleotides were assigned using a similar approach as for the B-DNA 
conformation, therefore 1H, gCOSY, and NOESY spectra were acquired (full spectra for the 
C8-arylguanine modified hairpin oligonucleotides are shown in Appendix C).  The 1H spectrum 
displays resonances in the chemical shift range of the aromatic base protons and the deoxyribose 
sugar protons similar to the B-DNA form.  However unlike the B-DNA spectra, the spectra of the 
modified hairpins in the Z-DNA conformation had much lower resolution, which can be generally 
ascribed to line broadening from the increase salt concentrations used to drive the B-/Z-DNA 
equilibrium toward the Z-DNA conformation.  The line broadening also leads to reduced 
resolution spectra.  As a result the gCOSY spectra does not provide the same level of structural 
detail for the Z forms of the modified hairpins compared to when they are in the B-DNA 
conformation.  Although the dG6-Ar/Ar, dC-H6/H5 and dT-H6/CH3 correlations can still be 
observed, there are less H1’/H2’/H2” pairs observable.  The NOESY spectra of the Z form can 
still be used to assign the H8/H6 to their respective H1’/H2’/H2” pairs as was the case for the B 
form.  Further the NOESY spectra is diagnostic of the Z-DNA conformation since the dG-H8/H1’ 
protons exhibit very strong NOE cross-peaks, characteristic of the dG bases in the syn-
conformation in the Z form.   
The assignment strategy for Z-DNA is slightly different than that used for B-DNA.  
Previously established assignment strategies156 and reports on Z-DNA hairpins120,121 combined 
with our previous work with C8-arylguanine modified oligonucleotides98,100 in the Z form, was 
used to assign the protons of the C8-arylguanine modified hairpin oligonucleotides in the Z-DNA 
conformation.  In general, the literature shows that any given dG(n)-H8 are close enough in 
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proximity to show NOE cross-peaks with a dC(n+1)-H6/H5.  Further the dG(n)-H2’/H2” will also 
show NOE correlations to the dC(n+1)-H2’/H2”.  Therefore, the assignment strategy utilizes the 
dG(n) and dC(n+1) pairs combined with the assignment of the G10 and C15 based on NOE cross-
peaks with T11 and T14, respectively.  In addition, the C8-aryl-G6 also display Ar/H1’ cross-peaks 
distinct from the rest of the dG-H8/H1’ NOE cross-peaks.  Therefore through a process of 
elimination the final C1 and G24 resonances can be assigned.   
As a representative example the HP-CG8HMPh resonance assignment for the Z-DNA 
conformation will be described.  In the Z form there is less dispersion of the resonances in the 
aromatic region; the nine dG-H8 protons are assumed to be the singlet resonances furthest 
downfield and located between 7.78 – 7.87 ppm, the four dT-H6 protons are probably the three 
singlets between 7.47 – 7.61 ppm and the 10 dC-H6 resonances are likely to be the overlapping 
signals between 7.38 – 7.49 ppm.  The C8-aryl-dG6 proton resonances can then be assumed to be 
the set of doublets between 7.65 – 7.70 ppm (Figure 3.30).  The H1’ protons range from 5.76 – 
6.31 ppm, where there is extensive overlap of the resonances (6.24 – 6.31 ppm).  Figure 3.31 shows 
the upfield region of the 1H spectrum which is where the H2’/H2” and the dT-CH3 resonances are 
located.  As with B-DNA conformation, the assignment of the 1H chemical shifts requires 2D 
gCOSY and NOESY data sets. 
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Figure 3.30.  Expansion of the HP-CG8HMPh aromatic region of the 1H NMR spectrum in the Z-DNA 
conformation.  The dG-H8, dG-C8-aryl (ArH), dT-H6, dC-H6/H5 and the H1’ proton resonances are labeled 
above and below the frequency axis (ppm). 
Figure 3.31.  Expansion of the HP-CG8HMPh upfield region of the 1H NMR spectrum of the Z-DNA 
conformation.  The H2’, H2” and dT-CH3 are labeled above the frequency axis (ppm). 
133 
 
The gCOSY data set of the HP-CG8HMPh oligonucleotide in the Z form was used in a similar 
manner as described for the B-DNA data.  Figure 3.32 shows an expansion of the gCOSY spectra 
of the HP-CG8HMPh in the Z-DNA conformation.  The gCOSY spectrum confirms the assumptions 
made in the 1H NMR spectrum.  The furthest downfield resonances do not show any off-diagonal 
correlations which is expected for the dG-H8 protons.  Since the C8-aryl-dG6 resonances are close 
in proximity the off-diagonal correlations shown in Figure 3.32a are so close to the diagonal that 
they are not as easily distinguishable as in the B form, however they are present with further 
expansion.  Figure 3.32b displays the dC-H6-H5 cross-peaks between the 7.38 to the 5.12 ppm.  
In addition, the downfield cross-peaks are likely to correspond to the dC1 and dC15 residues.  Unlike 
the B-DNA conformation, the dC-H5 are much further upfield 5.12 – 5.87 ppm with a difference 
between 0.10 – 0.40 ppm relative to the B form.   Figure 3.32c displays the dT-H6 to dT-CH3 four 
bond couplings, confirming the upfield singlets observed in the aromatic region correspond to the 
dT residues.  Although there is considerable overlap amongst the H1’ resonances of the hairpin 
oligonucleotides in the B form, most, if not all, of the H1’ had two distinct correlations 
corresponding to the two different H2’ and H2” protons.  The gCOSY Z-DNA spectra shows fewer 
H1’H2’/H2” pairs (Figure 3.32d).  Although the gCOSY spectra can be used to confirm the 
initial assumptions from the 1H spectrum, the NOESY spectral data are required to assign the 
proton resonances to a particular nucleotide in the hairpin sequence.  
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NOESY expansion of the aromatic region to the H1’ region indicates that the dG-H8 
display very strong NOEs to their H1’ (Figure 3.33a), which is expected for the Z-DNA 
conformation.  Further these dG-H1’ resonances show strong cross-peaks to the cluster of dC-H6 
resonances between 7.38 – 7.45 ppm.  Figure 3.33b labels the dT-H1’ resonances that are 
correlated to the upfield dT singlets in the aromatic region.  The 10 dC-H1’ resonances are labeled 
in Figure 3.33c, which show considerable overlap between 5.76 – 5.84 ppm.  Wolk et al.121 
reported that the stem component of Z-DNA hairpins contained six equivalent dC bases and it was 
concluded that these nucleotides were in the interior of the (CG)5 stem (C3, C5, C7, C17, C19 and 
Figure 3.32.  Expansion of the HP-CG8HMPh gCOSY spectra in the Z-DNA conformation.  The boxed areas 
show a) G6-HMPh Ar/Ar b) dC-H6/H6 c) dT-H6/CH3 and d) H1’/H2’/H2” cross-peaks. 
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C21).  In agreement with these results, there are several equivalent dC and dG residues based on 
the overlap of dC-H6/H1’ and dG-H8/H1’ NOE cross-peaks that also display dG-H1’/dC-H6 and 
dG-H8/dC-H6 cross-peaks.  From these NOEs the H8, H6, or C8-aryl protons can be identified 
and paired with their H1’ as well as their H2’/H2” protons 
(H8/H6(H5/CH3)/ArHH1’H2’/H2”).  For the dG nucleotides, 7.876.313.25/2.65 ppm, 
7.856.262.78/2.58 ppm, 7.836.262.78/2.58 ppm, 7.826.242.78/2.58 ppm, 
7.816.242.78/2.74 ppm, 7.816.243.21/2.44 ppm and 7.786.242.78/2.74 ppm were 
identified.  For the dC nucleotides, 7.49(5.87)5.842.66/1.78 ppm, 
7.44(5.74)5.812.43/1.64 ppm, 7.47(5.20)5.822.60/1.74 ppm, 7.44(5.23) 
5.862.64/1.74 ppm, 7.39(5.15)5.762.60/1.69 ppm and 7.38(5.12)5.762.60/1.69 ppm 
were identified.  Finally for the four dT nucleotides, 7.47(1.75) 5.992.31/2.15 ppm, 7.47(1.83) 
5.922.26/2.15, 7.59(1.90) 6.182.52/2.27 ppm and 7.61(1.78) 6.182.52/2.22 ppm 
were identified. 
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Now that the intranucleotide NOE correlations have been assigned, the internucleotide 
assignment requires the identification of dG(n)/dC(n+1), G6-Ar/C7, G10/T11 and T14/C15 NOE 
correlations.  G10-H1’ (the furthest downfield H1’ at 6.31 ppm) displays a NOE cross-peak to a dT 
at 7.61 ppm, which can be assumed to be T11.  Another dT at 7.59 ppm shows a cross-peak to a 
dC-H6 at 7.49 ppm and therefore can be assigned as C15.  Further the C15-H6 also shows a cross-
peak with the dT-CH3 at 1.90 ppm and thus the dT-H6 at 7.59 ppm can be assigned as T14.  Then, 
based on the NOE cross-peaks between dG-H8 (7.82 and 7.81 ppm) as well as the dG-H1’ at 6.24 
Figure 3.33.  NOESY expansion of the HP-CG8HMPh in the Z-DNA conformation.  The lines from the letters a, 
b, or c show the a) dG-H8/H1’ or dG-Ar-H1’, b) dT-H6/H1’ and c) dC-H6/H1’ correlations. 
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ppm to dC-H6 resonances at 7.38 ppm the interior dG(n) to dC(n+1) nucleotides are assigned 
yielding G2-C3, G4-C5, G16-C17, G18-C19 and G20-C21 pairs.  Unlike the previous reports, our hairpin 
oligonucleotides contain a G6-C8-aryl modification which displays a unique G6-H1’ to dC-H6 and 
G6-Ar to dC-H5 cross-peaks (6.24 to 7.44 ppm and 7.69 to 5.23 ppm) that can be used to assign 
G6 and C7.  Then G8 and C9 are assigned from H8 to H6 and H5 cross-peaks at 7.83 to 7.45 and 
5.20 ppm.  The remaining dG(n)/dC(n+1) pair (G22 to C23) is assigned from the cross-peak to the 
most upfield dG-H2” (2.44 ppm) to dC-H6 at 7.45 ppm.  Thus, the remaining C1 and G24 
nucleotides are assigned to 7.47/5.20 ppm and 7.85 ppm, respectively.  The T4 loop is assigned 
based on NOE cross-peaks from T11-H1’ (6.18 ppm) to T12-H6 at 7.47 ppm.  T12-CH3 also has 
NOE correlations to T13-H6 at 7.47 ppm.  This general procedure was used to assign the chemical 
shifts of the five C8-arylguanine modified hairpin oligonucleotides in the Z form (Table 3.17 – 
3.21).  The Z-DNA conformation of the unmodified hairpin was not assigned because the HP-CG 
was resistant to the salt Z-DNA conformation at the conditions used to assign the C8-arylguanine 
modified hairpins. 
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Table 3.17.  Non-exchangeable proton assignment of the modified HP-CG8Ph in the Z forma 
base 
no. 
1H Chemical Shifts (ppm) 
H8/H6 H5/CH3 H1' H2' H2" 
C1 7.45 5.20 5.83 2.62 1.74 
G2 7.79   6.24 2.77 2.72 
C3 7.38 5.12 5.76 2.60 1.70 
G4 7.81   6.24 2.77 2.72 
C5 7.38 5.12 5.76 2.60 1.70 
G6 7.84/7.56 6.23 2.83 2.68 
C7 7.43 5.23 5.76 2.57 2.42 
G8 7.82   6.25 2.77 2.72 
C9 7.42 5.20 5.76 2.60 1.70 
G10 7.86   6.31 3.33 2.63 
T11 7.61 1.77 6.18 2.51 2.21 
T12 7.46 1.83 5.92 2.26 2.14 
T13 7.46 1.74 5.98 2.30 2.14 
T14 7.58 1.90 6.18 2.51 2.26 
C15 7.48 5.86 5.82 2.62 1.74 
G16 7.81   6.24 2.77 2.64 
C17 7.38 5.12 5.76 2.60 1.70 
G18 7.81   6.25 2.77 2.72 
C19 7.38 5.12 5.76 2.60 1.70 
G20 7.77   6.23 2.77 2.74 
C21 7.38 5.15 5.76 2.6 1.7 
G22 7.79   6.24 3.21 2.44 
C23 7.43 5.73 5.80 2.43 1.63 
G24 7.83   6.25 2.77 2.72 
a NMR spectra (1H, gCOSY and NOESY) were acquired on 
oligonucleotide solutions (~ 1.5 mM) in deuterated sodium phosphate (10 
mM, pD 7.0) sodium chloride (25 mM) and magnesium chloride (50 mM) 
and at 25 °C. 
 
139 
 
 
  
Table 3.18.  Non-exchangeable proton assignment of the modified HP-CG8Tol in the Z forma 
base 
no. 
1H Chemical Shifts (ppm) 
H8/H6 H5/CH3 H1' H2' H2" 
C1 7.46 5.20 5.80 2.62 1.66 
G2 7.80   6.24 2.77 2.72 
C3 7.38 5.11 5.76 2.60 1.69 
G4 7.81   6.24 2.77 2.72 
C5 7.38 5.11 5.76 2.60 1.69 
G6b 7.57/7.51 6.22 2.85 2.69 
C7 7.42 5.22 5.80 2.43 1.62 
G8 7.83   6.26 2.74 2.58 
C9 7.43 5.19 5.86 2.64 1.71 
G10 7.87   6.32 3.35 2.66 
T11 7.61 1.77 6.18 2.52 2.22 
T12 7.47 1.83 5.92 2.27 2.15 
T13 7.47 1.75 5.99 2.31 2.15 
T14 7.59 1.90 6.18 2.52 2.27 
C15 7.49 5.86 5.83 2.62 1.71 
G16 7.80   6.24 2.77 2.72 
C17 7.38 5.11 5.76 2.60 1.69 
G18 7.81   6.24 2.77 2.72 
C19 7.38 5.11 5.76 2.60 1.69 
G20 7.77   6.25 2.74 2.72 
C21 7.39 5.15 5.76 2.60 1.69 
G22 7.79   6.24 3.22 2.44 
C23 7.44 5.73 5.80 2.43 1.63 
G24 7.84   6.26 2.79 2.74 
a NMR spectra (1H, gCOSY and NOESY) were acquired on oligonucleotide 
solutions (~ 1.5 mM) in deuterated sodium phosphate (10 mM, pD 7.0) 
sodium chloride (25 mM) and magnesium chloride (50 mM) and at 25 °C. 
bC8-Tol-CH3 = 2.50 ppm. 
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Table 3.19.  Non-exchangeable proton assignment of the modified HP-CG8HMPh in the Z forma 
base 
no. 
1H Chemical Shifts (ppm) 
H8/H6 H5/CH3 H1' H2' H2" 
C1 7.47 5.20 5.82 2.60 1.74 
G2 7.81   6.24 2.78 2.74 
C3 7.38 5.12 2.76 2.60 1.69 
G4 7.82   6.24 2.78 2.58 
C5 7.38 5.12 2.76 2.60 1.69 
G6 7.69/7.66 6.24 2.85 2.69 
C7 7.44 5.23 5.86 2.64 1.74 
G8 7.83   6.26 2.78 2.58 
C9 7.47 5.20 5.82 2.60 1.74 
G10 7.87   6.31 3.35 2.65 
T11 7.59 1.90 6.18 2.52 2.27 
T12 7.47 1.83 5.92 2.26 2.15 
T13 7.47 1.75 5.99 2.31 2.15 
T14 7.61 1.78 6.18 2.52 2.22 
C15 7.49 5.87 5.84 2.66 1.78 
G16 7.81   6.24 2.78 2.74 
C17 7.38 5.12 2.76 2.60 1.69 
G18 7.82   2.64 2.78 2.58 
C19 7.38 5.12 2.76 2.60 1.69 
G20 7.78   6.24 2.78 2.74 
C21 7.39 5.15 5.76 2.60 1.69 
G22 7.80   6.24 3.21 2.44 
C23 7.44 5.74 5.80 2.43 1.64 
G24 7.85   6.26 2.78 2.72 
a NMR spectra (1H, gCOSY and NOESY) were acquired on oligonucleotide 
solutions (~ 1.5 mM) in deuterated sodium phosphate (10 mM, pD 7.0) 
sodium chloride (25 mM) and magnesium chloride (50 mM) and at 25 °C. 
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Table 3.20.  Non-exchangeable proton assignment of the modified HP-CG8MMPh in the Z forma 
base 
no. 
1H Chemical Shifts (ppm) 
H8/H6 H5/CH3 H1' H2' H2" 
C1 7.45 5.19 5.84 2.64 1.75 
G2 7.80   6.22 2.76 2.73 
C3 7.00 5.12 5.75 2.60 1.69 
G4 7.80   6.22 2.76 2.73 
C5 7.37 5.12 5.75 2.60 1.69 
G6 7.69/7.65 6.22 2.85 2.69 
C7 7.42 5.22 5.77 2.43 1.63 
G8 7.82   6.22 2.70 2.57 
C9 7.42 5.19 5.77 2.43 1.63 
G10 7.86   6.31 3.35 2.65 
T11 7.58 1.90 6.18 2.51 2.22 
T12 7.46 1.83 5.99 2.30 2.15 
T13 7.46 1.75 5.92 2.26 2.15 
T14 7.60 1.77 6.18 2.51 2.27 
C15 7.48 5.85 5.82 2.70 1.66 
G16 7.80   6.22 3.22 2.44 
C17 7.37 5.12 5.75 2.60 1.69 
G18 7.80   6.22 2.76 2.73 
C19 7.38 5.14 5.75 2.60 1.69 
G20 7.79   6.22 2.76 2.73 
C21 7.37 5.12 5.75 2.60 1.69 
G22 7.82   6.22 2.70 2.57 
C23 7.42 5.70 5.77 2.43 1.63 
G24 7.83   6.25 2.76 2.73 
a NMR spectra (1H, gCOSY and NOESY) were acquired on oligonucleotide 
solutions (~ 1.5 mM) in deuterated sodium phosphate (10 mM, pD 7.0) 
sodium chloride (25 mM) and magnesium chloride (50 mM) and at 25 °C. 
bC8-MMPh-OCH3 = 3.51 ppm. 
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Table 3.21.  Non-exchangeable proton assignment of the modified HP-CG8CPh in the Z forma 
base 
no. 
1H Chemical Shifts (ppm) 
H8/H6 H5/CH3 H1' H2' H2" 
C1 7.42 5.70 5.76 2.43 1.62 
G2 7.80   6.24 2.76 2.71 
C3 7.38 5.10 5.75 2.59 1.57 
G4 7.80   6.24 2.76 2.71 
C5 7.38 5.10 5.75 2.59 1.57 
G6 7.84/7.56 6.23 2.83 2.68 
C7 7.43 5.22 5.78 2.43 1.62 
G8 7.80   6.24 2.76 2.71 
C9 7.42 5.20 5.76 2.60 1.70 
G10 7.86   6.31 3.34 2.65 
T11 7.59 1.77 6.17 2.51 2.27 
T12 7.46 1.82 5.91 2.26 2.15 
T13 7.46 1.74 5.98 2.29 2.15 
T14 7.57 1.89 6.17 2.51 2.27 
C15 7.49 5.85 5.83 2.60 1.71 
G16 7.80   6.24 2.76 2.71 
C17 7.38 5.10 5.75 2.59 1.57 
G18 7.80   6.24 2.76 2.71 
C19 7.39 5.14 5.75 2.59 1.57 
G20 7.80   6.24 2.76 2.71 
C21 7.38 5.10 5.75 2.59 1.57 
G22 7.80   6.24 3.20 2.44 
C23 7.45 5.20 5.84 2.64 1.73 
G24 7.83   6.24 2.76 2.71 
a NMR spectra (1H, gCOSY and NOESY) were acquired on oligonucleotide 
solutions (~ 1.5 mM) in deuterated sodium phosphate (10 mM, pD 7.0) 
sodium chloride (25 mM) and magnesium chloride (50 mM) and at 25 °C. 
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Chapter 4:  Molecular Modeling of the B- and Z-DNA Conformations  
of the Hairpin Oligonucleotides 
 
Molecular modeling is a computational approach used to study biological molecules of 
interest.  It uses mathematical equations to approximate the fundamental laws of physical 
chemistry.  Through the combination of molecular mechanics (MM) and molecular dynamics 
(MD) simulations the conformation(s) of oligonucleotides can be investigated.  Molecular 
modeling can also be used to calculate the free energy of the oligonucleotide systems.  The 
computational approach used here was applied to the B and Z forms of the unmodified and C8-
arylguanine modified hairpins studied by CD and NMR.  Molecular modeling can be used to 
generate computational models that are useful for interpreting the experimental results, especially 
the NMR data.  In addition, the simulation data provides a breakdown of the contributing factors 
(van der Waal interactions, electrostatics, etc.) that drive the oligonucleotide conformation.   
The unmodified and C8-arylguanine hairpin oligonucleotides in both the B-DNA and Z-
DNA conformation were subjected to MM/MD simulations.  This is required to compare the 
conformational effects of the C8-arylguanine base modification to the unmodified hairpin as well 
as on the local and global helicoidal parameters relative to the hairpin oligonucleotide 
conformation (B vs. Z form).  A description of the base pair and helical parameters has been 
previously reported and this terminology will be used here.165  In addition, free energy calculations 
were used to predict which conformation of the unmodified and C8-arylguanine modified hairpin 
oligonucleotides was most stable.  These calculations also yield an analysis of the individual 
components that compose the overall free energies for each conformation.  Although the 
computational method, here MM-PB(GB)SA, was originally designed for work with proteins, we 
have used them here for the B- and Z-DNA conformations of the hairpin oligonucleotides. 
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The computational studies described below were also used to compare the hairpin 
oligonucleotides with our previous computational studies with doubly modified double-stranded 
(CG)5 decamers.
99,100  In this section, the focus will be on the hairpin oligonucleotides:  HP-CG, 
HP-CG8Ph, HP-CG8Tol, HP-CG8HMPh, HP-CG8MMPh and HP-CG8CPh.  In the following chapter 
comparison between the doubly modified and singly modified hairpins will be described.  
 
A. General  
The computational studies require the hairpin oligonucleotides to be built and generally 
follows the protocol established by Heavner and Gannett.99  All the parameters for the C8-
arylguanine modified bases were generated either through the work of Heavner166 or 
Vongsutilers167 and were used in the Amber suite of programs such as xLEAP, sander, ptraj, and 
MM/PB(GB)SA.  The hairpin oligonucleotides were built using the previously constructed (CG)5 
decamers and the coordinate file of hairpin oligonucleotide with a T4 loop using Moil-View.
168  
Once the hairpin oligonucleotides are created then the input files are written for the MM 
calculations, which is applied to relax the hairpin oligonucleotide and the solvent molecules using 
sander.  Sander is further used in the MD simulations to produce trajectories that can be analyzed 
using ptraj and MM-PB(GB)SA to generate the most representative structures and determine the 
free energy of the hairpin systems, respectively.  The most representative structures were then 
analyzed using X3DNA169 to yield the base pair and helical parameters.   
 
145 
 
B. Hairpin Oligonucleotide Structure Building 
Previous work with a RNA hairpin had a –UUUU- tetraloop, here the U bases were 
changed to dT bases and aligned with our previously constructed (CG)5 decamer.  The hairpin 
oligonucleotides were constructed using MOIL-View.  In MOIL-View, both structures ((-T4- and 
(CG)5 decamer) can be loaded into the same window and then two atoms that are supposed to be 
the ‘same’ are picked (i.e. the dT-5’-Oxygen connected to the T4 loop and 3’-dG-5’-Oxygen of the 
(CG)5 decamer).  A root mean square deviation (RMSd) fit can be run on the two structures to 
align the two structures, which can then be saved as one coordinate file.  The resulting coordinate 
file requires manual editing to re-label the nucleotide residues 1 through 24.  This coordinate file 
is loaded into xLEAP and the required sander files generated.  The B- and Z-DNA conformations 
were created using the previously generated B and Z forms of the unmodified (CG)5 decamer.  To 
create the C8-arylguanine modified hairpin oligonucleotide the G6 residue was modified using the 
text editor with the appropriate C8-arylguanine modification, and the structure was loaded into 
xLEAP, the appropriate C8-arylguanine force field files (frcmod file and prep file), and the sander 
files written.  The B and Z forms of the unmodified and five C8-arylguanine modified hairpin 
oligonucleotides (12 structures total) were the starting structures for the MM simulations and the 
resulting structures used for the MD simulations.   
 
C. MM and MD Simulations 
The MM and MD simulations were performed using the sander program of Amber 11170 
and the parm99.dat of the Cornell force field.171  The B- and Z-DNA hairpin structures were loaded 
into xLEAP and the negatively charged residues of the phosphate backbone were neutralized by 
the addition of 23 sodium counter ions (24 for the HP-CG8CPh analog).  The hairpin 
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oligonucleotides were solvated by the addition of water box (TIP3) with a box size in any direction 
being a minimum of 10 Å from the oligonucleotide and counter ions.  Then the topology (top) and 
coordinate (crd) were created for the initial MM simulations. 
The computational studies begin with MM to minimize the energy of the system.  First a 
MM simulation is performed with the DNA fixed by 500 kcal/mol Å of positional restraints on all 
the hairpin oligonucleotide atoms for 1000 steps.  Then the atom positional restraints are removed 
and the entire system is minimized for 2500 steps.  In the following MD simulation (20 ps) the 
oligonucleotide is fixed again while the solvent box and counter ions are equilibrated and the 
system warmed to 300 K.  Then production MD simulations were performed at constant 
temperature (300 K) and pressure (1 atm) for 10 ns. 
 
D. Most Representative Structure 
The most representative structure is the structure with the smallest RMSd to all of the other 
structures in the trajectory.  This structure is used to determine the base pair and helical parameters 
as well as well as the major and minor groove widths which were then used to compare between 
the unmodified and modified hairpin oligonucleotides.  The most representative structure is 
determined using the cluster option in the Amber program ptraj.  The ptraj program reads the 3D 
coordinates of the MD trajectories based on the similarity of RMSd.  ptraj can also be used to strip 
the water and ions out of the coordinate files before creating the most representative pdb.   
The most representative structure is a model that can be used to help interpret the NMR 
data, especially with respect to the non-exchangeable proton assignment.  These models are used 
to predict NOE correlations seen in the NOESY spectra, since this data is distance dependent.  The 
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most representative structures all the hairpin oligonucleotides in the B-DNA conformation are 
shown in Figure 4.1.  The most representative structures for the hairpin oligonucleotides in the 
Z-DNA conformation are shown in Figure 4.2.  Initial inspection of the most representative 
structures show that the single C8-arylguanine modification has the most effect on the B-DNA 
conformation, when the modified base is contained within the DNA helix, but has little effect on 
the Z-DNA conformation when the base modification is outside the DNA helix.  A more 
quantitative analysis of the C8-arylguanine modification on the hairpin conformation is provided 
from the X3DNA, which can be used to determine the base pair and helical parameters. 
 
 
Figure 4.1.  The most representative structures of the unmodified and C8-arylguanine modified hairpin 
oligonucleotides in the B-DNA conformation.  The gold ribbon represents the phosphate backbone, the bases 
are drawn with stick bonds except for the modified base which rendered with spheres. 
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E. Structural Analysis 
 
1. General 
The computational structural analysis of the C8-arylguanine modified hairpin 
oligonucleotides was performed by X3DNA.169  This software program is used to determine the 
helicoidal parameters of the C8-arylguanine modified hairpin structure relative to the unmodified 
hairpin in both the B- and Z-DNA conformations.  The coordinate file of the most representative 
structure from the MD simulations is analyzed to determine the base pair (G6/C19) and base step 
(C5/G6) geometries that comprise the hairpin structure and to provide the major and minor groove 
Figure 4.2.  The most representative structures of the unmodified and C8-arylguanine modified hairpin 
oligonucleotides in the Z-DNA conformation.  The gold ribbon represents the phosphate backbone, the bases 
are drawn with stick bonds except for the modified base which rendered with spheres. 
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dimensions.  In general, the base pair and helical parameters that were analyzed were previously 
described and illustrated in Figure 4.3.169 
 
Figure 4.3.  Depiction of the base pairand base pairstep helical parameters.  Reprinted with permission from Dr. 
Xiang-Jun Lu and Nucleic Acids Research (ref 168).  
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2. Hairpin Oligonucleotides in the B-DNA conformation 
 
The C8-arylguanine modification has a significant conformational effect in the hairpin 
oligonucleotide in the B-DNA conformation.  Since the C8-arylguanine modified base is contained 
within the DNA helix in the B form the local base pair and helical parameters are altered relative 
to the unmodified hairpin.  Table 4.1 presents the base helicoidal parameters of the most 
representative structures determined by X3DNA.  
Although the intra-base pair values of the C8-arylguanine modified hairpins varied relative 
to the unmodified hairpin, there were no obvious trends for any given parameter with the exception 
of buckle (BKL).  The BKL value for the modified hairpins were all negative relative to the 
unmodified G6-C19 base pair with the greatest difference seen for the HP-CG
8Tol derivative  
(Δ 37.4 °).  The inter-base values for slide (SLD) were all slightly more negative relative to the 
unmodified hairpin.  The values for shift (SHF) between the G6 modified base and the 5’-cytosine 
(C5) base pair step are somewhat more negative than in the unmodified hairpin, especially for the 
HP-CG8CPh analog (Δ 0.82 Å), however the HP-CG8Ph and HP-CG8Tol are slightly more positive 
(< Δ 0.25 Å).  One consequence of the C8-arylguanine modification is an increase in rise (RIS), 
except for the HP-CG8Ph which exhibits a slight decrease in RIS, where the HP-CG8CPh displays 
the largest deviation relative to the unmodified C5-G6 inter-base step.  In addition, there is an 
increase in roll (ROL) for all the modified hairpins.  While there is a general increase in rise (RIS) 
and ROL, there is a general decrease in helical twist (TWT) for the all the C8-arylguanine 
modifications in the hairpin conformation with up to a 12.1 ° difference for the HP-CG8Tol 
derivative.   
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The base pair axis parameters for modified hairpins show a large increase for inclination 
(INC) with a difference of 36.7 ° in HP-CG8MMPh relative to the unmodified hairpin 
oligonucleotide.  The X-displacement (XDP) parameter for all the modified hairpins show a 
negative shift from the helical axis relative to the unmodified G6-C19 base pair.  The 
Y-displacement (YDP) parameters show modest changes with no obvious trends and all of the TIP 
values for the modified hairpins are more negative than the TIP value for the unmodified hairpin.   
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The differences in the helical parameters noted, produced some changes in the widths of 
the major and minor grooves.  Relative to the unmodified oligonucleotide, the major groove in the 
modified oligonucleotides (B form) increases in size if the para-substituent is non-polar (-H or -
Table 4.1.  Helical parameters for the unmodified and modified hairpin oligonucleotides in 
the B-DNA conformation determined by X3DNA. 
Intra-Base Paira 
  CG CG8Ph CG8Tol CG8HMPh CG8MMPh CG8CPh 
  G6/C19 G6/C19 G6/C19 G6/C19 G6/C19 G6/C19 
SHRb 0.60 0.15 0.05 0.01 -0.12 0.32 
STRb 0.07 -0.15 -0.08 -0.06 -0.11 0.00 
STGb -0.03 -0.15 -0.53 0.34 -0.76 -0.77 
BKLc 11.7 -12.6 -25.7 -13.5 -3.19 -16.3 
PRPc -2.89 -20.9 -13.9 -12.7 -16.6 -3.51 
OPNc -3.50 -0.07 2.71 -1.84 -0.58 -5.02 
              
Inter-Base Paira 
  CG CG8Ph CG8Tol CG8HMPh CG8MMPh CG8CPh 
  C5/G6 C5/G6 C5/G6 C5/G6 C5/G6 C5/G6 
SHFb 0.75 1.00 0.93 0.74 0.61 -0.07 
SLDb -0.16 -1.02 -1.74 -1.15 -2.07 -1.43 
RISb 3.56 3.2 3.92 3.49 3.79 4.12 
TLTc 0.38 10.9 8.4 0.83 5.12 4.15 
ROLc -2.43 15.5 10.9 7.46 15.6 14.2 
TWTc 35.8 29.3 23.7 27.4 24.2 27.9 
              
Base Pair-Helical Axisd 
  CG CG8Ph CG8Tol CG8HMPh CG8MMPh CG8CPh 
  G6/C19 G6/C19 G6/C19 G6/C19 G6/C19 G6/C19 
XDPb 0.12 -3.99 -6.75 -4.09 -7.51 -5.71 
YDPb -1.16 -0.07 0.40 -1.31 -0.09 1.03 
INCc -3.95 27.3 24.1 15.4 32.8 27.1 
TIPc -0.61 -19.2 -18.6 -1.70 -10.8 -7.94 
aValues reported are for the C5/G20–G6/C19 base pair step.  bValues are in units of Å.  cValues are in unites 
of degrees.  dValues reported are the average of both C5/G20 and G6/C19 base pair-axis values. 
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CH3) but is more narrow with polar (-COO
-or -CH2OH) substituents.  In addition, the minor groove 
width increases for the C8-arylguanine hairpin oligonucleotides.  
 
 
3. Hairpin Oligonucleotides in the Z-DNA Conformation 
 
The C8-arylguanine modification has less of a conformational effect on the Z-DNA 
conformation than was shown for the B-DNA conformation.  Based on the similarity of the 
representative structures (unmodified and modified) presented in Figure 4.2, this result was 
expected.  While there are distinct differences in the inter-base and base pair helical axis 
parameters for all of the C8-arylguanine modified hairpins relative to the unmodified hairpin in 
Table 4.2.  Major and minor groove widths for the unmodified and modified hairpin 
oligonucleotides in the B-DNA conformation determined by X3DNA. 
Major Groove Width (Å)a 
Base 
No. 
CG CG8Ph CG8Tol CG8CPh CG8MMPh CG8HMPh 
4 16.9 16.6 19.2 16.7 16.3 18.0 
5 20.3 20.6 21.6 19.4 17.2 16.9 
6 16.2 19.3 21.6 15.9 18.3 18.0 
7       
Average 17.8 18.8 20.8 17.3 17.3 17.6 
              
Minor Groove Width (Å)a 
Base 
No. 
CG CG8Ph CG8Tol CG8CPh CG8MMPh CG8HMPh 
4 12.3 13.8 13.8 12.6 13.8 12.9 
5 11.3 12.6 12.7 12.7 12.7 12.7 
6 11.8 12.7 12.0 15.4 13.1 12.7 
7       
Average 11.8 13.0 12.8 13.6 13.2 12.8 
aValues reported correspond to the average taken over G4–C7/G18–C21. 
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the B form, there were no significant deviations observed between the unmodified and modified 
hairpins in the Z form.  Table 4.3 presents the helical parameters of the hairpin oligonucleotides 
in the Z-DNA conformation. 
The majority of the intra-base pair parameters were similar for all of the hairpins, however, 
there are some minor deviations in the BKL and propeller (PRP) parameters.  The inter-base pair 
parameters for the modified hairpins were also similar to the unmodified hairpin and only a few 
parameters showed large differences relative to the unmodified hairpin.  The tilt (TLT) parameters 
for the HP-CG8Ph, HP-CG8MMPh and HP-CG8CPh were more positive relative to the unmodified 
value while the HP-CG8Tol and HP-CG8HMPh showed a decrease in values relative to the unmodified 
hairpin.  The base pair helical axis parameters were also very similar for all of the hairpin series 
and although there was some variation from the modified hairpins to unmodified hairpin, the 
variations did not show any consistent trends.  For example, the INC for the HP-CG8MMPh is nearly 
double the value of the unmodified INC value, but the HP-CG8Ph and HP-CG8CPh are nearly the 
same and the HP-CG8Tol and HP-CG8HMPh values are smaller than that of the HP-CG value.  Further 
the major and minor groove widths are nearly identical between the unmodified and modified 
hairpin oligonucleotides (Table 4.4).  Overall, the variation seen amongst the Z forms of the hairpin 
oligonucleotide series is not likely due to the C8-arylguanine modification as was the case in the 
B-DNA conformation and may be due the zigzag phosphate backbone in the Z-DNA 
conformation. 
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Table 4.3.  Helical parameters for the unmodified and modified hairpin oligonucleotides in 
the Z-DNA conformation determined by X3DNA. 
Intra-Base Paira 
  CG CG8Ph CG8Tol CG8HMPh CG8MMPh CG8CPh 
  G6/C19 G6/C19 G6/C19 G6/C19 G6/C19 G6/C19 
SHRb 0.16 0.26 -0.11 0.46 0.16 0.34 
STRb -0.06 -0.18 -0.06 -0.04 -0.33 -0.23 
STGb -0.25 -0.22 0.00 0.11 -0.77 -0.17 
BKLc -16.6 -1.77 -5.21 3.51 2.95 4.73 
PRPc 4.82 -5.68 6.15 -2.84 -12.0 -19.3 
OPNc 5.53 0.52 2.41 -2.80 9.34 2.94 
              
Inter-Base Paira 
  CG CG8Ph CG8Tol CG8HMPh CG8MMPh CG8CPh 
  C5/G6 C5/G6 C5/G6 C5/G6 C5/G6 C5/G6 
SHFb 0.16 -0.5 0.34 -0.31 0.39 0.60 
SLDb 5.39 5.70 5.30 5.10 5.11 5.38 
RISb 4.04 3.65 3.63 3.38 3.21 3.59 
TLTc 2.04 5.05 -1.33 0.84 8.64 11.6 
ROLc -5.39 -5.88 -3.13 -2.51 -14.9 -7.69 
TWTc -10.2 -10.9 -10.8 -7.42 -10.1 -9.82 
              
Base Pair-Helical Axisd 
  CG CG8Ph CG8Tol CG8HMPh CG8MMPh CG8CPh 
  G6/C19 G6/C19 G6/C19 G6/C19 G6/C19 G6/C19 
XDPb -14.3 -14.8 -20.7 -27.3 -2.67 -10.8 
YDPb 5.34 6.20 -0.90 1.08 8.17 13.2 
INCc 27.7 27.0 16.1 18.6 51.7 30.4 
TIPc 10.5 23.2 -6.84 6.27 30.1 45.8 
aValues reported are for the C5/G20–G6/C19 base pair step.  bValues are in units of Å.  cValues are in unites 
of degrees.  dValues reported are the average of both C5/G20 and G6/C19 base pair-axis values. 
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F. Free Energy Calculations 
 
The Molecular Mechanics/Poisson Boltzmann (generalized Born) Surface Area 
(MM/PB(GB)SA) program within Amber was used to calculate the absolute free energies of the 
unmodified and C8-arylguanine modified hairpin oligonucleotides from the MD trajectories.172  
MM/PB(GB)SA can be used to calculate the free energy difference between two different 
conformations.  Since the hairpin oligonucleotides are negatively charged molecules, their 
solvation energies are directly related to their electrostatic interactions with the solvent.  Here we 
used two different models that combine molecular mechanics calculations and continuum 
solvation models (PB and GB models) to determine and compare the free energies of the B and Z 
Table 4.4.  Major and minor groove widths for the unmodified and modified hairpin 
oligonucleotides in the Z-DNA conformation determined by X3DNA. 
Major Groove Width (Å)a 
Base No. CG CG8Ph CG8Tol CG8CPh CG8MMPh CG8HMPh 
4 15.0 14.6 15.1 16.8 - 15.5 
5 19.3 18.7 19.1 19.2 - 18.3 
6 14.6 14.2 14.2 14.1 - 15.0 
7             
Average 16.3 15.8 16.1 16.7 - 16.3 
              
              
Minor Groove Width (Å)a 
Base No. CG CG8Ph CG8Tol CG8CPh CG8MMPh CG8HMPh 
4 11.8 11.7 11.4 13.4 - 13.1 
5 11.4 11.0 11.3 12.9 - 12.3 
6 12.0 10.9 11.3 13.7 - 11.2 
7             
Average 11.7 11.2 11.3 13.3 - 12.2 
aValues reported correspond to the average taken over G4–C7/G18–C21. 
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forms of the unmodified and modified hairpins.  In the PB model, the free energies are derived by 
solving the linearized Poisson Boltzmann equation.  The GB model is a calculation that uses the 
generalized Born model to derive the free energies, which has been described as alternative and 
comparable model for the PB model.172   The following set of equations (eq 4.1-4.5) show the 
breakdown of the individual components used to obtain the free energies from MM/PB(GB)SA.   
 
 
 
 
 
The GB model was used as the primary comparison between the unmodified and modified 
hairpin oligonucleotides since this methodology for oligonucleotides is more firmly 
established.173,174  The GB free energy (ΔGGB) is derived from the sum of the molecular mechanical 
energy in the gas phase (GGAS) and the solvation energy (GSOLV) minus the total entropy term 
(TSTOT) (eq 4.5).  The GGAS term is the sum of several different components including the internal 
energy arising from the bond terms (BOND), the angle terms (ANGLE), the dihedral terms 
(DIHED) from the MM force field as well as the van der Waals contributions (VDWAALS), the 
electrostatic energy (EEL), van der Waals contributions (1-4 VDW) and electrostatic energy (1-4 
EEL) derived from interactions of atoms separated by 3 bonds (1-4 pairs) derived from the MM 
calculations (eq 4.1).  The solvation energy (GSOLV) is the sum of the electrostatic contribution to 
the solvation free energy using the GB model (EGB) and the non-polar contribution to the solvation 
free energy calculated by an empirical model (ESURF) to yield eq 4.2.  The total entropy term 
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(TSTOT) is derived from the summation of the translational (TSTRA), rotational (TSROT), and 
vibrational (TSVIB) entropies calculated using the ptraj module in Amber (eq 4.4). 
The free energy calculations were performed on both the B- and Z-DNA conformations of 
the unmodified and C8-arylguanine modified hairpin oligonucleotides and by subtracting free 
energy of the Z-DNA conformation (ΔGGB_Z) from the free energy of the B-DNA conformation 
(ΔGGB_B) to yield ΔΔGGB_B-Z.  This term can be used to compare the conformational effects of the 
C8-arylguanine modification of the relative stabilities of the B and Z forms of the hairpin 
oligonucleotides as well as to compare the unmodified hairpin to the modified hairpins.  Tables 
4.5 and 4.6 show the individual components used to derive the free energies of the B and Z forms 
of the hairpins, respectively.  Table 4.7 displays the difference between free energies of the B and 
Z forms as determined by the GB model. 
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Table 4.5.  Free Energies of the Unmodified and C8-Arylguanine Modified Hairpin 
Oligonucleotides Calculated by the MM/GBSA Model in the B-DNA Conformation.a 
  CG CG8Ph CG8Tol CG8HMPh CG8MMPh CG8CPh 
BOND 204.21 207.88 207.32 208.65 209.74 212.93 
ANGLE 407.94 417.22 418.15 416.09 520.08 667.46 
DIHED 517.45 515.22 522.31 518.06 461.68 626.67 
VDWAALS -406.76 -411.85 -412.99 -410.95 -392.06 -387.80 
EEL 4141.28 4116.06 4116.74 4088.99 4237.49 4710.80 
1-4 VDW 200.40 204.37 205.78 203.84 223.87 212.90 
1-4 EEL -3738.43 -3733.08 -3745.09 -3705.05 -3883.96 -3794.14 
EGB -6514.73 -6484.90 -6487.88 -6370.77 -6512.15 -7130.71 
ESURF 31.36 31.93 31.94 31.96 32.55 32.68 
GGAS 1326.09 1315.81 1312.22 1319.64 1376.86 2248.82 
GSOLV -6483.37 -6452.97 -6455.94 -6338.81 -6479.60 -7098.03 
GBTOT -5157.28 -5137.16 -5143.72 -5019.18 -5102.74 -4849.22 
TSTRA 15.65 15.66 15.66 15.66 15.66 15.66 
TSROT 15.52 15.52 15.54 15.50 15.55 15.53 
TSVIB 374.80 323.62 515.12 608.18 378.59 389.58 
TSTOT 405.96 354.79 546.31 639.34 409.80 420.77 
ΔGGB_B -5563.24 -5491.51 -5690.03 -5536.66 -5511.26 -5269.99 
aEnergy values are in kcal/mol. 
 
160 
 
 
 
 
Table 4.6.  Free Energies of the Unmodified and C8-Arylguanine Modified Hairpin 
Oligonucleotides Calculated by the MM/GBSA Model in the Z-DNA Conformation.a 
  CG CG8Ph CG8Tol CG8HMPh CG8MMPh CG8CPh 
BOND 205.94 208.92 208.43 209.27 210.61 213.63 
ANGLE 406.68 410.42 408.32 409.83 509.00 656.48 
DIHED 529.59 535.47 543.20 537.58 505.26 660.52 
VDWAALS -431.51 -431.53 -430.42 -438.99 -413.10 -402.15 
EEL 5054.74 5043.57 4974.77 4933.27 4749.82 5019.31 
1-4 VDW 198.58 203.09 203.69 203.38 223.51 216.06 
1-4 EEL -3724.13 -3709.81 -3721.08 -3678.08 -3855.23 -3758.74 
EGB -7408.49 -7404.92 -7340.81 -7199.06 -7026.43 -7460.05 
ESURF 30.19 30.96 31.09 31.09 31.54 32.11 
GGAS 2239.91 2260.14 2186.90 2176.24 1929.88 2605.12 
GSOLV -7378.30 -7373.96 -7309.72 -7167.97 -6994.89 -7427.94 
GBTOT -5138.39 -5113.82 -5122.82 -4991.73 -5065.01 -4822.82 
TSTRA 15.65 15.66 15.66 15.66 15.66 15.66 
TSROT 15.47 15.48 15.49 15.50 15.55 15.53 
TSVIB 419.09 653.09 674.87 673.31 689.06 704.80 
TSTOT 450.20 684.22 706.01 704.47 720.27 735.98 
ΔGGB_Z -5588.59 -5798.04 -5828.83 -5696.19 -5785.28 -5558.80 
aEnergy values are in kcal/mol. 
 
Table 4.7.  Free Energy Difference between the B- and Z-DNA Conformations for the 
Unmodified and Modified Hairpins.a,b 
  CG CG8Ph CG8Tol CG8HMPh CG8MMPh CG8CPh 
ΔΔGGB_B-Z -18.89 -23.34 -20.90 -27.45 -37.73 -26.40 
aDetermined from ΔGGB_B - ΔGGB_Z.  bEnergy values are in kcal/mol. 
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The ΔΔGGB_B-Z values demonstrate whether the B or Z form is energetically more 
favorable, however from inspection Table 4.7 all the hairpin forms prefer the Z form since all the 
ΔΔGGB_B-Z values are negative.  This result does not agree with the CD and NMR experimental 
results since the unmodified HP-CG should prefer the B-DNA conformation.  This may be a ‘zero’ 
point issue and if the value for the unmodified hairpin were normalized to reflect the experimental 
results where the B form is preferred then the other C8-arylguanine modified hairpins are in the 
right direction.  However the rank order as predicted by the MM/GBSA are not in agreement with 
the experimental results.  The MM/GBSA method predicts the free energies of the modified hairpin 
series to be HP-CG8MMPh < HP-CG8HMPh < HP-CG8CPh < HP-CG8Ph < HP-CG8Tol.  The energy value 
determined for the HP-CG8MMPh is too negative in comparison to the other C8-arylguanine 
modifications, which may be the result of the overall system not being in equilibrium at the end of 
the simulations.  The individual components used to derive the free energies of HP-CG8MMPh and 
HP-CG8CPh often show differences relative to the other C8-arylguanine derivatives which suggests 
a systematic error, however the HP-CG8HMPh also shows differences from the relative trends 
several values such as 1-4 EEL, EGB, GSOLV and GBTOT.   
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Chapter 5:  Discussions and Conclusions 
 
Several DNA modifications, specifically C8-substituted guanines, have been previously 
shown to alter the B-/Z-DNA equilibrium including C8-bromoguanine,130,175 C8-
methylguanine,157,158 and C8-arylguanine.98,100  Our research focuses on C8-arylguanine 
modifications derived from carcinogenic arylhydrazines.90,176  These compounds are part of an 
important class of carcinogens that have a large potential for human exposure and produce DNA 
adducts.83,177  Although it is known that arylhydrazines generate DNA adducts in vivo,91,92 it is 
unclear how DNA adduct formation is related to their carcinogenicity.83  Recent research in our 
laboratory group has demonstrated that the incorporation of several different C8-arylguanine 
modifications drive the B-/Z-DNA equilibrium toward the Z-DNA conformation at or near 
physiological conditions.  Therefore it may be possible that arylhydrazine DNA adducts may 
confer their carcinogenicity through a Z-DNA mediated mechanism. 
Our previous studies investigated, first, the C8-phenylguanine modification,98 derived from 
the metabolism/bioactivation of phenylhydrazine, and subsequent studies examined 
C8-phenylguanine modifications with various para-substituents, also derived from known 
carcinogenic arylhydrazines.100  These studies incorporated the C8-arylguanine modifications into 
(CG)5 decamer sequences (d(CGCGCG*CGCG))2 where G* is the C8-arylguanine modified base.  
The palindromic nature of these sequences produces two base modifications in the oligonucleotide 
double helix that are in consecutive base steps.  In this system, it is unclear if the conformational 
effects of the C8-arylguanine modifications were due to the modifications acting independently or 
in combination (additive or synergistic).  Further the biological significance of our previous results 
are questionable since it is highly unlikely for two C8-arylguanine modifications to occur in 
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successive base pairs, one on each strand, in vivo.  The work presented here sought to determine 
if the conformations effects of this modification are similar or significantly diminished if only a 
single C8-arylguanine adduct is present.  To address this question, a hairpin oligonucleotide 
(d(CG)5T4(CG)5) containing an intramolecular (CG)5 duplex was synthesized permitting the 
incorporation of only one C8-arylguanine modification.   
The single C8-arylguanine modified hairpin oligonucleotides were prepared by first 
synthesizing the C8-aryl-2’-deoxyguanosine modified phosphoramidite and then incorporating the 
modified phosphoramidite into the hairpin sequence.  The synthetic hairpin products require 
purification (FPLC) and confirmation (ESI-MS) before conformational analysis by CD and NMR.  
The hairpin oligonucleotides were also analyzed using computational methods to help interpret the 
experimental results.  A thorough discussion of the results obtained with the single modified 
hairpins as well as comparison to the doubly modified double-stranded oligonucleotides will be 
presented here. 
 
A. Single C8-Arylguanine Modified Hairpin Synthesis 
The synthetic procedure used to synthesize the C8-arylguanine modified hairpins requires 
the synthesis of the C8-aryl-2’-doexyguanosine phosphoramidite since they are not commercially 
available.  In general, the synthetic procedure used here followed the work by Vongsutilers et al.125 
which provides for a broad range of conditions that can accommodate several different para-
substituted C8-aryl-2’-deoxyguanosine analogs.  Most of the starting materials in the synthetic 
procedure are commercially available with the exception of 4-(TBS-O-methyl)-phenyl boronic 
acid however the work of Zheng et al.160 and Vongsutilers167 provided protocols for synthetic 
procedures of the C8-hydroxymethylphenyl-2’-deoxyguanosine derivative.  All the reactions en 
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route the C8-aryl-2’-deoxyguanosine phosphoramidites provided acceptable yields which led to 
successful incorporation of the C8-arylguanine modified base into the hairpin oligonucleotide 
sequence.   
The synthetic scheme (Scheme 2.1) begins with the Suzuki coupling reaction from 
8-bromo-2’-deoxyguanosine and the appropriate arylboronic acid.  Table 5.1 summarizes the 
synthetic yields of the various C8-aryl-2’-deoxyguanosine coupling and subsequent protection 
reactions.  The next step of the synthetic procedure converts the exocylic amine to a 
dimethylformamidine.  Table 5.1 demonstrates that the first two steps in the synthetic scheme 
produce good yields and further the 1H NMR spectrum of these products showed they do not 
require purification.  In the case of the NH2-protection reaction the excess DMF leftover from the 
reaction does not interfere with the 5’-OH tritylation reaction and therefore purification is not 
necessary.  However the crude product from the tritylation reaction does require purification before 
use in the phosphitylation reaction.   
 
 
Table 5.1.  Synthetic Yields of the C8-Aryl-2’-deoxyguanosine Analogs and Protection 
Reactions. 
  Yield (%) 
C8-Aryl-2'-deoxguanosine Suzuki 
Coupling 
Dimethylformamidine 5'-OH 
Tritylation Modification Protection 
8-Phenyl 96.9 94.0 50.0 
8-Tolyl 92.0 96.3 48.5 
8-Hydroxymethylphenyl 74.9 84.6 39.3 
8-Methoxymethylphenyl 91.5 95.2 53.5 
8-Carboxyphenyl 92.0 93.5 67.8 
*Synthetic conditions from in Scheme 2.1 and described in Chapter 3, Parm temp I, A.2. 
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Unlike the yields of the previous reactions, the yields from the tritylation reaction were 
relatively low (39.3 – 67.8 %), which is probably the result of several factors including product 
degradation, additional side reactions and sample loss during chromatography.  Since the 
glycosidic bond is more prone to acid cleavage after the addition of the aryl substituent to the C8 
position of guanine relative to the unmodified 2’-deoxyguanosine, sample degradation is likely 
even though basic alumina was used in the column chromatography over the conventional silica 
stationary phase.  Further the DMTr functional group itself is also an acid labile functional group 
which can also be degraded during synthesis and/or column purification. 
The final step in the synthetic scheme functionalizes the 3’-hydroxyl into the 
phosphoramidite used in DNA synthesis.  The method established by Vongsutilers et al.125 was 
used to produce the modified C8-aryl-2’-deoxyguanosine phosphoramidites in sufficient quantity 
and purity to make the C8-arylguanine modified hairpin oligonucleotides.  While the modified 
phosphoramidites can be purified as with the tritylated products, this does not seem to be necessary 
as the crude phosphoramidites can be used for effective DNA synthesis as demonstrated by ESI-
MS.  The tradeoff between purity versus quantity favors having more phosphoramidite material 
because our DNA synthesis procedure uses nearly twice the phosphoramidite used in the standard 
DNA coupling reaction, which already uses an excess of phosphoramidite to ensure effective 
coupling.  1H NMR analysis can be used as a quick check of the crude phosphoramidite material, 
however the 1H NMR spectrum becomes significantly more complicated with the addition of the 
3’-phosphoramidite functional group and the water sensitive nature of this compound makes it 
difficult to acquire a suitable spectrum.  In the method used here, the phosphitylation reaction was 
monitored by TLC versus a standard of pure DMTr-protected starting material, where the 
disappearance of the DMTr spot indicated the reaction was complete.  In addition, during the 
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solvent removal of the reaction material on the Rotaevap if the crude material produced a solid, 
crystalline like material, versus a gelatinous material, then the reaction was assumed to be 
successful.  This assumption was reinforced based on the knowledge that each time the crystalline 
material was used in DNA coupling reaction successful C8-arylguanine modified hairpin synthesis 
resulted (i.e. the major DNA synthesis product was the full-length 24-mer sequence) as 
demonstrated by FPLC.  
The C8-arylguanine phosphoramidites display an unfortunate characteristic with regard to 
DNA synthesis because they do not have the same solubility as unmodified phosphoramidites in 
ACN, which is the solvent used in DNA synthesis.  The C8-arylguanine modified 
phosphoramidites precipitate out of solution shortly after dissolution with ACN into gel-like 
material, and we hypothesize that this may be due to G-quartet formation.  In general, G-quartet 
formation requires the presence of cations to stabilize the G-quartet structure, however there has 
been at least one report that has demonstrated G-quartets without a metal cation.178  Regardless of 
the cause and the composition of the gelatinous material, this material is no longer sufficient for 
use in DNA synthesis.   Therefore the C8-arylguanine modified phosphoramidites were manual 
coupled to the growing hairpin oligonucleotide chain. 
Initial hairpin oligonucleotide synthesis was largely unsuccessful (Figure 5.1A).  
Originally in the manual coupling of the C8-arylguanine modified phosphoramidite, the solid 
phosphoramidite was dissolved with ACN and then mixed with activator before being introduced 
into the CPG synthetic column.  This procedure mainly resulted in the production of the 18-mer 
product rather than the full-length 24-mer hairpin sequence (> 80 %).  This result can be explained 
since the activated phosphoramidite is extremely sensitive water and therefore when the already 
highly reactive phosphoramidite is exposed to an open atmosphere, the C8-arylguanine 
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phosphoramidite may be inactivated toward DNA coupling before introduction into the CPG DNA 
column.  However when the coupling procedure was adapted to better match the protocol used by 
the DNA synthesizer,137 more successful C8-arylguanine hairpin oligonucleotide products ( > 80 
%) were achieved (Figure 5.1B).  As described in the experimental section, the dissolved modified 
phosphoramidite was delivered to the CPG column at nearly the same time as the activator 
solution, which enhances the coupling reaction.  Further rather than mixing and letting the 
activated phosphoramidite solution sit and react in the CPG column, the activated phosphoramidite 
was repeatedly mixed through the CPG column which helped to bring fresh C8-arylguanine 
phosphoramidite to the site of reaction.   
 
 
 
 
 
 
 
  
A) B) 
Figure 5.1.  FPLC chromatograms of A) failed HP-CG8Ph synthesis and B) successful HP-CG8Ph synthesis.  
Failed syntheses resulted in the major product as the 18-mer sequence and successful syntheses produced the 
full-length 24-mer sequence.   
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Since the manual coupling procedure is not 100% percent efficient and incomplete 
extension as well as decomposition may occur during hairpin oligonucleotide synthesis, the hairpin 
oligonucleotide products require FPLC purification before the conformational analysis 
experiments.  Initial DNA synthesis products demonstrated that there are several incomplete 
sequences with the major side product being the incomplete 18-mer sequence where coupling of 
the C8-arylguanine phosphoramidite was unsuccessful.  The main objective of the FPLC 
purification was purify out all hairpin oligonucleotide products that were not the full-length 24-mer 
sequence and then check to make sure that the purification run was successful by confirming the 
purification product was a single molecular species.  After ESI-MS successfully confirmed the 
unmodified and C8-arylguanine modified hairpin oligonucleotide products then the post-
purification analysis used the aliquots of ESI-MS confirmed hairpin oligonucleotides as internal 
standards to confirm the purified synthetic product. 
All five C8-arylguanine modified hairpin oligonucleotides were prepared successfully 
using a standardized approach.100  The modified hairpins were obtained in relatively low yield 
when compared to the unmodified hairpin, which is likely due to the susceptibility of the glycosidic 
bond of the C8-arylguanine modified base to acid cleavage that may occur during the detritylation 
step in DNA synthesis subsequent to the addition of the C8-aryl modification.  Since DNA 
synthesis is performed in the 3’ to the 5’ direction, locating the C8-arylguanine modification closer 
to the 5’ end of the hairpin minimizes this problem.  FPLC and ESI-MS confirmed that the 
synthetic products were sufficiently pure before structural and conformational analysis by CD and 
NMR. 
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B. CD Analysis and Mole Fraction Calculations 
 
CD analysis can be used to determine the global conformation of the hairpin 
oligonucleotides.  By acquiring CD over a range of salt concentrations the conformational effects 
of the C8-arylguanine modification(s) on the B-/Z-DNA equilibrium can be evaluated.  CD 
analysis demonstrated that the presence of a single C8-arylguanine modification will shift the 
B-/Z-DNA equilibrium toward the Z-DNA conformation.  Initial experiments at a single 
temperature (37 °C) can be used to qualitatively examine the salt concentration where the single 
C8-arylguanine modified hairpins transition from B- to Z-DNA relative to the unmodified hairpin.  
However the CD experiments acquired over a range of salt concentrations and temperature can 
also be used to quantitatively determine the conformational effects on the B-/Z-DNA equilibrium 
and calculating the mole fractions of the B-, Z-, and ss-DNA in solution.  The mole fraction data 
can be used to determine the transition concentration (Tc), the transition free energy (ΔGt) and the 
thermodynamic parameters (ΔG, ΔH, and ΔS) which can be used to more accurately compare the 
conformational effects of the single C8-arylguanine modification relative to the unmodified 
hairpin as well as to our previously studied doubly modified double-stranded oligonucleotides.   
There have been many studies that have examined hairpin stability as a function of loop 
composition or size.  Loops of four-to-five bases were found to yield the most stable hairpins and 
did not significantly affect the B-/Z-DNA equilibrium.  In addition, Xodo et al. compared TM, ΔH, 
ΔS and ΔG of the B- and Z-DNA forms of hairpins with loop sizes of two, three, and four 
thymidines and CG palindromic stems (d(CG)nTn(CG)n).  They determined that the B and Z forms 
were most similar to the double-stranded CG counterpart when the loop contained four thymidines.  
Furthermore, a loop with four thymidines does not appear to alter the conformation of the 
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double-stranded portion as compared to the same sequence but lacking the loop (e.g., (d(CG)n)2 
vs. d(CG)nT4(CG)n)).
118,120  Therefore the loop should not bias the system and should closely 
resemble the previously studied double-stranded oligonucleotides.114,116,117,119,121 
The unmodified hairpin and double-stranded oligonucleotides were found to be quite 
similar with respect to the effect on the B-/Z-DNA equilibrium as demonstrated by the similar 
transition concentrations and free energies (Table 1).  Both unmodified oligonucleotides required 
approximately 3 M NaCl to obtain B-/Z-DNA ratio of one and their free energies differed by only 
0.3 kcal/mol, which further demonstrates that the modified hairpins can be used to compare the 
conformational effects of the one or two C8-arylguanine bases.  The relative enthalpic and entropic 
contributions to the free energy do differ and both terms for the hairpin were reduced four- to 
five-fold relative to the double-stranded system.  A difference in entropy between the two systems 
is expected since the hairpin loop holds the two strands of the double-stranded stem in close 
proximity.  The entropy effect is offset by the more positive enthalpy of the hairpin system 
resulting in the net effect of similar free energies.   
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Substitution of the C8-guanine position has been shown to reduce the salt concentration 
required to obtain a 1:1 B-:Z-DNA ratio.  Examples include C8-bromoguanine,130,175 C8-
methylguanine,157,158 and C8-arylguanine98,179 containing oligonucleotides.  Consistent with these 
results we find that the presence of only one C8-arylguanine modified base in the hairpin 
oligonucleotides reduces the transition concentration (Tc) approximately four-fold relative to the 
unmodified hairpin with the specific transition concentration being dependent upon the identity of 
Table 5.2.  Transition and Thermodynamic Parameters for the B/Z-DNA Equilibrium of 
Unmodified and Modified Double-Stranded and Hairpin Oligonucleotides. 
 
Oligonucleotide Form 
Transition 
Concentration  
(mM NaCl)a 
ΔGtb ΔGc ΔHc ΔSc 
CG 
ds 3180 14.4 1.1 -11.6 -42.3 
hp 2978 18.4 1.4 -2.1 -11.4 
CG8Tol 
ds 926 9.1 -1.41 -30.6 -97.9 
hp 708 10.9 -0.52 -8.08 -25.4 
CG8HMPh 
ds 710 9.5 -1.72 -27.8 -87.5 
hp 744 11.1 -0.5 -6.07 -18.7 
CG8MMPh 
ds 675 8.5 -1.96 -29.9 -93.8 
hp 730 10.0 -0.6 -7.63 -23.6 
CG8Ph 
ds 585 7.0 -2.13 -29.9 -93.2 
hp 822 12.7 -0.58 -6.99 -21.5 
CG8CPh 
ds 121 4.0 -1.98 -14.8 -42.9 
hp 621 9.9 -0.92 -7.30 -21.4 
aDetermined from plots of ln(Kobs) vs ln[NaCl] (mM). Similar values were determined by interpolation of 
the mole fraction data obtained by CD (see experimental).  bCalculated for T = 310 K, KB/Z = 1.  
cThermodynamic parameters were calculated from data obtained on oligonucleotide solutions (25 µM) 
dissolved in sodium phosphate (10 mM, pH 7.0) and NaCl (1000 mM (modified hairpins) and 2000 mM 
(unmodified hairpin)) at 298 K (25 oC).  ΔG, ΔGt, and ΔH are in kcal mol-1 K-1, ΔS is in cal mol-1 K-1.  
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the para-substituent on the C8-aryl group.  At the same time the data in Table 1 indicate there are 
some differences between the C8-arylguanine modified hairpins and double-stranded (CG)5 
oligonucleotides.  The rank-order for the hairpin oligonucleotides with respect to the Tc is 
C8-carboxyphenyl- (HP-CG8CPh) > C8-tolyl- (HP-CG8Tol) > C8-methoxymethylphenyl- 
(HP-CG8MMPh) ~ C8-hydroxymethylphenyl- (HP-CG8HMPh) > C8-phenylguanine (HP-CG8Ph).  
This order differs from the double-stranded as the G8Tol and G8Ph are reversed.  In addition, the 
G8CPh in the hairpin system does not shift the B-/Z-DNA equilibrium toward the Z-DNA 
conformation to the same extent as in the double stranded system (Tc = 659 mM NaCl for the 
hairpin and 121 mM NaCl for the double-stranded oligonucleotide).  The dramatic conformational 
effect in the double modified oligonucleotides can be ascribed to the close proximity of the 
negatively charged carboxy groups to the phosphate backbone in the B form179 as well as the 
energy compensation of this hydrophilic group interacting with the solvent in the Z form.158  
Regardless, on average, the doubly modified oligonucleotides require 600 mM NaCl concentration 
for a 1:1 B-/Z-DNA ratio while for the hairpins the value is quite similar (760 mM NaCl).  The 
lower number for the double-stranded system is driven largely by the Tc of the G
8CPh derivative.  
If the data for the G8CPh modified oligonucleotides were not included then the average Tc for the 
two systems are nearly identical (Tc = 751 mM NaCl for the hairpins and 724 mM NaCl for the 
double-stranded oligonucleotides).  Overall, the similarity in the transition concentrations indicate 
that the conformational effect of the C8-aryl modification is largely independent of whether there 
are one or two modified bases.  
The TM trends seen in the single modified hairpin oligonucleotides were similar as the 
trends for the doubly modified double-stranded oligonucleotides with the main exception that the 
TM is much higher for the hairpin oligonucleotides relative to the double-stranded oligonucleotides 
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which was based on previous reports with hairpin oligonucleotides.114,118,121  Comparison of the 
TM between unmodified and modified hairpin oligonucleotides provides some insight as to why 
the C8-arylguanine modification causes a shift in the B-/Z-DNA equilibrium.  Table 2 lists, for 
each of the indicated salt concentrations, the difference in the TM between the unmodified and C8-
arylguanine modified hairpins.  At low salt concentrations where the B form is predominant (25–
250 mM NaCl), the modified hairpins have a TM that are 4-16 °C lower than the unmodified 
hairpin.  At salt concentrations where the Z form is predominant (1000–4000 mM NaCl), the 
difference is small (1–3 °C).  The data suggest that in the modified oligonucleotides, the C8-
arylguanine modified base is responsible for destabilization of the B form but not the Z form.179  
The molecular modeling results suggest that there is some perturbation in structure where the 
modified hairpins show increased RIS and decreased TWT (local unwinding) to accommodate the 
changes in INC at the modified base-step.  These changes are likely due to steric interactions in 
the B form which are non-existent in the Z form.  The only penalty the Z form should experience 
is the unfavorable interaction between water and the C8-aryl group that is fully exposed outside 
the DNA helix in the Z form.   
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In our previous research, the conformational effects of the C8-arylguanine modifications 
on the B-/Z-DNA equilibrium were only evaluated in the presence of NaCl.  However, the effect 
of divalent cations on the B/Z-DNA equilibrium has been reported and is much stronger than that 
of monovalent cations.  For example, poly(dG-dC) requires 2.7 M NaCl to exist as a 1:1 mixture 
of B-/Z-DNA but only 0.7 M MgCl2 is required to achieve the same equilibrium.
13  Similar results 
have been obtained in smaller oligonucleotides (d(CG)13) and hairpins (d(CG)5T4(CG)5) with a 1:1 
B-/Z-DNA ratio at 0.66 M and 0.94 M MgCl2, respectively.
12,13,114  The effect is believed to be, at 
least in part, that Mg2+ and other positively charged species such as spermine are more effective at 
screening the negative charge of the phosphate backbone and thereby stabilize the Z form better 
than monovalent cations.163,180  In addition, the coordination geometry is complementary to the 
arrangement of the phosphate oxygens in DNA when it is in the Z form.  Specifically, Mg2+ ions 
have been demonstrated to coordinate to oxygens of two phosphate residues as well as to the N7 
of guanine.144,181  Spermine is a ubiquitous tetravalent polyamine that has been demonstrated to 
stabilize the Z-DNA conformation.21,163  Spermine is involved in many cellular processes notably 
Table 5.3.  Salt Dependence of the Difference in TM between the Unmodified Hairpin and the 
C8-Arylguanine Modified Hairpins.a 
Hairpin NaCl Concentration (mM) 
 25 50 100 250 500 1000 2000 4000 
CG8Ph 12 12 15 14 7  0  1 3 
CG8Tol 9 12 14 4 4 -1  1 1 
CG8MMPh 8 10 10 4 4 -2  1 1 
CG8HMPh 16 12 14 8 8  2  1 2 
CG8CPh 10 11 15 6 5 -1 -2 1 
aThe values correspond to the difference of the TM of the unmodified hairpin minus 
the TM of the modified hairpin.  The table entries are in oC. 
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in the regulation of transcription and translation as well as nucleic acid structure and stability.182  
Further spermine can alter the gene expression levels and thought to have a role in the MAPK 
pathway.183,184  Thus spermine may have a regulatory role in Z-DNA formation in vivo.  The effect 
of Mg2+ and spermine on the C8-arylguanine modified hairpins with respect to the B-/Z-DNA 
equilibrium is quite profound.  While there is no effect on the unmodified hairpin, the presence of 
Mg2+ and spermine renders the C8-arylguanine modified hairpin oligonucleotides stable in the Z 
form under physiological conditions (2 mM MgCl2, 10 mM NaCl, 140 mM KCl and 1 mM 
spermine).  To the best of our knowledge this is the first hairpin oligonucleotide stable in the Z-
DNA conformation under physiological conditions. 
 
C. NMR and Molecular Modeling Analysis 
 
The NMR of a hairpin containing a T4 loop with an alternating CG stem (d(CG)2T4(CG)2) 
has been reported.119  NMR of hairpin oligonucleotides in the B- and Z-DNA conformation has 
been previously reported in particular with the sequence used here (d(CG)5T4(CG)5).
121  In these 
reports the main concern was whether the presence of the loop would present an energy barrier to 
the B-/Z-DNA transition.  The chemical shifts of the unmodified and single C8-arylguanine 
modified hairpins were very similar and in qualitative agreement with the previously reported 
chemical shifts, especially for the T4 loop, which indicates the overall conformations are largely 
similar.  The obvious exception is at the C5-C8-aryl-G6 base step, which indicates the 
conformational effects of the C8-arylguanine modification occur locally and do not affect the 
global conformation of the hairpin structure relative to the unmodified hairpin in the B-DNA 
conformation.  As demonstrated by the most representative structures and TM of the Z forms of the 
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hairpin oligonucleotides the C8-arylguanine modification has little to no effect on the hairpin 
structure.  Since the C8-arylguanine modification is outside the DNA helix in the Z-DNA 
conformation, the steric and/or electronic interactions of the C8-arylguanine modification in the B 
form with the phosphate backbone are no longer present and alleviating these unfavorable 
interactions is likely the driving force for Z-DNA formation.   
Previous NMR studies of the doubly modified oligonucleotides found that the C8-aryl 
protons in the B form were shifted upfield, by up to 1.2 ppm, of the free nucleoside while in the Z 
form they were shifted downfield of the corresponding nucleoside (Table 5.4).  This suggested the 
oligonucleotide was in a conformation such that the C8-aromatic ring of the modified base was 
located over the adjacent 5’-cytosine (C5) thereby shielding the aromatic protons (see Figure 5.2B).  
In contrast, in the Z form, the aromatic protons shift downfield which is expected since the 
aromatic group is outside of the helix and cannot be shielded.   
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The chemical shift behavior of the C8-aryl protons of the hairpins in the B form were quite 
different (Table 5.4).  Instead of upfield shifts, the chemical shifts were similar to those of the free 
nucleoside or shifted slightly downfield.  Consequently, the C8-aryl group of the modified base is 
not stacking over the adjacent base.  In addition, unlike in the doubly modified double-stranded 
oligonucleotides where the C8-aryl resonances displayed a typical AA’XX’ pattern characteristic 
of a 1,4-disubstituted benzene ring the C8-arylguanine resonances in the single modified hairpin 
oligonucleotide exhibited at least three distinct chemical shifts (HP-CG8Tol, HP-CG8HMPh and 
Table 5.4.  Chemical Shifts of the C8-Aryl Protons in Double-Stranded and Hairpin 
Oligonucleotides. 
DNA Form Nucleosidea B-DNAb Z-DNAc 
   2/6d 3/5e 2/6 3/5 4 f 2/6 3/5 4 f 
CG8Tol 
ds 
7.53 7.34 
6.28 6.86 - 7.64 7.69 - 
hp 7.52 7.81/7.65 - 7.51 7.57 - 
CG8HMPh 
ds 
7.62g 7.46g 
6.37 7.07 - 7.73 7.76 - 
hp 7.73 7.84/7.67 - 7.66 7.69 - 
CG8MMPh 
ds 
7.47 7.63 
6.38 7.07 - 7.74 7.78 - 
hp 7.77 7.82/7.67 - 7.65 7.69 - 
CG8Ph 
ds 
7.55h 7.64h 
6.35/7.28 7.04/7.32 7.33 7.55 7.65 7.84 
hp 7.53/7.74 7.82/7.68 7.62 7.56 7.68 7.84 
CG8CPh 
ds 
7.80 8.07 
6.72 7.79 - 7.81 8.16 - 
hp 7.83/7.55 8.07/7.64 - 7.72 8.07 - 
aIn dmso-d6.  bAll samples were in 25 mM NaCl and 10 mM sodium phosphate, pD 7.0 at 25 oC.  cMeasured 
on samples that with the addition of 50 mM MgCl2. d2/6 protons are orm tempho to C8-atom of guanine, 
e3/5 protons are meta to C8-atom of guanine, f4 proton is para to C8-atom of guanine. gAs the TBS ether.  
hBoth resonances were multiplets, the downfield resonance integrated to two protons.   
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HP-CG8MMPh) while in the HP-CG8Ph and HP8CPh hairpins all the C8-aryl protons displayed distinct 
resonances.  When the C8-arylguanine modified base has restricted free rotation about the aryl-dG 
bond the ortho and meta protons become magnetically equivalent, which was ascribed to the 
constraints of imposed by the C5 and C8-aryl-G6 stacking interactions.  However this is not the 
case in the single modified hairpin systems since the stacking interactions are less pronounced as 
they are in the double modified system.  Figure 5.2 demonstrates that while the stacking 
interactions between C5-G6 vary between the double and single modified systems, the location and 
geometry of the C8-aryl modification relative to the phosphate backbone is similar, which could 
also impede the free rotation of the C8-aryl moiety based on steric and/or electronic interactions 
when contained in the DNA helix in the B-DNA conformation.   
As in the case of the doubly modified double-stranded oligonucleotides, the protons of C5 
in the hairpin oligonucleotides are upfield shifted (0.24–0.29 ppm) relative to their location in the 
unmodified hairpin.  This upfield shift suggests that the adjacent C5 H5 and H6 protons are located 
under the C8-aryl ring and thereby shielded (see Figure 5.2D).  Both of these results are in 
agreement with the molecular modeling results.  Furthermore, this orientation is expected to result 
in NOE correlations between the C8-arylguanine aromatic protons and the H5/6 protons of the C5 
as observed.  Also, it is the NOEs between the H5/6 cytosine protons and the C8-aromatic ring 
protons that allowed the assignment of the aromatic ring protons.  In the Z form the aromatic 
protons of the modified base are shifted downfield relative to the free nucleoside and are nearly 
the same as those in the doubly modified double-stranded oligonucleotides. 
Figure 5.2 displays the C5–G6 base step for both the double-stranded and hairpin 
unmodified CG and modified CG8HMPh oligonucleotides.  The changes in the relative orientation 
between C5 and G6 produced by the G6-C8-aryl group (B and D) can be seen by comparison with 
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the unmodified base step (A and C).  In particular, the differences in SLD and SHF cause G6 to be 
shifted toward the helical axis in the modified double-stranded oligonucleotides, though to a lesser 
extent for the hairpin oligonucleotides.  In turn, the C8-aromatic ring is drawn over and partially 
stacks on C5.  The twist of the aromatic ring attached to G6 is readily apparent.  Finally, unlike the 
B forms, there were few differences seen in the helical parameters of the Z forms for the modified 
C8-arylguanine hairpin oligonucleotides relative to the unmodified hairpin CG (Figure 4.2), which 
is also true for the double-stranded oligonucleotides.  
 
 
Figure 5.2.  Double-stranded and hairpin C5-G6 base step.  The unmodified or modified G6 is shown in gray, its 
base-paired dC in blue, C5 is tan and its base-paired unmodified or modified dG, cyan.  Shown are A) 
unmodified double-stranded CG, B) CG8HMPh modified double-stranded, C) unmodified hairpin CG and D) 
CG8HMPh modified hairpin.  Also shown for the modified duplex and hairpin is the hydroxyl methyl hydrogen 
(yellow) and one of the phosphate oxygens (red) of the modified base. 
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Molecular modeling can also be used to compare the individual helical parameters that 
most affect the oligonucleotide conformation and/or drive Z-DNA formation.  Generally, the 
C8-arylguanine modifications in the doubly modified double-stranded oligonucleotides 
significantly distort the B-DNA conformation.  The major factor ascribed to affect the 
oligonucleotide conformation was the stacking interactions between the C5-G6 as well as the purine 
component of the two modified bases (G6/G16) (Figure 5.2B).  Since this result is not possible in 
the single C8-arylguanine modified hairpin system, there must other factors that drive Z-DNA 
formation, especially in light of the CD results which generally suggest that the Tc for the single 
and double modified oligonucleotides are nearly identical (excluding the G8CPh derivatives).  Table 
5.5 displays the comparison of the helicoidal parameters that had the most significant differences 
between the unmodified and modified oligonucleotides in the B-DNA form. 
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Table 5.5.  Key Helical Parameters of the Most Representative Structure for Unmodified and 
Modified Double-Stranded and Hairpin Oligonucleotides in the B-DNA Conformation. 
    Inter-Base Paira 
    CG CG8Ph CG8Tol CG8HMPh CG8MMPh CG8CPh 
SHFd 
ds 0.67 0.41 0.24 -0.31 -0.12 1.09 
hp  0.75 1.00 0.93 0.74 0.61 -0.07 
SLDd 
ds -1.27 -3.01 -3.57 -2.67 -0.09 1.05 
hp  -0.16 -1.02 -1.74 -1.15 -2.07 -1.43 
RISd 
ds 3.00 4.90 5.33 3.98 3.26 2.94 
hp  3.56 3.20 3.92 3.49 3.79 4.12 
TWTe 
ds 30.9 19.0 16.1 20.5 28.8 25.1 
hp  35.8 29.3 23.7 27.4 29.2 27.9 
  
    Base Pair-Helical Axisb 
    CG CG8Ph CG8Tol CG8HMPh CG8MMPh CG8CPh 
XDPd 
ds -3.56 -8.85 -1.39 -8.97 -0.82 2.24 
hp  0.12 -3.99 -6.75 -4.09 -7.51 -5.71 
YDPd 
ds -1.76 -2.71 -8.65 2.99 -1.93 -3.11 
hp  -1.16 -0.07 0.40 -1.31 -0.09 1.03 
INCe 
ds 15.3 -1.40 -31.0 10.5 6.47 1.36 
hp  -3.95 27.3 24.1 15.4 32.8 27.1 
  
    Groove Widthc (Å) 
Groove   CG CG8Ph CG8Tol CG8HMPh CG8MMPh CG8CPh 
Major 
ds 18.6 24.1 26.9 22.8 18.9 - 
hp  17.8 18.8 20.8 17.6 17.3 17.3 
Minor 
ds 13.7 11.6 10.7 12.9 - - 
hp  11.8 13.0 12.8 12.8 13.2 13.6 
 aValues reported are for the C5/G20–G6/C19 base pair step.  bValues reported are the average of both C5/G20 and 
G6/C19 base pair-axis values.  cValues reported correspond to the average taken over G4–C7/G18–C21.  dValues 
are in units of Å.  eValues are in unites of degrees.   
182 
 
The modified hairpin oligonucleotides yield similar trends as the double-stranded 
oligonucleotides but substantially attenuated at the modified base step (C5–G6).  For example, the 
decrease in the helical twist at the C8-arylguanine modified C5-G6 base step for the doubly 
modified double-stranded oligonucleotides was less than the value for unmodified C5-G6 base step.  
Although the TWT for the C5-G6 base step of all the modified hairpins was less than the value for 
the unmodified C5-G6 base step, there is considerably less variation at the C5-G6 base step in the 
hairpin system.  In addition, the major and minor groove widths were affected more in the doubly 
modified double-stranded oligonucleotides that in the single modified hairpins in comparison to 
the unmodified counterparts.   
 
D. Conclusions 
 
The C8-arylguanine modifications in a double-stranded purine-pyrimidine repeat, one on 
each strand, was previously found to have large changes in the local base pair geometry, especially 
with respect to base pair location relative to the helical axis.  These changes were ascribed to 
stacking interactions and were suggested to be responsible for the shift in the B/Z-DNA 
equilibrium.  In the present case there is only one C8-arylguanine modified base and the 
modification causes only minimal changes in local conformation relative to the unmodified 
hairpin.   Nevertheless, the single modification produces a shift in the B/Z-DNA equilibrium 
similar to the one observed in the doubly modified system.  These results lead us to conclude that 
both single and double C8-arylguanine modifications destabilize the B form that produces a shift 
in the B/Z-DNA equilibrium toward the Z-DNA conformation.  Further, destabilization of the B 
form is largely responsible for the observed conformational preferences.  
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Destabilization of the B-DNA conformation can result in at least two different outcomes 
including adopting an alternative conformation or denaturation to the single-stranded form.  Our 
results show that adopting the Z-DNA conformation is preferred over denaturation under 
physiological salt concentrations.  This result is quite surprising as current dogma states that 
Z-DNA formation requires very high salt concentrations to screen the negative charges along the 
phosphate backbone.  Here, the introduction of a single C8-arylguanine modification is sufficient 
to shift the B/Z-DNA equilibrium because the modification destabilizes the B form.  In addition, 
our results also suggest that the Z form may be more favorable than previously thought and the 
reason that Z-DNA is not observed under physiological conditions is mainly due to the B form 
being much more energetically favorable.   
Our results here have potential biological implications.  It is well documented that Z-DNA 
forming sequences are most commonly found in promoter regions of the human genome where 
Z-DNA formation can regulate transcription and nucleosome positioning.29,41,63,185  Consequently, 
dysregulation in these sequences can lead to unregulated gene transcription.  Furthermore, proteins 
that stabilize the Z-DNA conformation (Z-DNA binding proteins, ZBP) are thought to maintain 
control of transient Z-DNA formation in vivo.  The virulence factor of the vaccinia virus (E3L) is 
believed to escape the host immune response by competing with the endogenous ZBPs (ADAR1 
and DAI).53,54,186,187  In another example, the complex of methyl-CpG-binding protein (MeCP2) 
combined with two members of the nuclear factor 1 transcription factor family (NF1C and NF1X) 
maintain transcriptional suppression of the ADAM-12 gene through binding to a Z-DNA forming 
negative response element.45  Carcinogenic arylhydrazines are known to produce DNA adducts on 
the C8-position of guanine.  In turn, these adducts are predicted to shift the B/Z-DNA equilibrium 
towards the Z-DNA conformer.79,179  Therefore, after exposure to these carcinogenic chemicals, 
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Z-DNA formation may overwhelm the normal cellular response to Z-DNA formation and may 
produce the mutagenic or carcinogenic consequences associated with Z-DNA.31,65  
 
E. Future Directions 
 
Although this work in comparison with our previous results suggest a possible novel 
carcinogenic mechanism from DNA adduct formation, additional in vitro experiments are required 
to further support this hypothesis.  Since the single C8-arylguanine modified hairpin 
oligonucleotides have been shown to adopt the Z-DNA conformation under physiological 
conditions, they should be used to investigate the interactions (protein: DNA interactions) with 
Z-DNA binding proteins (ZBP).  In addition, C8-arylguanine modified oligonucleotides can be 
used as a tool to further investigate the proposed mechanism of the ZBP mediated B-/Z-DNA 
transition. 
The relationship of DNA adduct formation and arylhydrazine carcinogenesis remains 
unclear, however Z-DNA formation may play an intermediary role between DNA adduct 
formation and arylhydrazine carcinogenesis.  Since Z-DNA is thought to play a regulatory role in 
gene expression, the C8-arylguanine modified sequences used here could be further used in a 
reporter gene188 or promoter assays189 to determine if the presence C8-arylguanine modification 
enhances gene expression.  In addition, it may also be possible to utilize the C8-arylguanine 
modifications to induce Z-DNA formation in a similar manner as was used to demonstrate the role 
of Z-DNA formation in negative supercoiling25,190,191 and gene deletions.65,192  Future, in vitro 
studies, will be required to properly ascertain the role of the C8-arylguanine modification in the 
context of Z-DNA formation, even though there have been reports using Z-DNA antibodies32,193 
to determine Z-DNA formation detection in vitro.   
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Another possible use for the C8-arylguanine modified oligonucleotides is for the 
examination of the currently proposed mechanism of the B-/Z-DNA transition induced by ZBPs.  
The current hypothesis suggests that ZBPs, though known to bind Z-DNA with a stronger affinity 
than B-DNA,24 bind B-DNA and actively convert it to the Z-DNA conformation.56  However this 
has not been demonstrated in vivo.  Further, the unmodified oligonucleotide sequences that have 
been studied are resistant to Z-DNA under physiological conditions.  Although ZBPs have been 
investigated with brominated oligonucleotides23,24 or oligonucleotides stabilized by cobalt 
hexamine,194,195 neither of these conditions are considered to be physiologically relevant.   
Preliminary CD data of the ZBP DNA-dependent activator of interferon-regulatory factors 
(DAI) and the unmodified HP-CG and single modified HP-CG8MMPh has been acquired (Figure 
5.5).  The modified HP-CG8MMPh is converted to Z-DNA between a 2:1 and 3:1 ZBP:HP-CG8MMPh 
ratio (10 µM ZBP: 5 µM HP-CG8MMPh to 15 µM ZBP: 5 µM HP-CG8MMPh) whereas the unmodified 
HP-CG requires 50 µM ZBP to transition to the Z-DNA conformation (10:1 ZBP: HP-CG).  The 
CD data suggest the C8-arylguanine does not impede the ZBP binding to the hairpin 
oligonucleotide.  Moreover, the ZBPs may even prefer to bind to the  Z-DNA prone modified 
hairpin oligonucleotides.  CD should be obtained for all the C8-arylguanine modifications with 
both the DAI-α and DAI-β proteins. 
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Since the ZBP DAI-β will bind the C8-arylguanine modified oligonucleotides, the ZBP  
B-/Z-DNA transition mechanism could be further evaluated with either the single or double 
C8-arylguanine modified oligonucleotides, which can be accomplished using surface plasmon 
resonance (SPR).  SPR is an optical technique that can be used to provide equilibrium and kinetic 
information about biomolecular interactions,196,197 which can be specifically used in future studies 
of ZBP: C8-arylguanine modified oligonucleotide interactions.  SPR requires a molecule of 
interest to be immobilized on a thin layer of a metal, typically gold, film.  Then, analyte solutions 
are injected into the flow cell of the SPR instrument and introduced to the immobilized molecule 
where there interactions can be detected.  These SPR experiments could follow previous SPR 
A) B) 
Figure 5.3.  CD spectra with DAI-β in complex with unmodified HP-CG (A) and HP-CG8MMPh (B).  CD was 
obtained with various DAI-β concentrations, 0 µM (black), 5 µM (violet), 10 µM (purple), 15 µM (blue), 20 
µM (green), 30 µM (orange) and 50 µM (red), in complex with oligonucleotide (5 µM).  CD was acquired at 
20 °C in a buffer solutions (pH 7.4) of sodium phosphate (10 mM) and sodium chloride (150 mM).   
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experiments24,198 which have immobilized the oligonucleotide onto the gold film and introduced 
varying concentrations of ZBP.  
The phenomenon of SPR is based on the changes of the refractive index of the gold film, 
which is directly proportional to the amount of mas bound on the surface.  When the ZBP meets 
the immobilized oligonucleotide, the ZBP binds to the oligonucleotide and changes the refractive 
index of the gold film or the SPR signal that can be translated into a response signal in the SPR 
sensorgram.  In general, SPR is a way to detect the mass immobilized on the surface, which will 
change depending on the binding event, and by monitoring the amount of analyte (ZBP) injected 
into the SPR instrument over a period of time followed by a period of time that where only buffer 
solution Kon and Koff can be determined, respectively, which can be used to derive KD (KD = 
Koff/Kon).  Using SPR the ZBP mediate B-/Z-DNA transition can be fully elucidated, because the 
kinetics of ZBP binding to both the B- and Z-DNA conformations under physiological conditions 
(Scheme 5.1). 
 
  
Scheme 5.1.  Novel approach of the ZBP mediated B-/Z-DNA transition using C8-arylguanine modified 
oligonucleotides.  Using the C8-arylguanine modified oligonucleotides, the ZBP kinetics of binding to both B- 
and Z-DNA can be determined. 
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APPENDIX A:  Abbreviations 
 
 
Chemicals Experimental
 
8-BrdG, 8-bromo-
2’-deoxyguanosine 
4-CPhBA, 4-carboxyphenyl 
boronic acid 
4-MMPhBA, 4-
methoxymethyphenyl boronic 
acid 
ACN, Acetonitrile 
CEDCIP, 2-cyanoethyl 
diisopropylchloro-
phosphoramidite 
CE-PA, cyanoethyl 
phosphoramidites 
dG, 2’-deoxyguanosine 
D2O, deuterium oxide 
DEME, diethylaminoethyl 
dG, 2’-deoxyguanosine 
DMF, dimethylformamidine 
DMTr-Cl, 4,4’-dimethoxytrityl 
chloride 
LAH, lithium aluminum 
hydride 
NBS, N-bromosuccinimide 
Pd(OAc)2, palladium acetate 
TBS, tert-butyldimethylsilyl 
TCA, Trichloroacetic acid 
THF, tetrahydrofuran  
TEA, triethylamine 
TEAA, triethylammonium 
acetate 
TMS, tetramethylsilane 
TPPTS, Tris-(3-
sulfantophenyl)phosphine 
 
1D, one dimension 
2D, two dimensions 
COSY, correlation 
spectroscopy 
CI, chemical ionization 
CPG, controlled pore 
glass 
EI, electron ionization 
ESI, electrospray 
ionization 
FPLC, fast protein liquid 
chromatography 
gCOSY, gradient 
correlation spectroscopy 
HPLC, high performance 
liquid chromatography 
MD, molecular dynamics 
MM, molecular 
mechanics 
MS, mass spectrometry 
MW, molecular weight 
m/z , mass to charge ratio 
NMR, nuclear magnetic 
resonance spectroscopy 
NOE, nuclear 
Overhauser effect 
NOESY, nuclear 
Overhauser effect 
correlation spectroscopy 
nt, transients 
ppm, parts per million 
R, gas constant 
RF, radio frequency 
RMSd, root mean square 
deviation 
RP-TLC, reverse phase-
thin layer 
chromatography 
SPE, solid phase 
extraction 
TLC, thin layer 
chromatography 
TM, melting temperature 
UV, ultraviolet 
ΔE, energy gap 
ΔG, free energy 
ΔH, enthalpy 
ΔS, entropy 
A¸ Absorbance 
B0, magnetic field 
strength 
fB, mole fraction of 
B-DNA 
fSS, mole fraction of 
ss-DNA 
fZ, mole fraction of Z-
DNA 
h, Planck’s constant 
I, spin number 
J, coupling constant 
v, applied radio 
frequency 
v0, Larmor frequency 
δ, chemical shift  
ε, molar absorptivity/ 
total ellipticity 
Δε, molar ellipticity 
γ, gyromagnetic ratio 
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APPENDIX B:  Chemical Structures 
 
 
1) 8-Bromo-2’-deoxyguanosine 
2) 4-(TBS-O-methyl)-phenyl bromide 
3) 4-(TBS-O-methyl) phenyl boronic acid 
4) 8-phenyl-2’-deoxyguanosine 
5) 8-p-tolyl-2’-deoxyguanosine 
6) 8-(4-(TBS-O-methyl)phenyl)-2’-deoxyguanosine 
7) 8-(4-methoxymethylphenyl)-2’-deoxyguanosine 
8) 8-(4-carboxyphenyl)-2’-deoxyguanosine 
9) N2-(N,N-Dimethylformamidine)-8-phenyl-2’-deoxyguanosine 
10) N2-(N,N-Dimethylformamidine)-8-p-tolyl-2’-deoxyguanosine 
11) N2-(N,N-Dimethylformamidine)-8-(4-(TBS-O-methyl)phenyl-2’-deoxyguanosine 
12) N2-(N,N-Dimethylformamidine)-8-(4-methoxymethylphenyl)-2’-deoxyguanosine 
13) N2-(N,N-Dimethylformamidine)-8-(4-carboxyphenyl)-2’-deoxyguanosine 
14) 5’-O-(4,4’-Dimethoxytrityl)- N2-(N,N-Dimethylformamidine)-8-phenyl-2’-deoxyguanosine 
15) 5’-O-(4,4’-Dimethoxytrityl)- N2-(N,N-Dimethylformamidine)-8-p-tolyl-2’-deoxyguanosine 
16) 5’-O-(4,4’-Dimethoxytrityl)- N2-(N,N-Dimethylformamidine)-8-(4-(TBS-O-methyl)phenyl-
2’-deoxyguanosine 
17) 5’-O-(4,4’-Dimethoxytrityl)- N2-(N,N-Dimethylformamidine)-8-(4-methoxymethylphenyl)-
2’-deoxyguanosine 
18) 5’-O-(4,4’-Dimethoxytrityl)- N2-(N,N-Dimethylformamidine)-8-(4-carboxyphenyl)-2’-
deoxyguanosine 
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19) 3’-O-[2-Cyanoethoxy)(diisopropylamino)phosphine]-5’-O-(4,4’-Dimethoxytrityl)-N2-(N,N-
Dimethylformamidine)-8-phenyl-2’-deoxyguanosine 
20) 3’-O-[2-Cyanoethoxy)(diisopropylamino)phosphine]-5’-O-(4,4’-Dimethoxytrityl)-N2-(N,N-
Dimethylformamidine)-8-p-tolyl-2’-deoxyguanosine 
21) 3’-O-[2-Cyanoethoxy)(diisopropylamino)phosphine]-5’-O-(4,4’-Dimethoxytrityl)-N2-(N,N-
Dimethylformamidine)-8-(4-TBS-O-methyl)phenyl)-2’-deoxyguanosine 
22) 3’-O-[2-Cyanoethoxy)(diisopropylamino)phosphine]-5’-O-(4,4’-Dimethoxytrityl)-N2-(N,N-
Dimethylformamidine)-8-(4-methoxymethylphenyl)-2’-deoxyguanosine 
23) 3’-O-[2-Cyanoethoxy)(diisopropylamino)phosphine]-5’-O-(4,4’-Dimethoxytrityl)-N2-(N,N-
Dimethylformamidine)-8-(4-carboxyphenyl)-2’-deoxyguanosine 
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Compound Formula Molecular Weight 
1) 
 
C10H12O4N5Br 346.14 
2) 
 
C13H21OSiBr 301.30 
3) 
 
C13H23O3SiB 266.22 
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Compound Formula Molecular Weight 
4) 
 
C16H17O4N5 343.34 
5) 
 
C17H19O4N5 357.37 
6) 
 
C23H33O5N5Si 487.63 
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Compound Formula Molecular Weight 
7) 
 
C18H21O5N5 387.40 
8) 
 
C17H17O6N5 387.35 
9) 
 
C19H22O4N6 398.42 
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Compound Formula Molecular Weight 
10) 
 
C20H24O4N6 412.45 
11) 
 
C26H38O5N6Si 542.71 
12) 
 
C21H26O5N6 442.48 
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Compound Formula Molecular Weight 
13) 
 
C20H22O6N6 442.43 
14) 
 
C40H40O6N6 700.81 
15) 
 
C41H42O6N6 714.84 
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Compound Formula Molecular Weight 
16) 
 
C47H56O7N6Si 845.08 
17) 
 
C42H44O7N6 744.85 
18) 
 
C41H40O8N6 744.80 
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Compound Formula Molecular Weight 
19) 
 
C49H57O7N8P 901.03 
20) 
 
C50H59O7N8P 915.06 
21) 
 
C56H73O8N8SiP 1045.30 
213 
 
Compound Formula Molecular Weight 
22) 
 
C51H61O8N8P 945.07 
23) 
 
C50H57O9N8P 945.02 
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Appendix C:  Experimental Spectra and Chromatograms 
 
1H NMR of 8-Bromo-2’-deoxyguanosine (1)  217 
1H NMR of 4-(TBS-O-methyl)-phenyl bromide (2)  218 
1H NMR of 4-(TBS-O-methyl) phenyl boronic acid (3)  219 
1H NMR of 8-phenyl-2’-deoxyguanosine (4)  220 
1H NMR of 8-p-tolyl-2’-deoxyguanosine (5)  221 
1H NMR of 8-(4-(TBS-O-methyl)phenyl)-2’-deoxyguanosine (6)  222 
1H NMR of 8-(4-methoxymethylphenyl)-2’-deoxyguanosine (7)  223 
1H NMR of 8-(4-carboxyphenyl)-2’-deoxyguanosine (8)  224 
1H NMR of N2-(N,N-Dimethylformamidine)-8-phenyl-2’-deoxyguanosine (9)  225 
1H NMR of N2-(N,N-Dimethylformamidine)-8-p-tolyl-2’-deoxyguanosine (10) 226 
1H NMR of N2-(N,N-Dimethylformamidine)-8-(4-(TBS-O-methyl) phenyl-
2’-deoxyguanosine (11)  227 
1H NMR of N2-(N,N-Dimethylformamidine)-8-(4-methoxymethylphenyl)-2’-
deoxyguanosine (12)  228 
1H NMR of N2-(N,N-Dimethylformamidine)-8-(4-carboxyphenyl)- 
2’-deoxyguanosine (13)  229 
1H NMR of 5’-O-(4,4’-Dimethoxytrityl)- N2-(N,N-Dimethylformamidine)- 
8-phenyl-2’-deoxyguanosine (14)  230 
1H NMR of 5’-O-(4,4’-Dimethoxytrityl)- N2-(N,N-Dimethylformamidine)- 
8-p-tolyl-2’-deoxyguanosine (15)  231 
1H NMR of 5’-O-(4,4’-Dimethoxytrityl)- N2-(N,N-Dimethylformamidine)-8-
(4-(TBS-O-methyl)phenyl-2’-deoxyguanosine (16)  232 
1H NMR of 5’-O-(4,4’-Dimethoxytrityl)- N2-(N,N-Dimethylformamidine)-8-
(4-methoxymethylphenyl)-2’-deoxyguanosine (17)  233 
1H NMR of 5’-O-(4,4’-Dimethoxytrityl)- N2-(N,N-Dimethylformamidine)-8-
(4-carboxyphenyl)-2’-deoxyguanosine (18)  234 
FPLC Chromatogram of the HP-CG  235 
FPLC Chromatogram of the HP-CG8Tol  236 
FPLC Chromatogram of the HP-CG8HMPh  237 
FPLC Chromatogram of the HP-CG8MMPh  238 
FPLC Chromatogram of the HP-CG8CPh  239 
MS- Spectrum of HP-CG  240 
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MS- Spectrum of HP-CG8Ph  241 
MS- Spectrum of HP-CG8Tol  242 
MS- Spectrum of HP-CG8HMPh  243 
MS- Spectrum of HP-CG8MMPh  244 
MS- Spectrum of HP-CG8CPh  245 
1H NMR Spectrum of HP-CG in the B-DNA Conformation  246 
1H-1H gCOSY NMR Spectra of HP-CG in the B-DNA Conformation  247 
1H-1H NOESY NMR Spectra of HP-CG in the B-DNA Conformation  248 
1H NMR Spectrum of HP-CG8Ph in the B-DNA Conformation  249 
1H-1H gCOSY NMR Spectra of HP-CG8Ph in the B-DNA Conformation  250 
1H-1H NOESY NMR Spectra of HP-CG8Ph in the B-DNA Conformation  251 
1H NMR Spectrum of HP-CG8Ph in the Z-DNA Conformation  252 
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